id	sid	tid	token	lemma	pos
ajlm-2700	1	1	abstract	abstract	ADJ
ajlm-2700	1	2	introduction	introduction	NOUN
ajlm-2700	1	3	methods	method	NOUN
ajlm-2700	1	4	results	result	VERB
ajlm-2700	1	5	discussion	discussion	NOUN
ajlm-2700	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2700	1	7	references	reference	NOUN
ajlm-2700	1	8	about	about	ADP
ajlm-2700	1	9	the	the	DET
ajlm-2700	1	10	author(s	author(s	NOUN
ajlm-2700	1	11	)	)	PUNCT
ajlm-2700	1	12	nokuthula	nokuthula	PROPN
ajlm-2700	1	13	nhlapo	nhlapo	PROPN
ajlm-2700	1	14	department	department	PROPN
ajlm-2700	1	15	of	of	ADP
ajlm-2700	1	16	chemical	chemical	PROPN
ajlm-2700	1	17	pathology	pathology	PROPN
ajlm-2700	1	18	,	,	PUNCT
ajlm-2700	1	19	faculty	faculty	NOUN
ajlm-2700	1	20	of	of	ADP
ajlm-2700	1	21	health	health	NOUN
ajlm-2700	1	22	sciences	sciences	PROPN
ajlm-2700	1	23	,	,	PUNCT
ajlm-2700	1	24	university	university	NOUN
ajlm-2700	1	25	of	of	ADP
ajlm-2700	1	26	the	the	DET
ajlm-2700	1	27	witwatersrand	witwatersrand	NOUN
ajlm-2700	1	28	,	,	PUNCT
ajlm-2700	1	29	johannesburg	johannesburg	PROPN
ajlm-2700	1	30	,	,	PUNCT
ajlm-2700	1	31	south	south	PROPN
ajlm-2700	1	32	africa	africa	PROPN
ajlm-2700	1	33	doreen	doreen	PROPN
ajlm-2700	1	34	jacob	jacob	PROPN
ajlm-2700	1	35	department	department	PROPN
ajlm-2700	1	36	of	of	ADP
ajlm-2700	1	37	chemical	chemical	PROPN
ajlm-2700	1	38	pathology	pathology	PROPN
ajlm-2700	1	39	,	,	PUNCT
ajlm-2700	1	40	faculty	faculty	NOUN
ajlm-2700	1	41	of	of	ADP
ajlm-2700	1	42	health	health	NOUN
ajlm-2700	1	43	sciences	sciences	PROPN
ajlm-2700	1	44	,	,	PUNCT
ajlm-2700	1	45	university	university	NOUN
ajlm-2700	1	46	of	of	ADP
ajlm-2700	1	47	the	the	DET
ajlm-2700	1	48	witwatersrand	witwatersrand	NOUN
ajlm-2700	1	49	,	,	PUNCT
ajlm-2700	1	50	johannesburg	johannesburg	PROPN
ajlm-2700	1	51	,	,	PUNCT
ajlm-2700	1	52	south	south	PROPN
ajlm-2700	1	53	africa	africa	PROPN
ajlm-2700	1	54	department	department	PROPN
ajlm-2700	1	55	of	of	ADP
ajlm-2700	1	56	chemical	chemical	PROPN
ajlm-2700	1	57	pathology	pathology	PROPN
ajlm-2700	1	58	,	,	PUNCT
ajlm-2700	1	59	national	national	PROPN
ajlm-2700	1	60	health	health	PROPN
ajlm-2700	1	61	laboratory	laboratory	PROPN
ajlm-2700	1	62	service	service	PROPN
ajlm-2700	1	63	,	,	PUNCT
ajlm-2700	1	64	johannesburg	johannesburg	PROPN
ajlm-2700	1	65	,	,	PUNCT
ajlm-2700	1	66	south	south	PROPN
ajlm-2700	1	67	africa	africa	PROPN
ajlm-2700	1	68	siyabonga	siyabonga	PROPN
ajlm-2700	1	69	khoza	khoza	PROPN
ajlm-2700	1	70	department	department	PROPN
ajlm-2700	1	71	of	of	ADP
ajlm-2700	1	72	chemical	chemical	PROPN
ajlm-2700	1	73	pathology	pathology	PROPN
ajlm-2700	1	74	,	,	PUNCT
ajlm-2700	1	75	faculty	faculty	NOUN
ajlm-2700	1	76	of	of	ADP
ajlm-2700	1	77	health	health	NOUN
ajlm-2700	1	78	sciences	sciences	PROPN
ajlm-2700	1	79	,	,	PUNCT
ajlm-2700	1	80	university	university	NOUN
ajlm-2700	1	81	of	of	ADP
ajlm-2700	1	82	the	the	DET
ajlm-2700	1	83	witwatersrand	witwatersrand	NOUN
ajlm-2700	1	84	,	,	PUNCT
ajlm-2700	1	85	johannesburg	johannesburg	PROPN
ajlm-2700	1	86	,	,	PUNCT
ajlm-2700	1	87	south	south	PROPN
ajlm-2700	1	88	africa	africa	PROPN
ajlm-2700	1	89	department	department	PROPN
ajlm-2700	1	90	of	of	ADP
ajlm-2700	1	91	chemical	chemical	PROPN
ajlm-2700	1	92	pathology	pathology	PROPN
ajlm-2700	1	93	,	,	PUNCT
ajlm-2700	1	94	national	national	PROPN
ajlm-2700	1	95	health	health	PROPN
ajlm-2700	1	96	laboratory	laboratory	PROPN
ajlm-2700	1	97	service	service	PROPN
ajlm-2700	1	98	,	,	PUNCT
ajlm-2700	1	99	johannesburg	johannesburg	PROPN
ajlm-2700	1	100	,	,	PUNCT
ajlm-2700	1	101	south	south	PROPN
ajlm-2700	1	102	africa	africa	PROPN
ajlm-2700	1	103	mpho	mpho	PROPN
ajlm-2700	1	104	r.	r.	PROPN
ajlm-2700	1	105	maphayi	maphayi	PROPN
ajlm-2700	1	106	department	department	PROPN
ajlm-2700	1	107	of	of	ADP
ajlm-2700	1	108	chemical	chemical	PROPN
ajlm-2700	1	109	pathology	pathology	PROPN
ajlm-2700	1	110	,	,	PUNCT
ajlm-2700	1	111	faculty	faculty	NOUN
ajlm-2700	1	112	of	of	ADP
ajlm-2700	1	113	health	health	NOUN
ajlm-2700	1	114	sciences	sciences	PROPN
ajlm-2700	1	115	,	,	PUNCT
ajlm-2700	1	116	university	university	NOUN
ajlm-2700	1	117	of	of	ADP
ajlm-2700	1	118	the	the	DET
ajlm-2700	1	119	witwatersrand	witwatersrand	NOUN
ajlm-2700	1	120	,	,	PUNCT
ajlm-2700	1	121	johannesburg	johannesburg	PROPN
ajlm-2700	1	122	,	,	PUNCT
ajlm-2700	1	123	south	south	PROPN
ajlm-2700	1	124	africa	africa	PROPN
ajlm-2700	1	125	department	department	PROPN
ajlm-2700	1	126	of	of	ADP
ajlm-2700	1	127	chemical	chemical	PROPN
ajlm-2700	1	128	pathology	pathology	PROPN
ajlm-2700	1	129	,	,	PUNCT
ajlm-2700	1	130	national	national	PROPN
ajlm-2700	1	131	health	health	PROPN
ajlm-2700	1	132	laboratory	laboratory	PROPN
ajlm-2700	1	133	service	service	PROPN
ajlm-2700	1	134	,	,	PUNCT
ajlm-2700	1	135	johannesburg	johannesburg	PROPN
ajlm-2700	1	136	,	,	PUNCT
ajlm-2700	1	137	south	south	PROPN
ajlm-2700	1	138	africa	africa	PROPN
ajlm-2700	1	139	citation	citation	PROPN
ajlm-2700	1	140	nhlapo	nhlapo	PROPN
ajlm-2700	1	141	n	n	CCONJ
ajlm-2700	1	142	,	,	PUNCT
ajlm-2700	1	143	jacob	jacob	PROPN
ajlm-2700	1	144	d	d	PROPN
ajlm-2700	1	145	,	,	PUNCT
ajlm-2700	1	146	khoza	khoza	PROPN
ajlm-2700	1	147	s	s	PART
ajlm-2700	1	148	,	,	PUNCT
ajlm-2700	1	149	maphayi	maphayi	PROPN
ajlm-2700	1	150	mr	mr	PROPN
ajlm-2700	1	151	.	.	PROPN
ajlm-2700	1	152	comparison	comparison	NOUN
ajlm-2700	1	153	of	of	ADP
ajlm-2700	1	154	second	second	ADJ
ajlm-2700	1	155	and	and	CCONJ
ajlm-2700	1	156	third	third	ADJ
ajlm-2700	1	157	-	-	PUNCT
ajlm-2700	1	158	generation	generation	NOUN
ajlm-2700	1	159	parathyroid	parathyroid	ADJ
ajlm-2700	1	160	hormone	hormone	NOUN
ajlm-2700	1	161	assays	assay	NOUN
ajlm-2700	1	162	at	at	ADP
ajlm-2700	1	163	a	a	DET
ajlm-2700	1	164	tertiary	tertiary	ADJ
ajlm-2700	1	165	hospital	hospital	NOUN
ajlm-2700	1	166	in	in	ADP
ajlm-2700	1	167	south	south	PROPN
ajlm-2700	1	168	africa	africa	PROPN
ajlm-2700	1	169	.	.	PUNCT
ajlm-2700	2	1	afr	afr	PROPN
ajlm-2700	2	2	j	j	PROPN
ajlm-2700	2	3	lab	lab	PROPN
ajlm-2700	2	4	med	med	PROPN
ajlm-2700	2	5	.	.	PUNCT
ajlm-2700	3	1	2025;14(1	2025;14(1	NUM
ajlm-2700	3	2	)	)	PUNCT
ajlm-2700	3	3	,	,	PUNCT
ajlm-2700	3	4	a2700	a2700	NUM
ajlm-2700	3	5	.	.	PUNCT
ajlm-2700	3	6	https://doi.org/10.4102/ajlm.v14i1.2700	https://doi.org/10.4102/ajlm.v14i1.2700	NUM
ajlm-2700	3	7	note	note	VERB
ajlm-2700	3	8	:	:	PUNCT
ajlm-2700	3	9	additional	additional	ADJ
ajlm-2700	3	10	supporting	support	VERB
ajlm-2700	3	11	information	information	NOUN
ajlm-2700	3	12	may	may	AUX
ajlm-2700	3	13	be	be	AUX
ajlm-2700	3	14	found	find	VERB
ajlm-2700	3	15	in	in	ADP
ajlm-2700	3	16	the	the	DET
ajlm-2700	3	17	online	online	ADJ
ajlm-2700	3	18	version	version	NOUN
ajlm-2700	3	19	of	of	ADP
ajlm-2700	3	20	this	this	DET
ajlm-2700	3	21	article	article	NOUN
ajlm-2700	3	22	as	as	ADP
ajlm-2700	3	23	supplementary	supplementary	ADJ
ajlm-2700	3	24	document	document	NOUN
ajlm-2700	3	25	1	1	NUM
ajlm-2700	3	26	.	.	PUNCT
ajlm-2700	3	27	original	original	ADJ
ajlm-2700	3	28	research	research	NOUN
ajlm-2700	3	29	comparison	comparison	NOUN
ajlm-2700	3	30	of	of	ADP
ajlm-2700	3	31	second	second	ADJ
ajlm-2700	3	32	and	and	CCONJ
ajlm-2700	3	33	third	third	ADJ
ajlm-2700	3	34	-	-	PUNCT
ajlm-2700	3	35	generation	generation	NOUN
ajlm-2700	3	36	parathyroid	parathyroid	ADJ
ajlm-2700	3	37	hormone	hormone	NOUN
ajlm-2700	3	38	assays	assay	NOUN
ajlm-2700	3	39	at	at	ADP
ajlm-2700	3	40	a	a	DET
ajlm-2700	3	41	tertiary	tertiary	ADJ
ajlm-2700	3	42	hospital	hospital	NOUN
ajlm-2700	3	43	in	in	ADP
ajlm-2700	3	44	south	south	PROPN
ajlm-2700	3	45	africa	africa	PROPN
ajlm-2700	3	46	nokuthula	nokuthula	PROPN
ajlm-2700	3	47	nhlapo	nhlapo	PROPN
ajlm-2700	3	48	,	,	PUNCT
ajlm-2700	3	49	doreen	doreen	PROPN
ajlm-2700	3	50	jacob	jacob	PROPN
ajlm-2700	3	51	,	,	PUNCT
ajlm-2700	3	52	siyabonga	siyabonga	PROPN
ajlm-2700	3	53	khoza	khoza	PROPN
ajlm-2700	3	54	,	,	PUNCT
ajlm-2700	3	55	mpho	mpho	PROPN
ajlm-2700	3	56	r.	r.	PROPN
ajlm-2700	3	57	maphayi	maphayi	PROPN
ajlm-2700	3	58	received	receive	VERB
ajlm-2700	3	59	:	:	PUNCT
ajlm-2700	3	60	22	22	NUM
ajlm-2700	3	61	nov	nov	PROPN
ajlm-2700	3	62	.	.	PROPN
ajlm-2700	3	63	2024	2024	NUM
ajlm-2700	3	64	;	;	PUNCT
ajlm-2700	3	65	accepted	accept	VERB
ajlm-2700	3	66	:	:	PUNCT
ajlm-2700	3	67	24	24	NUM
ajlm-2700	3	68	june	june	PROPN
ajlm-2700	3	69	2025	2025	NUM
ajlm-2700	3	70	;	;	PUNCT
ajlm-2700	3	71	published	publish	VERB
ajlm-2700	3	72	:	:	PUNCT
ajlm-2700	3	73	30	30	NUM
ajlm-2700	3	74	aug	aug	NOUN
ajlm-2700	3	75	.	.	PROPN
ajlm-2700	3	76	2025	2025	NUM
ajlm-2700	3	77	copyright	copyright	NOUN
ajlm-2700	3	78	:	:	PUNCT
ajlm-2700	4	1	©	©	PROPN
ajlm-2700	4	2	2025	2025	NUM
ajlm-2700	4	3	.	.	PUNCT
ajlm-2700	5	1	the	the	DET
ajlm-2700	5	2	author(s	author(s	PROPN
ajlm-2700	5	3	)	)	PUNCT
ajlm-2700	5	4	.	.	PUNCT
ajlm-2700	6	1	licensee	licensee	NOUN
ajlm-2700	6	2	:	:	PUNCT
ajlm-2700	6	3	aosis	aosis	NOUN
ajlm-2700	6	4	.	.	PUNCT
ajlm-2700	7	1	this	this	PRON
ajlm-2700	7	2	is	be	AUX
ajlm-2700	7	3	an	an	DET
ajlm-2700	7	4	open	open	ADJ
ajlm-2700	7	5	access	access	NOUN
ajlm-2700	7	6	article	article	NOUN
ajlm-2700	7	7	distributed	distribute	VERB
ajlm-2700	7	8	under	under	ADP
ajlm-2700	7	9	the	the	DET
ajlm-2700	7	10	terms	term	NOUN
ajlm-2700	7	11	of	of	ADP
ajlm-2700	7	12	the	the	DET
ajlm-2700	7	13	creative	creative	ADJ
ajlm-2700	7	14	commons	common	NOUN
ajlm-2700	7	15	attribution	attribution	NOUN
ajlm-2700	7	16	license	license	NOUN
ajlm-2700	7	17	,	,	PUNCT
ajlm-2700	7	18	which	which	PRON
ajlm-2700	7	19	permits	permit	VERB
ajlm-2700	7	20	unrestricted	unrestricted	ADJ
ajlm-2700	7	21	use	use	NOUN
ajlm-2700	7	22	,	,	PUNCT
ajlm-2700	7	23	distribution	distribution	NOUN
ajlm-2700	7	24	,	,	PUNCT
ajlm-2700	7	25	and	and	CCONJ
ajlm-2700	7	26	reproduction	reproduction	NOUN
ajlm-2700	7	27	in	in	ADP
ajlm-2700	7	28	any	any	DET
ajlm-2700	7	29	medium	medium	NOUN
ajlm-2700	7	30	,	,	PUNCT
ajlm-2700	7	31	provided	provide	VERB
ajlm-2700	7	32	the	the	DET
ajlm-2700	7	33	original	original	ADJ
ajlm-2700	7	34	work	work	NOUN
ajlm-2700	7	35	is	be	AUX
ajlm-2700	7	36	properly	properly	ADV
ajlm-2700	7	37	cited	cite	VERB
ajlm-2700	7	38	.	.	PUNCT
ajlm-2700	8	1	abstract	abstract	ADJ
ajlm-2700	8	2	background	background	NOUN
ajlm-2700	8	3	:	:	PUNCT
ajlm-2700	8	4	parathyroid	parathyroid	ADJ
ajlm-2700	8	5	hormone	hormone	NOUN
ajlm-2700	8	6	(	(	PUNCT
ajlm-2700	8	7	pth	pth	NOUN
ajlm-2700	8	8	)	)	PUNCT
ajlm-2700	8	9	measurement	measurement	NOUN
ajlm-2700	8	10	is	be	AUX
ajlm-2700	8	11	key	key	ADJ
ajlm-2700	8	12	for	for	ADP
ajlm-2700	8	13	diagnosing	diagnose	VERB
ajlm-2700	8	14	parathyroid	parathyroid	ADJ
ajlm-2700	8	15	disorders	disorder	NOUN
ajlm-2700	8	16	,	,	PUNCT
ajlm-2700	8	17	and	and	CCONJ
ajlm-2700	8	18	for	for	ADP
ajlm-2700	8	19	management	management	NOUN
ajlm-2700	8	20	of	of	ADP
ajlm-2700	8	21	chronic	chronic	ADJ
ajlm-2700	8	22	kidney	kidney	NOUN
ajlm-2700	8	23	disease	disease	NOUN
ajlm-2700	8	24	.	.	PUNCT
ajlm-2700	9	1	available	available	ADJ
ajlm-2700	9	2	pth	pth	NOUN
ajlm-2700	9	3	assays	assay	NOUN
ajlm-2700	9	4	include	include	VERB
ajlm-2700	9	5	second	second	ADJ
ajlm-2700	9	6	(	(	PUNCT
ajlm-2700	9	7	intact	intact	ADJ
ajlm-2700	9	8	pth	pth	NOUN
ajlm-2700	9	9	)	)	PUNCT
ajlm-2700	9	10	and	and	CCONJ
ajlm-2700	9	11	third	third	ADJ
ajlm-2700	9	12	(	(	PUNCT
ajlm-2700	9	13	pth	pth	NOUN
ajlm-2700	9	14	1–84	1–84	NOUN
ajlm-2700	9	15	)	)	PUNCT
ajlm-2700	9	16	generations	generation	NOUN
ajlm-2700	9	17	.	.	PUNCT
ajlm-2700	10	1	data	datum	NOUN
ajlm-2700	10	2	comparing	compare	VERB
ajlm-2700	10	3	interchangeable	interchangeable	ADJ
ajlm-2700	10	4	use	use	NOUN
ajlm-2700	10	5	are	be	AUX
ajlm-2700	10	6	insufficient	insufficient	ADJ
ajlm-2700	10	7	.	.	PUNCT
ajlm-2700	11	1	objective	objective	NOUN
ajlm-2700	11	2	:	:	PUNCT
ajlm-2700	11	3	the	the	DET
ajlm-2700	11	4	objective	objective	NOUN
ajlm-2700	11	5	of	of	ADP
ajlm-2700	11	6	this	this	DET
ajlm-2700	11	7	study	study	NOUN
ajlm-2700	11	8	was	be	AUX
ajlm-2700	11	9	to	to	PART
ajlm-2700	11	10	compare	compare	VERB
ajlm-2700	11	11	intact	intact	ADJ
ajlm-2700	11	12	and	and	CCONJ
ajlm-2700	11	13	1–84	1–84	NOUN
ajlm-2700	11	14	pth	pth	NOUN
ajlm-2700	11	15	assays	assay	NOUN
ajlm-2700	11	16	to	to	PART
ajlm-2700	11	17	determine	determine	VERB
ajlm-2700	11	18	the	the	DET
ajlm-2700	11	19	difference	difference	NOUN
ajlm-2700	11	20	in	in	ADP
ajlm-2700	11	21	analytical	analytical	ADJ
ajlm-2700	11	22	performance	performance	NOUN
ajlm-2700	11	23	and	and	CCONJ
ajlm-2700	11	24	impact	impact	NOUN
ajlm-2700	11	25	on	on	ADP
ajlm-2700	11	26	clinical	clinical	ADJ
ajlm-2700	11	27	interpretation	interpretation	NOUN
ajlm-2700	11	28	.	.	PUNCT
ajlm-2700	12	1	methods	method	NOUN
ajlm-2700	12	2	:	:	PUNCT
ajlm-2700	12	3	a	a	DET
ajlm-2700	12	4	method	method	ADJ
ajlm-2700	12	5	comparison	comparison	NOUN
ajlm-2700	12	6	was	be	AUX
ajlm-2700	12	7	done	do	VERB
ajlm-2700	12	8	on	on	ADP
ajlm-2700	12	9	residual	residual	ADJ
ajlm-2700	12	10	samples	sample	NOUN
ajlm-2700	12	11	with	with	ADP
ajlm-2700	12	12	pth	pth	NOUN
ajlm-2700	12	13	requests	request	NOUN
ajlm-2700	12	14	(	(	PUNCT
ajlm-2700	12	15	06	06	NUM
ajlm-2700	12	16	april	april	PROPN
ajlm-2700	12	17	2022	2022	NUM
ajlm-2700	12	18	–	–	PUNCT
ajlm-2700	12	19	21	21	NUM
ajlm-2700	12	20	september	september	PROPN
ajlm-2700	12	21	2022	2022	NUM
ajlm-2700	12	22	)	)	PUNCT
ajlm-2700	12	23	from	from	ADP
ajlm-2700	12	24	a	a	DET
ajlm-2700	12	25	tertiary	tertiary	ADJ
ajlm-2700	12	26	hospital	hospital	NOUN
ajlm-2700	12	27	in	in	ADP
ajlm-2700	12	28	south	south	PROPN
ajlm-2700	12	29	africa	africa	PROPN
ajlm-2700	12	30	.	.	PUNCT
ajlm-2700	13	1	parathyroid	parathyroid	ADJ
ajlm-2700	13	2	hormone	hormone	NOUN
ajlm-2700	13	3	was	be	AUX
ajlm-2700	13	4	measured	measure	VERB
ajlm-2700	13	5	using	use	VERB
ajlm-2700	13	6	both	both	PRON
ajlm-2700	13	7	intact	intact	ADJ
ajlm-2700	13	8	pth	pth	NOUN
ajlm-2700	13	9	and	and	CCONJ
ajlm-2700	13	10	1–84	1–84	NOUN
ajlm-2700	13	11	pth	pth	NOUN
ajlm-2700	13	12	assays	assay	NOUN
ajlm-2700	13	13	.	.	PUNCT
ajlm-2700	14	1	clinical	clinical	ADJ
ajlm-2700	14	2	performance	performance	NOUN
ajlm-2700	14	3	was	be	AUX
ajlm-2700	14	4	compared	compare	VERB
ajlm-2700	14	5	in	in	ADP
ajlm-2700	14	6	the	the	DET
ajlm-2700	14	7	diagnosis	diagnosis	NOUN
ajlm-2700	14	8	of	of	ADP
ajlm-2700	14	9	hypoand	hypoand	NOUN
ajlm-2700	14	10	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	14	11	,	,	PUNCT
ajlm-2700	14	12	and	and	CCONJ
ajlm-2700	14	13	in	in	ADP
ajlm-2700	14	14	pre	pre	ADJ
ajlm-2700	14	15	-	-	NOUN
ajlm-2700	14	16	dialysis	dialysis	NOUN
ajlm-2700	14	17	and	and	CCONJ
ajlm-2700	14	18	dialysis	dialysis	NOUN
ajlm-2700	14	19	chronic	chronic	ADJ
ajlm-2700	14	20	kidney	kidney	NOUN
ajlm-2700	14	21	disease	disease	NOUN
ajlm-2700	14	22	patients	patient	NOUN
ajlm-2700	14	23	.	.	PUNCT
ajlm-2700	15	1	results	result	NOUN
ajlm-2700	15	2	:	:	PUNCT
ajlm-2700	15	3	among	among	ADP
ajlm-2700	15	4	481	481	NUM
ajlm-2700	15	5	samples	sample	NOUN
ajlm-2700	15	6	,	,	PUNCT
ajlm-2700	15	7	intact	intact	ADJ
ajlm-2700	15	8	pth	pth	NOUN
ajlm-2700	15	9	had	have	AUX
ajlm-2700	15	10	a	a	DET
ajlm-2700	15	11	higher	high	ADJ
ajlm-2700	15	12	median	median	ADJ
ajlm-2700	15	13	concentration	concentration	NOUN
ajlm-2700	15	14	than	than	ADP
ajlm-2700	15	15	pth	pth	NOUN
ajlm-2700	15	16	1–84	1–84	NOUN
ajlm-2700	15	17	(	(	PUNCT
ajlm-2700	15	18	9.85	9.85	NUM
ajlm-2700	15	19	pmol	pmol	NOUN
ajlm-2700	15	20	/	/	SYM
ajlm-2700	15	21	l	l	NOUN
ajlm-2700	15	22	vs.	vs.	ADP
ajlm-2700	15	23	8.51	8.51	NUM
ajlm-2700	15	24	pmol	pmol	X
ajlm-2700	15	25	/	/	SYM
ajlm-2700	15	26	l	l	PROPN
ajlm-2700	15	27	,	,	PUNCT
ajlm-2700	15	28	p	p	X
ajlm-2700	15	29	<	<	X
ajlm-2700	15	30	0.0001	0.0001	NUM
ajlm-2700	15	31	)	)	PUNCT
ajlm-2700	15	32	,	,	PUNCT
ajlm-2700	15	33	but	but	CCONJ
ajlm-2700	15	34	the	the	DET
ajlm-2700	15	35	two	two	NUM
ajlm-2700	15	36	showed	show	VERB
ajlm-2700	15	37	good	good	ADJ
ajlm-2700	15	38	correlation	correlation	NOUN
ajlm-2700	15	39	(	(	PUNCT
ajlm-2700	15	40	r	r	NOUN
ajlm-2700	15	41	=	=	NOUN
ajlm-2700	15	42	0.994	0.994	NUM
ajlm-2700	15	43	,	,	PUNCT
ajlm-2700	15	44	p	p	X
ajlm-2700	15	45	<	<	X
ajlm-2700	15	46	0.0001	0.0001	NUM
ajlm-2700	15	47	)	)	PUNCT
ajlm-2700	15	48	.	.	PUNCT
ajlm-2700	16	1	regression	regression	NOUN
ajlm-2700	16	2	analysis	analysis	NOUN
ajlm-2700	16	3	revealed	reveal	VERB
ajlm-2700	16	4	systematic	systematic	ADJ
ajlm-2700	16	5	(	(	PUNCT
ajlm-2700	16	6	intercept	intercept	NOUN
ajlm-2700	16	7	=	=	SYM
ajlm-2700	16	8	0.887	0.887	NUM
ajlm-2700	16	9	pmol	pmol	NOUN
ajlm-2700	16	10	/	/	SYM
ajlm-2700	16	11	l	l	NOUN
ajlm-2700	17	1	[	[	X
ajlm-2700	17	2	95	95	NUM
ajlm-2700	17	3	%	%	NOUN
ajlm-2700	17	4	confidence	confidence	NOUN
ajlm-2700	17	5	interval	interval	NOUN
ajlm-2700	17	6	:	:	PUNCT
ajlm-2700	17	7	0.788	0.788	NUM
ajlm-2700	17	8	–	–	PUNCT
ajlm-2700	17	9	1.005	1.005	NUM
ajlm-2700	17	10	]	]	PUNCT
ajlm-2700	17	11	)	)	PUNCT
ajlm-2700	17	12	and	and	CCONJ
ajlm-2700	17	13	proportional	proportional	ADJ
ajlm-2700	17	14	differences	difference	NOUN
ajlm-2700	17	15	(	(	PUNCT
ajlm-2700	17	16	slope	slope	NOUN
ajlm-2700	17	17	=	=	NOUN
ajlm-2700	17	18	0.713	0.713	NUM
ajlm-2700	17	19	pmol	pmol	X
ajlm-2700	17	20	/	/	SYM
ajlm-2700	17	21	l	l	NOUN
ajlm-2700	17	22	,	,	PUNCT
ajlm-2700	17	23	[	[	X
ajlm-2700	17	24	95	95	NUM
ajlm-2700	17	25	%	%	NOUN
ajlm-2700	17	26	confidence	confidence	NOUN
ajlm-2700	17	27	interval	interval	NOUN
ajlm-2700	17	28	:	:	PUNCT
ajlm-2700	17	29	0.703	0.703	NUM
ajlm-2700	17	30	–	–	PUNCT
ajlm-2700	17	31	0.723	0.723	NUM
ajlm-2700	17	32	]	]	PUNCT
ajlm-2700	17	33	)	)	PUNCT
ajlm-2700	17	34	,	,	PUNCT
ajlm-2700	17	35	with	with	ADP
ajlm-2700	17	36	increased	increase	VERB
ajlm-2700	17	37	deviations	deviation	NOUN
ajlm-2700	17	38	at	at	ADP
ajlm-2700	17	39	higher	high	ADJ
ajlm-2700	17	40	concentrations	concentration	NOUN
ajlm-2700	17	41	.	.	PUNCT
ajlm-2700	18	1	the	the	DET
ajlm-2700	18	2	average	average	ADJ
ajlm-2700	18	3	bias	bias	NOUN
ajlm-2700	18	4	was	be	AUX
ajlm-2700	18	5	18.5	18.5	NUM
ajlm-2700	18	6	%	%	NOUN
ajlm-2700	18	7	,	,	PUNCT
ajlm-2700	18	8	exceeding	exceed	VERB
ajlm-2700	18	9	allowable	allowable	ADJ
ajlm-2700	18	10	limits	limit	NOUN
ajlm-2700	18	11	.	.	PUNCT
ajlm-2700	19	1	among	among	ADP
ajlm-2700	19	2	the	the	DET
ajlm-2700	19	3	276	276	NUM
ajlm-2700	19	4	patients	patient	NOUN
ajlm-2700	19	5	(	(	PUNCT
ajlm-2700	19	6	170	170	NUM
ajlm-2700	19	7	women	woman	NOUN
ajlm-2700	19	8	,	,	PUNCT
ajlm-2700	19	9	106	106	NUM
ajlm-2700	19	10	men	man	NOUN
ajlm-2700	19	11	,	,	PUNCT
ajlm-2700	19	12	age	age	NOUN
ajlm-2700	19	13	range	range	NOUN
ajlm-2700	19	14	:	:	PUNCT
ajlm-2700	19	15	18–89	18–89	NUM
ajlm-2700	19	16	years	year	NOUN
ajlm-2700	19	17	)	)	PUNCT
ajlm-2700	19	18	included	include	VERB
ajlm-2700	19	19	in	in	ADP
ajlm-2700	19	20	the	the	DET
ajlm-2700	19	21	clinical	clinical	ADJ
ajlm-2700	19	22	study	study	NOUN
ajlm-2700	19	23	,	,	PUNCT
ajlm-2700	19	24	interpretation	interpretation	NOUN
ajlm-2700	19	25	was	be	AUX
ajlm-2700	19	26	unchanged	unchanged	ADJ
ajlm-2700	19	27	.	.	PUNCT
ajlm-2700	20	1	conclusion	conclusion	NOUN
ajlm-2700	20	2	:	:	PUNCT
ajlm-2700	20	3	a	a	DET
ajlm-2700	20	4	bias	bias	NOUN
ajlm-2700	20	5	was	be	AUX
ajlm-2700	20	6	observed	observe	VERB
ajlm-2700	20	7	between	between	ADP
ajlm-2700	20	8	the	the	DET
ajlm-2700	20	9	pth	pth	NOUN
ajlm-2700	20	10	assays	assay	NOUN
ajlm-2700	20	11	,	,	PUNCT
ajlm-2700	20	12	indicating	indicate	VERB
ajlm-2700	20	13	that	that	SCONJ
ajlm-2700	20	14	they	they	PRON
ajlm-2700	20	15	should	should	AUX
ajlm-2700	20	16	not	not	PART
ajlm-2700	20	17	be	be	AUX
ajlm-2700	20	18	used	use	VERB
ajlm-2700	20	19	interchangeably	interchangeably	ADV
ajlm-2700	20	20	.	.	PUNCT
ajlm-2700	21	1	however	however	ADV
ajlm-2700	21	2	,	,	PUNCT
ajlm-2700	21	3	no	no	DET
ajlm-2700	21	4	changes	change	NOUN
ajlm-2700	21	5	in	in	ADP
ajlm-2700	21	6	clinical	clinical	ADJ
ajlm-2700	21	7	interpretation	interpretation	NOUN
ajlm-2700	21	8	were	be	AUX
ajlm-2700	21	9	observed	observe	VERB
ajlm-2700	21	10	when	when	SCONJ
ajlm-2700	21	11	one	one	NUM
ajlm-2700	21	12	assay	assay	NOUN
ajlm-2700	21	13	was	be	AUX
ajlm-2700	21	14	used	use	VERB
ajlm-2700	21	15	over	over	ADP
ajlm-2700	21	16	the	the	DET
ajlm-2700	21	17	other	other	ADJ
ajlm-2700	21	18	.	.	PUNCT
ajlm-2700	22	1	what	what	PRON
ajlm-2700	22	2	this	this	DET
ajlm-2700	22	3	study	study	NOUN
ajlm-2700	22	4	adds	add	VERB
ajlm-2700	22	5	:	:	PUNCT
ajlm-2700	22	6	the	the	DET
ajlm-2700	22	7	study	study	NOUN
ajlm-2700	22	8	confirms	confirm	VERB
ajlm-2700	22	9	the	the	DET
ajlm-2700	22	10	recommendation	recommendation	NOUN
ajlm-2700	22	11	by	by	ADP
ajlm-2700	22	12	kidney	kidney	NOUN
ajlm-2700	22	13	disease	disease	NOUN
ajlm-2700	22	14	:	:	PUNCT
ajlm-2700	22	15	improving	improve	VERB
ajlm-2700	22	16	global	global	ADJ
ajlm-2700	22	17	outcomes	outcome	NOUN
ajlm-2700	22	18	for	for	ADP
ajlm-2700	22	19	the	the	DET
ajlm-2700	22	20	use	use	NOUN
ajlm-2700	22	21	of	of	ADP
ajlm-2700	22	22	assay	assay	NOUN
ajlm-2700	22	23	-	-	PUNCT
ajlm-2700	22	24	specific	specific	ADJ
ajlm-2700	22	25	upper	upper	ADJ
ajlm-2700	22	26	limit	limit	NOUN
ajlm-2700	22	27	of	of	ADP
ajlm-2700	22	28	normal	normal	ADJ
ajlm-2700	22	29	instead	instead	ADV
ajlm-2700	22	30	of	of	ADP
ajlm-2700	22	31	generic	generic	ADJ
ajlm-2700	22	32	cut	cut	NOUN
ajlm-2700	22	33	-	-	PUNCT
ajlm-2700	22	34	off	off	NOUN
ajlm-2700	22	35	in	in	ADP
ajlm-2700	22	36	dialysis	dialysis	NOUN
ajlm-2700	22	37	patients	patient	NOUN
ajlm-2700	22	38	.	.	PUNCT
ajlm-2700	23	1	this	this	DET
ajlm-2700	23	2	study	study	NOUN
ajlm-2700	23	3	further	further	ADJ
ajlm-2700	23	4	highlights	highlight	NOUN
ajlm-2700	23	5	the	the	DET
ajlm-2700	23	6	need	need	NOUN
ajlm-2700	23	7	for	for	ADP
ajlm-2700	23	8	standardisation	standardisation	NOUN
ajlm-2700	23	9	of	of	ADP
ajlm-2700	23	10	pth	pth	NOUN
ajlm-2700	23	11	assays	assay	NOUN
ajlm-2700	23	12	.	.	PUNCT
ajlm-2700	24	1	keywords	keyword	NOUN
ajlm-2700	24	2	:	:	PUNCT
ajlm-2700	24	3	parathyroid	parathyroid	ADJ
ajlm-2700	24	4	hormone	hormone	NOUN
ajlm-2700	24	5	;	;	PUNCT
ajlm-2700	24	6	second	second	ADJ
ajlm-2700	24	7	-	-	PUNCT
ajlm-2700	24	8	generation	generation	NOUN
ajlm-2700	24	9	pth	pth	NOUN
ajlm-2700	24	10	assays	assay	NOUN
ajlm-2700	24	11	(	(	PUNCT
ajlm-2700	24	12	intact	intact	ADJ
ajlm-2700	24	13	pth	pth	NOUN
ajlm-2700	24	14	)	)	PUNCT
ajlm-2700	24	15	;	;	PUNCT
ajlm-2700	24	16	third	third	ADJ
ajlm-2700	24	17	-	-	PUNCT
ajlm-2700	24	18	generation	generation	NOUN
ajlm-2700	24	19	pth	pth	NOUN
ajlm-2700	24	20	assays	assay	NOUN
ajlm-2700	24	21	(	(	PUNCT
ajlm-2700	24	22	pth	pth	NOUN
ajlm-2700	24	23	1–84	1–84	NOUN
ajlm-2700	24	24	)	)	PUNCT
ajlm-2700	24	25	;	;	PUNCT
ajlm-2700	24	26	chronic	chronic	ADJ
ajlm-2700	24	27	kidney	kidney	NOUN
ajlm-2700	24	28	disease	disease	NOUN
ajlm-2700	24	29	;	;	PUNCT
ajlm-2700	24	30	dialysis	dialysis	NOUN
ajlm-2700	24	31	;	;	PUNCT
ajlm-2700	24	32	method	method	PROPN
ajlm-2700	24	33	comparison	comparison	NOUN
ajlm-2700	24	34	;	;	PUNCT
ajlm-2700	24	35	bias	bias	NOUN
ajlm-2700	24	36	,	,	PUNCT
ajlm-2700	24	37	estimated	estimate	VERB
ajlm-2700	24	38	glomerular	glomerular	ADJ
ajlm-2700	24	39	filtration	filtration	NOUN
ajlm-2700	24	40	rate	rate	NOUN
ajlm-2700	24	41	;	;	PUNCT
ajlm-2700	24	42	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	24	43	.	.	PUNCT
ajlm-2700	25	1	introduction	introduction	NOUN
ajlm-2700	25	2	chronic	chronic	ADJ
ajlm-2700	25	3	kidney	kidney	NOUN
ajlm-2700	25	4	disease	disease	NOUN
ajlm-2700	25	5	(	(	PUNCT
ajlm-2700	25	6	ckd	ckd	NOUN
ajlm-2700	25	7	)	)	PUNCT
ajlm-2700	25	8	is	be	AUX
ajlm-2700	25	9	a	a	DET
ajlm-2700	25	10	global	global	ADJ
ajlm-2700	25	11	health	health	NOUN
ajlm-2700	25	12	problem	problem	NOUN
ajlm-2700	25	13	with	with	ADP
ajlm-2700	25	14	a	a	DET
ajlm-2700	25	15	prevalence	prevalence	NOUN
ajlm-2700	25	16	of	of	ADP
ajlm-2700	25	17	5	5	NUM
ajlm-2700	25	18	%	%	NOUN
ajlm-2700	25	19	–	–	PUNCT
ajlm-2700	25	20	10%.1	10%.1	NUM
ajlm-2700	25	21	in	in	ADP
ajlm-2700	25	22	africa	africa	PROPN
ajlm-2700	25	23	,	,	PUNCT
ajlm-2700	25	24	ckd	ckd	PROPN
ajlm-2700	25	25	presents	present	VERB
ajlm-2700	25	26	a	a	DET
ajlm-2700	25	27	major	major	ADJ
ajlm-2700	25	28	public	public	ADJ
ajlm-2700	25	29	health	health	NOUN
ajlm-2700	25	30	concern	concern	NOUN
ajlm-2700	25	31	,	,	PUNCT
ajlm-2700	25	32	particularly	particularly	ADV
ajlm-2700	25	33	against	against	ADP
ajlm-2700	25	34	a	a	DET
ajlm-2700	25	35	background	background	NOUN
ajlm-2700	25	36	of	of	ADP
ajlm-2700	25	37	limited	limited	ADJ
ajlm-2700	25	38	resources.2	resources.2	ADJ
ajlm-2700	25	39	such	such	ADJ
ajlm-2700	25	40	patients	patient	NOUN
ajlm-2700	25	41	have	have	VERB
ajlm-2700	25	42	an	an	DET
ajlm-2700	25	43	increased	increase	VERB
ajlm-2700	25	44	risk	risk	NOUN
ajlm-2700	25	45	of	of	ADP
ajlm-2700	25	46	ckd	ckd	NOUN
ajlm-2700	25	47	-	-	NOUN
ajlm-2700	25	48	mineral	mineral	NOUN
ajlm-2700	25	49	and	and	CCONJ
ajlm-2700	25	50	bone	bone	NOUN
ajlm-2700	25	51	disorder	disorder	NOUN
ajlm-2700	25	52	(	(	PUNCT
ajlm-2700	25	53	ckd	ckd	PROPN
ajlm-2700	25	54	-	-	PUNCT
ajlm-2700	25	55	mbd	mbd	PROPN
ajlm-2700	25	56	)	)	PUNCT
ajlm-2700	25	57	,	,	PUNCT
ajlm-2700	25	58	which	which	PRON
ajlm-2700	25	59	is	be	AUX
ajlm-2700	25	60	associated	associate	VERB
ajlm-2700	25	61	with	with	ADP
ajlm-2700	25	62	high	high	ADJ
ajlm-2700	25	63	morbidity	morbidity	NOUN
ajlm-2700	25	64	and	and	CCONJ
ajlm-2700	25	65	mortality.1	mortality.1	NOUN
ajlm-2700	25	66	bone	bone	NOUN
ajlm-2700	25	67	histomorphometry	histomorphometry	NOUN
ajlm-2700	25	68	is	be	AUX
ajlm-2700	25	69	the	the	DET
ajlm-2700	25	70	gold	gold	ADJ
ajlm-2700	25	71	standard	standard	NOUN
ajlm-2700	25	72	in	in	ADP
ajlm-2700	25	73	the	the	DET
ajlm-2700	25	74	assessment	assessment	NOUN
ajlm-2700	25	75	of	of	ADP
ajlm-2700	25	76	renal	renal	PROPN
ajlm-2700	25	77	osteodystrophy	osteodystrophy	PROPN
ajlm-2700	25	78	,	,	PUNCT
ajlm-2700	25	79	which	which	PRON
ajlm-2700	25	80	reflects	reflect	VERB
ajlm-2700	25	81	the	the	DET
ajlm-2700	25	82	skeletal	skeletal	ADJ
ajlm-2700	25	83	facet	facet	NOUN
ajlm-2700	25	84	of	of	ADP
ajlm-2700	25	85	ckd	ckd	PROPN
ajlm-2700	25	86	-	-	PUNCT
ajlm-2700	25	87	mbd	mbd	PROPN
ajlm-2700	25	88	.	.	PUNCT
ajlm-2700	26	1	however	however	ADV
ajlm-2700	26	2	,	,	PUNCT
ajlm-2700	26	3	it	it	PRON
ajlm-2700	26	4	is	be	AUX
ajlm-2700	26	5	invasive	invasive	ADJ
ajlm-2700	26	6	,	,	PUNCT
ajlm-2700	26	7	expensive	expensive	ADJ
ajlm-2700	26	8	,	,	PUNCT
ajlm-2700	26	9	and	and	CCONJ
ajlm-2700	26	10	requires	require	VERB
ajlm-2700	26	11	expertise	expertise	NOUN
ajlm-2700	26	12	not	not	PART
ajlm-2700	26	13	readily	readily	ADV
ajlm-2700	26	14	available	available	ADJ
ajlm-2700	26	15	,	,	PUNCT
ajlm-2700	26	16	thus	thus	ADV
ajlm-2700	26	17	measurement	measurement	NOUN
ajlm-2700	26	18	of	of	ADP
ajlm-2700	26	19	circulating	circulate	VERB
ajlm-2700	26	20	biomarkers	biomarker	NOUN
ajlm-2700	26	21	,	,	PUNCT
ajlm-2700	26	22	including	include	VERB
ajlm-2700	26	23	parathyroid	parathyroid	ADJ
ajlm-2700	26	24	hormone	hormone	NOUN
ajlm-2700	26	25	(	(	PUNCT
ajlm-2700	26	26	pth	pth	NOUN
ajlm-2700	26	27	)	)	PUNCT
ajlm-2700	26	28	,	,	PUNCT
ajlm-2700	26	29	offers	offer	VERB
ajlm-2700	26	30	an	an	DET
ajlm-2700	26	31	attractive	attractive	ADJ
ajlm-2700	26	32	non	non	ADJ
ajlm-2700	26	33	-	-	ADJ
ajlm-2700	26	34	invasive	invasive	ADJ
ajlm-2700	26	35	alternative.1,3	alternative.1,3	ADJ
ajlm-2700	26	36	changes	change	NOUN
ajlm-2700	26	37	in	in	ADP
ajlm-2700	26	38	pth	pth	NOUN
ajlm-2700	26	39	concentrations	concentration	NOUN
ajlm-2700	26	40	contribute	contribute	VERB
ajlm-2700	26	41	to	to	ADP
ajlm-2700	26	42	the	the	DET
ajlm-2700	26	43	bone	bone	NOUN
ajlm-2700	26	44	abnormalities	abnormality	NOUN
ajlm-2700	26	45	observed	observe	VERB
ajlm-2700	26	46	in	in	ADP
ajlm-2700	26	47	ckd	ckd	PROPN
ajlm-2700	26	48	-	-	PROPN
ajlm-2700	26	49	mbd.4	mbd.4	PROPN
ajlm-2700	26	50	this	this	PRON
ajlm-2700	26	51	makes	make	VERB
ajlm-2700	26	52	its	its	PRON
ajlm-2700	26	53	measurement	measurement	NOUN
ajlm-2700	26	54	essential	essential	ADJ
ajlm-2700	26	55	in	in	ADP
ajlm-2700	26	56	the	the	DET
ajlm-2700	26	57	management	management	NOUN
ajlm-2700	26	58	of	of	ADP
ajlm-2700	26	59	ckd	ckd	PROPN
ajlm-2700	26	60	-	-	PUNCT
ajlm-2700	26	61	mbd	mbd	PROPN
ajlm-2700	26	62	.	.	PUNCT
ajlm-2700	27	1	parathyroid	parathyroid	PROPN
ajlm-2700	27	2	hormone	hormone	NOUN
ajlm-2700	27	3	regulates	regulate	VERB
ajlm-2700	27	4	calcium	calcium	NOUN
ajlm-2700	27	5	and	and	CCONJ
ajlm-2700	27	6	phosphate	phosphate	ADJ
ajlm-2700	27	7	homeostasis	homeostasis	NOUN
ajlm-2700	27	8	and	and	CCONJ
ajlm-2700	27	9	bone	bone	NOUN
ajlm-2700	27	10	remodelling,4	remodelling,4	NOUN
ajlm-2700	27	11	and	and	CCONJ
ajlm-2700	27	12	determination	determination	NOUN
ajlm-2700	27	13	thereof	thereof	ADV
ajlm-2700	27	14	is	be	AUX
ajlm-2700	27	15	crucial	crucial	ADJ
ajlm-2700	27	16	in	in	ADP
ajlm-2700	27	17	the	the	DET
ajlm-2700	27	18	diagnostic	diagnostic	ADJ
ajlm-2700	27	19	workup	workup	NOUN
ajlm-2700	27	20	of	of	ADP
ajlm-2700	27	21	hypocalcaemia	hypocalcaemia	PROPN
ajlm-2700	27	22	,	,	PUNCT
ajlm-2700	27	23	hypercalcaemia	hypercalcaemia	NOUN
ajlm-2700	27	24	,	,	PUNCT
ajlm-2700	27	25	and	and	CCONJ
ajlm-2700	27	26	in	in	ADP
ajlm-2700	27	27	the	the	DET
ajlm-2700	27	28	perioperative	perioperative	ADJ
ajlm-2700	27	29	assessment	assessment	NOUN
ajlm-2700	27	30	in	in	ADP
ajlm-2700	27	31	thyroid	thyroid	NOUN
ajlm-2700	27	32	or	or	CCONJ
ajlm-2700	27	33	parathyroid	parathyroid	NOUN
ajlm-2700	27	34	surgery.1,4	surgery.1,4	ADV
ajlm-2700	27	35	therefore	therefore	ADV
ajlm-2700	27	36	,	,	PUNCT
ajlm-2700	27	37	accurate	accurate	ADJ
ajlm-2700	27	38	and	and	CCONJ
ajlm-2700	27	39	reliable	reliable	ADJ
ajlm-2700	27	40	pth	pth	NOUN
ajlm-2700	27	41	assays	assay	NOUN
ajlm-2700	27	42	are	be	AUX
ajlm-2700	27	43	needed	need	VERB
ajlm-2700	27	44	for	for	ADP
ajlm-2700	27	45	proper	proper	ADJ
ajlm-2700	27	46	patient	patient	ADJ
ajlm-2700	27	47	management	management	NOUN
ajlm-2700	27	48	.	.	PUNCT
ajlm-2700	28	1	parathyroid	parathyroid	ADJ
ajlm-2700	28	2	hormone	hormone	NOUN
ajlm-2700	28	3	is	be	AUX
ajlm-2700	28	4	composed	compose	VERB
ajlm-2700	28	5	of	of	ADP
ajlm-2700	28	6	a	a	DET
ajlm-2700	28	7	single	single	ADJ
ajlm-2700	28	8	polypeptide	polypeptide	NOUN
ajlm-2700	28	9	produced	produce	VERB
ajlm-2700	28	10	exclusively	exclusively	ADV
ajlm-2700	28	11	by	by	ADP
ajlm-2700	28	12	the	the	DET
ajlm-2700	28	13	chief	chief	ADJ
ajlm-2700	28	14	cells	cell	NOUN
ajlm-2700	28	15	of	of	ADP
ajlm-2700	28	16	parathyroid	parathyroid	ADJ
ajlm-2700	28	17	glands	gland	NOUN
ajlm-2700	28	18	,	,	PUNCT
ajlm-2700	28	19	with	with	ADP
ajlm-2700	28	20	a	a	DET
ajlm-2700	28	21	molecular	molecular	ADJ
ajlm-2700	28	22	weight	weight	NOUN
ajlm-2700	28	23	of	of	ADP
ajlm-2700	28	24	~9.5	~9.5	PUNCT
ajlm-2700	28	25	kda.5	kda.5	NOUN
ajlm-2700	28	26	it	it	PRON
ajlm-2700	28	27	is	be	AUX
ajlm-2700	28	28	sequentially	sequentially	ADV
ajlm-2700	28	29	cleaved	cleave	VERB
ajlm-2700	28	30	at	at	ADP
ajlm-2700	28	31	the	the	DET
ajlm-2700	28	32	amino	amino	PROPN
ajlm-2700	28	33	terminal	terminal	PROPN
ajlm-2700	28	34	end	end	VERB
ajlm-2700	28	35	to	to	PART
ajlm-2700	28	36	yield	yield	VERB
ajlm-2700	28	37	the	the	DET
ajlm-2700	28	38	mature	mature	NOUN
ajlm-2700	28	39	biologically	biologically	ADV
ajlm-2700	28	40	active	active	ADJ
ajlm-2700	28	41	84	84	NUM
ajlm-2700	28	42	amino	amino	NOUN
ajlm-2700	28	43	acid	acid	NOUN
ajlm-2700	28	44	molecule	molecule	NOUN
ajlm-2700	28	45	pth	pth	NOUN
ajlm-2700	28	46	(	(	PUNCT
ajlm-2700	28	47	1–84	1–84	NOUN
ajlm-2700	28	48	)	)	PUNCT
ajlm-2700	28	49	,	,	PUNCT
ajlm-2700	28	50	which	which	PRON
ajlm-2700	28	51	consists	consist	VERB
ajlm-2700	28	52	of	of	ADP
ajlm-2700	28	53	two	two	NUM
ajlm-2700	28	54	main	main	ADJ
ajlm-2700	28	55	parts	part	NOUN
ajlm-2700	28	56	:	:	PUNCT
ajlm-2700	28	57	the	the	DET
ajlm-2700	28	58	amino	amino	NOUN
ajlm-2700	28	59	(	(	PUNCT
ajlm-2700	28	60	n	n	CCONJ
ajlm-2700	28	61	)	)	PUNCT
ajlm-2700	28	62	terminus	terminus	NOUN
ajlm-2700	28	63	,	,	PUNCT
ajlm-2700	28	64	made	make	VERB
ajlm-2700	28	65	up	up	ADP
ajlm-2700	28	66	of	of	ADP
ajlm-2700	28	67	the	the	DET
ajlm-2700	28	68	first	first	ADJ
ajlm-2700	28	69	34	34	NUM
ajlm-2700	28	70	amino	amino	NOUN
ajlm-2700	28	71	acids	acid	NOUN
ajlm-2700	28	72	,	,	PUNCT
ajlm-2700	28	73	and	and	CCONJ
ajlm-2700	28	74	the	the	DET
ajlm-2700	28	75	carboxyl	carboxyl	NOUN
ajlm-2700	28	76	(	(	PUNCT
ajlm-2700	28	77	c	c	NOUN
ajlm-2700	28	78	)	)	PUNCT
ajlm-2700	28	79	terminus	terminus	NOUN
ajlm-2700	28	80	,	,	PUNCT
ajlm-2700	28	81	that	that	PRON
ajlm-2700	28	82	contains	contain	VERB
ajlm-2700	28	83	the	the	DET
ajlm-2700	28	84	remaining	remain	VERB
ajlm-2700	28	85	50	50	NUM
ajlm-2700	28	86	amino	amino	NOUN
ajlm-2700	28	87	acids	acid	NOUN
ajlm-2700	28	88	.	.	PUNCT
ajlm-2700	29	1	as	as	ADP
ajlm-2700	29	2	a	a	DET
ajlm-2700	29	3	result	result	NOUN
ajlm-2700	29	4	of	of	ADP
ajlm-2700	29	5	rapid	rapid	ADJ
ajlm-2700	29	6	proteolytic	proteolytic	ADJ
ajlm-2700	29	7	cleavage	cleavage	NOUN
ajlm-2700	29	8	in	in	ADP
ajlm-2700	29	9	circulation	circulation	NOUN
ajlm-2700	29	10	,	,	PUNCT
ajlm-2700	29	11	pth	pth	NOUN
ajlm-2700	29	12	exists	exist	VERB
ajlm-2700	29	13	as	as	ADP
ajlm-2700	29	14	intact	intact	ADJ
ajlm-2700	29	15	pth	pth	NOUN
ajlm-2700	29	16	(	(	PUNCT
ajlm-2700	29	17	1–84	1–84	NOUN
ajlm-2700	29	18	)	)	PUNCT
ajlm-2700	29	19	and	and	CCONJ
ajlm-2700	29	20	various	various	ADJ
ajlm-2700	29	21	fragments	fragment	NOUN
ajlm-2700	29	22	,	,	PUNCT
ajlm-2700	29	23	that	that	ADV
ajlm-2700	29	24	is	is	ADV
ajlm-2700	29	25	,	,	PUNCT
ajlm-2700	29	26	n	n	CCONJ
ajlm-2700	29	27	-	-	PUNCT
ajlm-2700	29	28	terminal	terminal	ADJ
ajlm-2700	29	29	,	,	PUNCT
ajlm-2700	29	30	mid	mid	NOUN
ajlm-2700	29	31	-	-	NOUN
ajlm-2700	29	32	region	region	NOUN
ajlm-2700	29	33	and	and	CCONJ
ajlm-2700	29	34	c	c	NOUN
ajlm-2700	29	35	-	-	PUNCT
ajlm-2700	29	36	terminal	terminal	ADJ
ajlm-2700	29	37	pth	pth	NOUN
ajlm-2700	29	38	,	,	PUNCT
ajlm-2700	29	39	the	the	DET
ajlm-2700	29	40	most	most	ADV
ajlm-2700	29	41	abundant	abundant	ADJ
ajlm-2700	29	42	being	being	NOUN
ajlm-2700	29	43	7–84	7–84	NOUN
ajlm-2700	29	44	pth.6	pth.6	VERB
ajlm-2700	29	45	although	although	SCONJ
ajlm-2700	29	46	the	the	DET
ajlm-2700	29	47	plasma	plasma	NOUN
ajlm-2700	29	48	half	half	ADJ
ajlm-2700	29	49	-	-	PUNCT
ajlm-2700	29	50	life	life	NOUN
ajlm-2700	29	51	of	of	ADP
ajlm-2700	29	52	pth	pth	NOUN
ajlm-2700	29	53	(	(	PUNCT
ajlm-2700	29	54	1–84	1–84	NOUN
ajlm-2700	29	55	)	)	PUNCT
ajlm-2700	29	56	is	be	AUX
ajlm-2700	29	57	between	between	ADP
ajlm-2700	29	58	2	2	NUM
ajlm-2700	29	59	and	and	CCONJ
ajlm-2700	29	60	4	4	NUM
ajlm-2700	29	61	min	min	NOUN
ajlm-2700	29	62	,	,	PUNCT
ajlm-2700	29	63	c	c	NOUN
ajlm-2700	29	64	-	-	PUNCT
ajlm-2700	29	65	terminal	terminal	ADJ
ajlm-2700	29	66	pth	pth	NOUN
ajlm-2700	29	67	fragments	fragment	NOUN
ajlm-2700	29	68	have	have	VERB
ajlm-2700	29	69	a	a	DET
ajlm-2700	29	70	longer	long	ADJ
ajlm-2700	29	71	half	half	ADJ
ajlm-2700	29	72	-	-	PUNCT
ajlm-2700	29	73	life	life	NOUN
ajlm-2700	29	74	of	of	ADP
ajlm-2700	29	75	several	several	ADJ
ajlm-2700	29	76	hours	hour	NOUN
ajlm-2700	29	77	because	because	SCONJ
ajlm-2700	29	78	of	of	ADP
ajlm-2700	29	79	renal	renal	ADJ
ajlm-2700	29	80	clearance.6,7	clearance.6,7	PROPN
ajlm-2700	29	81	the	the	DET
ajlm-2700	29	82	latter	latter	ADJ
ajlm-2700	29	83	may	may	AUX
ajlm-2700	29	84	account	account	VERB
ajlm-2700	29	85	for	for	ADP
ajlm-2700	29	86	more	more	ADJ
ajlm-2700	29	87	than	than	ADP
ajlm-2700	29	88	20	20	NUM
ajlm-2700	29	89	%	%	NOUN
ajlm-2700	29	90	of	of	ADP
ajlm-2700	29	91	circulating	circulate	VERB
ajlm-2700	29	92	pth	pth	NOUN
ajlm-2700	29	93	in	in	ADP
ajlm-2700	29	94	normal	normal	ADJ
ajlm-2700	29	95	kidney	kidney	NOUN
ajlm-2700	29	96	function	function	NOUN
ajlm-2700	29	97	individuals	individual	NOUN
ajlm-2700	29	98	and	and	CCONJ
ajlm-2700	29	99	up	up	ADP
ajlm-2700	29	100	to	to	PART
ajlm-2700	29	101	45	45	NUM
ajlm-2700	29	102	%	%	NOUN
ajlm-2700	29	103	in	in	ADP
ajlm-2700	29	104	patients	patient	NOUN
ajlm-2700	29	105	with	with	ADP
ajlm-2700	29	106	renal	renal	ADJ
ajlm-2700	29	107	failure.6	failure.6	NOUN
ajlm-2700	29	108	this	this	DET
ajlm-2700	29	109	heterogeneity	heterogeneity	NOUN
ajlm-2700	29	110	of	of	ADP
ajlm-2700	29	111	pth	pth	NOUN
ajlm-2700	29	112	in	in	ADP
ajlm-2700	29	113	circulation	circulation	NOUN
ajlm-2700	29	114	has	have	AUX
ajlm-2700	29	115	made	make	VERB
ajlm-2700	29	116	its	its	PRON
ajlm-2700	29	117	measurement	measurement	NOUN
ajlm-2700	29	118	challenging	challenge	VERB
ajlm-2700	29	119	.	.	PUNCT
ajlm-2700	30	1	parathyroid	parathyroid	ADJ
ajlm-2700	30	2	hormone	hormone	NOUN
ajlm-2700	30	3	measurements	measurement	NOUN
ajlm-2700	30	4	have	have	VERB
ajlm-2700	30	5	numerous	numerous	ADJ
ajlm-2700	30	6	pitfalls	pitfall	NOUN
ajlm-2700	30	7	.	.	PUNCT
ajlm-2700	31	1	currently	currently	ADV
ajlm-2700	31	2	,	,	PUNCT
ajlm-2700	31	3	no	no	DET
ajlm-2700	31	4	reference	reference	NOUN
ajlm-2700	31	5	method	method	NOUN
ajlm-2700	31	6	exists	exist	VERB
ajlm-2700	31	7	,	,	PUNCT
ajlm-2700	31	8	and	and	CCONJ
ajlm-2700	31	9	although	although	SCONJ
ajlm-2700	31	10	the	the	DET
ajlm-2700	31	11	use	use	NOUN
ajlm-2700	31	12	of	of	ADP
ajlm-2700	31	13	a	a	DET
ajlm-2700	31	14	single	single	ADJ
ajlm-2700	31	15	recognised	recognise	VERB
ajlm-2700	31	16	international	international	ADJ
ajlm-2700	31	17	standard	standard	NOUN
ajlm-2700	31	18	,	,	PUNCT
ajlm-2700	31	19	for	for	ADP
ajlm-2700	31	20	example	example	NOUN
ajlm-2700	31	21	,	,	PUNCT
ajlm-2700	31	22	world	world	PROPN
ajlm-2700	31	23	health	health	NOUN
ajlm-2700	31	24	organization	organization	PROPN
ajlm-2700	31	25	pth	pth	NOUN
ajlm-2700	31	26	95/646	95/646	NOUN
ajlm-2700	31	27	,	,	PUNCT
ajlm-2700	31	28	has	have	AUX
ajlm-2700	31	29	been	be	AUX
ajlm-2700	31	30	proposed	propose	VERB
ajlm-2700	31	31	,	,	PUNCT
ajlm-2700	31	32	it	it	PRON
ajlm-2700	31	33	has	have	AUX
ajlm-2700	31	34	not	not	PART
ajlm-2700	31	35	been	be	AUX
ajlm-2700	31	36	fully	fully	ADV
ajlm-2700	31	37	implemented	implement	VERB
ajlm-2700	31	38	,	,	PUNCT
ajlm-2700	31	39	and	and	CCONJ
ajlm-2700	31	40	pth	pth	NOUN
ajlm-2700	31	41	measurement	measurement	NOUN
ajlm-2700	31	42	remains	remain	VERB
ajlm-2700	31	43	unstandardised.8,9	unstandardised.8,9	NOUN
ajlm-2700	31	44	the	the	DET
ajlm-2700	31	45	radioimmunoassay	radioimmunoassay	NOUN
ajlm-2700	31	46	was	be	AUX
ajlm-2700	31	47	a	a	DET
ajlm-2700	31	48	first	first	ADJ
ajlm-2700	31	49	-	-	PUNCT
ajlm-2700	31	50	generation	generation	NOUN
ajlm-2700	31	51	competitive	competitive	ADJ
ajlm-2700	31	52	pth	pth	NOUN
ajlm-2700	31	53	assay	assay	NOUN
ajlm-2700	31	54	that	that	PRON
ajlm-2700	31	55	utilised	utilise	VERB
ajlm-2700	31	56	a	a	DET
ajlm-2700	31	57	single	single	ADJ
ajlm-2700	31	58	polyclonal	polyclonal	ADJ
ajlm-2700	31	59	antibody	antibody	NOUN
ajlm-2700	31	60	generated	generate	VERB
ajlm-2700	31	61	against	against	ADP
ajlm-2700	31	62	epitopes	epitope	NOUN
ajlm-2700	31	63	in	in	ADP
ajlm-2700	31	64	the	the	DET
ajlm-2700	31	65	midor	midor	ADJ
ajlm-2700	31	66	c	c	NOUN
ajlm-2700	31	67	-	-	PUNCT
ajlm-2700	31	68	terminus	terminus	NOUN
ajlm-2700	31	69	of	of	ADP
ajlm-2700	31	70	the	the	DET
ajlm-2700	31	71	pth	pth	NOUN
ajlm-2700	31	72	peptide.7	peptide.7	NOUN
ajlm-2700	31	73	the	the	DET
ajlm-2700	31	74	radioimmunoassays	radioimmunoassay	NOUN
ajlm-2700	31	75	had	have	VERB
ajlm-2700	31	76	several	several	ADJ
ajlm-2700	31	77	limitations	limitation	NOUN
ajlm-2700	31	78	,	,	PUNCT
ajlm-2700	31	79	including	include	VERB
ajlm-2700	31	80	cross	cross	NOUN
ajlm-2700	31	81	reactivity	reactivity	NOUN
ajlm-2700	31	82	with	with	ADP
ajlm-2700	31	83	the	the	DET
ajlm-2700	31	84	biologically	biologically	ADV
ajlm-2700	31	85	inactive	inactive	ADJ
ajlm-2700	31	86	c	c	NOUN
ajlm-2700	31	87	-	-	PUNCT
ajlm-2700	31	88	fragments	fragment	NOUN
ajlm-2700	31	89	,	,	PUNCT
ajlm-2700	31	90	which	which	PRON
ajlm-2700	31	91	are	be	AUX
ajlm-2700	31	92	highest	high	ADJ
ajlm-2700	31	93	in	in	ADP
ajlm-2700	31	94	ckd	ckd	PROPN
ajlm-2700	31	95	patients	patient	NOUN
ajlm-2700	31	96	because	because	SCONJ
ajlm-2700	31	97	of	of	ADP
ajlm-2700	31	98	decreased	decrease	VERB
ajlm-2700	31	99	renal	renal	ADJ
ajlm-2700	31	100	clearance.10,11	clearance.10,11	NOUN
ajlm-2700	31	101	to	to	PART
ajlm-2700	31	102	overcome	overcome	VERB
ajlm-2700	31	103	this	this	DET
ajlm-2700	31	104	issue	issue	NOUN
ajlm-2700	31	105	,	,	PUNCT
ajlm-2700	31	106	the	the	DET
ajlm-2700	31	107	immunometric	immunometric	ADJ
ajlm-2700	31	108	secondand	secondand	NOUN
ajlm-2700	31	109	third	third	ADJ
ajlm-2700	31	110	-	-	PUNCT
ajlm-2700	31	111	generation	generation	NOUN
ajlm-2700	31	112	pth	pth	NOUN
ajlm-2700	31	113	assays	assay	NOUN
ajlm-2700	31	114	were	be	AUX
ajlm-2700	31	115	developed	develop	VERB
ajlm-2700	31	116	.	.	PUNCT
ajlm-2700	32	1	the	the	DET
ajlm-2700	32	2	second	second	ADJ
ajlm-2700	32	3	-	-	PUNCT
ajlm-2700	32	4	generation	generation	NOUN
ajlm-2700	32	5	pth	pth	NOUN
ajlm-2700	32	6	assay	assay	NOUN
ajlm-2700	32	7	is	be	AUX
ajlm-2700	32	8	a	a	DET
ajlm-2700	32	9	non	non	ADJ
ajlm-2700	32	10	-	-	ADJ
ajlm-2700	32	11	competitive	competitive	ADJ
ajlm-2700	32	12	sandwich	sandwich	NOUN
ajlm-2700	32	13	immunoassay	immunoassay	NOUN
ajlm-2700	32	14	that	that	PRON
ajlm-2700	32	15	makes	make	VERB
ajlm-2700	32	16	use	use	NOUN
ajlm-2700	32	17	of	of	ADP
ajlm-2700	32	18	two	two	NUM
ajlm-2700	32	19	antibodies	antibody	NOUN
ajlm-2700	32	20	,	,	PUNCT
ajlm-2700	32	21	generated	generate	VERB
ajlm-2700	32	22	against	against	ADP
ajlm-2700	32	23	the	the	DET
ajlm-2700	32	24	mid	mid	NOUN
ajlm-2700	32	25	-	-	NOUN
ajlm-2700	32	26	region	region	NOUN
ajlm-2700	32	27	n	n	CCONJ
ajlm-2700	32	28	-	-	PUNCT
ajlm-2700	32	29	terminal	terminal	ADJ
ajlm-2700	32	30	and	and	CCONJ
ajlm-2700	32	31	c	c	NOUN
ajlm-2700	32	32	-	-	PUNCT
ajlm-2700	32	33	terminal	terminal	ADJ
ajlm-2700	32	34	amino	amino	NOUN
ajlm-2700	32	35	acids	acid	NOUN
ajlm-2700	32	36	.	.	PUNCT
ajlm-2700	33	1	it	it	PRON
ajlm-2700	33	2	was	be	AUX
ajlm-2700	33	3	assumed	assume	VERB
ajlm-2700	33	4	that	that	SCONJ
ajlm-2700	33	5	it	it	PRON
ajlm-2700	33	6	detected	detect	VERB
ajlm-2700	33	7	the	the	DET
ajlm-2700	33	8	biologically	biologically	ADV
ajlm-2700	33	9	active	active	ADJ
ajlm-2700	33	10	pth	pth	NOUN
ajlm-2700	33	11	(	(	PUNCT
ajlm-2700	33	12	1–84	1–84	NOUN
ajlm-2700	33	13	)	)	PUNCT
ajlm-2700	33	14	and	and	CCONJ
ajlm-2700	33	15	avoided	avoid	VERB
ajlm-2700	33	16	cross	cross	NOUN
ajlm-2700	33	17	reactivity	reactivity	NOUN
ajlm-2700	33	18	with	with	ADP
ajlm-2700	33	19	c	c	NOUN
ajlm-2700	33	20	-	-	PUNCT
ajlm-2700	33	21	fragments	fragment	NOUN
ajlm-2700	33	22	,	,	PUNCT
ajlm-2700	33	23	and	and	CCONJ
ajlm-2700	33	24	thus	thus	ADV
ajlm-2700	33	25	was	be	AUX
ajlm-2700	33	26	referred	refer	VERB
ajlm-2700	33	27	to	to	ADP
ajlm-2700	33	28	as	as	SCONJ
ajlm-2700	33	29	the	the	DET
ajlm-2700	33	30	‘	'	PUNCT
ajlm-2700	33	31	intact	intact	ADJ
ajlm-2700	33	32	’	'	PUNCT
ajlm-2700	33	33	pth	pth	NOUN
ajlm-2700	33	34	assay.11,12	assay.11,12	NOUN
ajlm-2700	33	35	however	however	ADV
ajlm-2700	33	36	,	,	PUNCT
ajlm-2700	33	37	subsequent	subsequent	ADJ
ajlm-2700	33	38	studies	study	NOUN
ajlm-2700	33	39	revealed	reveal	VERB
ajlm-2700	33	40	that	that	SCONJ
ajlm-2700	33	41	these	these	DET
ajlm-2700	33	42	assays	assay	NOUN
ajlm-2700	33	43	overestimated	overestimate	VERB
ajlm-2700	33	44	values	value	NOUN
ajlm-2700	33	45	in	in	ADP
ajlm-2700	33	46	patients	patient	NOUN
ajlm-2700	33	47	with	with	ADP
ajlm-2700	33	48	kidney	kidney	NOUN
ajlm-2700	33	49	failure	failure	NOUN
ajlm-2700	33	50	compared	compare	VERB
ajlm-2700	33	51	to	to	ADP
ajlm-2700	33	52	pth	pth	NOUN
ajlm-2700	33	53	values	value	NOUN
ajlm-2700	33	54	in	in	ADP
ajlm-2700	33	55	normal	normal	ADJ
ajlm-2700	33	56	subjects	subject	NOUN
ajlm-2700	33	57	because	because	SCONJ
ajlm-2700	33	58	of	of	ADP
ajlm-2700	33	59	the	the	DET
ajlm-2700	33	60	accumulation	accumulation	NOUN
ajlm-2700	33	61	of	of	ADP
ajlm-2700	33	62	n	n	CCONJ
ajlm-2700	33	63	-	-	PUNCT
ajlm-2700	33	64	truncated	truncate	VERB
ajlm-2700	33	65	pth	pth	NOUN
ajlm-2700	33	66	fragments	fragment	NOUN
ajlm-2700	33	67	,	,	PUNCT
ajlm-2700	33	68	the	the	DET
ajlm-2700	33	69	most	most	ADV
ajlm-2700	33	70	abundant	abundant	ADJ
ajlm-2700	33	71	of	of	ADP
ajlm-2700	33	72	which	which	PRON
ajlm-2700	33	73	is	be	AUX
ajlm-2700	33	74	7–84	7–84	NOUN
ajlm-2700	33	75	pth.13,14	pth.13,14	ADP
ajlm-2700	33	76	the	the	DET
ajlm-2700	33	77	third	third	ADJ
ajlm-2700	33	78	-	-	PUNCT
ajlm-2700	33	79	generation	generation	NOUN
ajlm-2700	33	80	pth	pth	NOUN
ajlm-2700	33	81	assays	assay	NOUN
ajlm-2700	33	82	use	use	VERB
ajlm-2700	33	83	a	a	DET
ajlm-2700	33	84	capture	capture	NOUN
ajlm-2700	33	85	antibody	antibody	NOUN
ajlm-2700	33	86	against	against	ADP
ajlm-2700	33	87	the	the	DET
ajlm-2700	33	88	c	c	NOUN
ajlm-2700	33	89	-	-	PUNCT
ajlm-2700	33	90	terminal	terminal	ADJ
ajlm-2700	33	91	amino	amino	ADJ
ajlm-2700	33	92	acids	acid	NOUN
ajlm-2700	33	93	similar	similar	ADJ
ajlm-2700	33	94	to	to	ADP
ajlm-2700	33	95	the	the	DET
ajlm-2700	33	96	second	second	ADJ
ajlm-2700	33	97	-	-	PUNCT
ajlm-2700	33	98	generation	generation	NOUN
ajlm-2700	33	99	.	.	PUNCT
ajlm-2700	34	1	however	however	ADV
ajlm-2700	34	2	,	,	PUNCT
ajlm-2700	34	3	the	the	DET
ajlm-2700	34	4	detection	detection	NOUN
ajlm-2700	34	5	antibody	antibody	NOUN
ajlm-2700	34	6	is	be	AUX
ajlm-2700	34	7	directed	direct	VERB
ajlm-2700	34	8	against	against	ADP
ajlm-2700	34	9	epitopes	epitope	NOUN
ajlm-2700	34	10	in	in	ADP
ajlm-2700	34	11	the	the	DET
ajlm-2700	34	12	first	first	ADJ
ajlm-2700	34	13	four	four	NUM
ajlm-2700	34	14	amino	amino	ADJ
ajlm-2700	34	15	acids	acid	NOUN
ajlm-2700	34	16	of	of	ADP
ajlm-2700	34	17	the	the	DET
ajlm-2700	34	18	n	n	NOUN
ajlm-2700	34	19	-	-	PUNCT
ajlm-2700	34	20	terminus	terminus	NOUN
ajlm-2700	34	21	,	,	PUNCT
ajlm-2700	34	22	which	which	PRON
ajlm-2700	34	23	avoids	avoid	VERB
ajlm-2700	34	24	cross	cross	NOUN
ajlm-2700	34	25	reactivity	reactivity	NOUN
ajlm-2700	34	26	with	with	ADP
ajlm-2700	34	27	7–84	7–84	NOUN
ajlm-2700	34	28	pth	pth	NOUN
ajlm-2700	34	29	fragments.7,11	fragments.7,11	NOUN
ajlm-2700	34	30	third	third	ADJ
ajlm-2700	34	31	-	-	PUNCT
ajlm-2700	34	32	generation	generation	NOUN
ajlm-2700	34	33	assays	assay	NOUN
ajlm-2700	34	34	were	be	AUX
ajlm-2700	34	35	termed	term	VERB
ajlm-2700	34	36	bio	bio	ADJ
ajlm-2700	34	37	-	-	ADJ
ajlm-2700	34	38	intact	intact	ADJ
ajlm-2700	34	39	(	(	PUNCT
ajlm-2700	34	40	bio	bio	NOUN
ajlm-2700	34	41	-	-	NOUN
ajlm-2700	34	42	pth	pth	NOUN
ajlm-2700	34	43	)	)	PUNCT
ajlm-2700	34	44	or	or	CCONJ
ajlm-2700	34	45	whole	whole	ADJ
ajlm-2700	34	46	pth	pth	NOUN
ajlm-2700	34	47	assays	assay	NOUN
ajlm-2700	34	48	,	,	PUNCT
ajlm-2700	34	49	as	as	SCONJ
ajlm-2700	34	50	they	they	PRON
ajlm-2700	34	51	were	be	AUX
ajlm-2700	34	52	more	more	ADV
ajlm-2700	34	53	specific	specific	ADJ
ajlm-2700	34	54	for	for	ADP
ajlm-2700	34	55	pth	pth	NOUN
ajlm-2700	34	56	(	(	PUNCT
ajlm-2700	34	57	1–84).12	1–84).12	NUM
ajlm-2700	34	58	second	second	ADJ
ajlm-2700	34	59	-	-	PUNCT
ajlm-2700	34	60	generation	generation	NOUN
ajlm-2700	34	61	assays	assay	NOUN
ajlm-2700	34	62	have	have	AUX
ajlm-2700	34	63	provided	provide	VERB
ajlm-2700	34	64	the	the	DET
ajlm-2700	34	65	basis	basis	NOUN
ajlm-2700	34	66	for	for	ADP
ajlm-2700	34	67	the	the	DET
ajlm-2700	34	68	kidney	kidney	NOUN
ajlm-2700	34	69	disease	disease	NOUN
ajlm-2700	34	70	:	:	PUNCT
ajlm-2700	34	71	improving	improve	VERB
ajlm-2700	34	72	global	global	ADJ
ajlm-2700	34	73	outcomes	outcome	NOUN
ajlm-2700	34	74	(	(	PUNCT
ajlm-2700	34	75	kdigo	kdigo	PROPN
ajlm-2700	34	76	)	)	PUNCT
ajlm-2700	34	77	clinical	clinical	ADJ
ajlm-2700	34	78	guidelines	guideline	NOUN
ajlm-2700	34	79	on	on	ADP
ajlm-2700	34	80	management	management	NOUN
ajlm-2700	34	81	of	of	ADP
ajlm-2700	34	82	ckd	ckd	PROPN
ajlm-2700	34	83	-	-	PROPN
ajlm-2700	34	84	mbd.12,15	mbd.12,15	PROPN
ajlm-2700	34	85	significant	significant	ADJ
ajlm-2700	34	86	inter	inter	ADJ
ajlm-2700	34	87	-	-	ADJ
ajlm-2700	34	88	method	method	ADJ
ajlm-2700	34	89	variability	variability	NOUN
ajlm-2700	34	90	among	among	ADP
ajlm-2700	34	91	second	second	ADJ
ajlm-2700	34	92	-	-	PUNCT
ajlm-2700	34	93	generation	generation	NOUN
ajlm-2700	34	94	assays	assay	NOUN
ajlm-2700	34	95	has	have	AUX
ajlm-2700	34	96	been	be	AUX
ajlm-2700	34	97	shown	show	VERB
ajlm-2700	34	98	,	,	PUNCT
ajlm-2700	34	99	thus	thus	ADV
ajlm-2700	34	100	affecting	affect	VERB
ajlm-2700	34	101	comparability	comparability	NOUN
ajlm-2700	34	102	of	of	ADP
ajlm-2700	34	103	results.3	results.3	NOUN
ajlm-2700	34	104	taking	take	VERB
ajlm-2700	34	105	this	this	PRON
ajlm-2700	34	106	into	into	ADP
ajlm-2700	34	107	consideration	consideration	NOUN
ajlm-2700	34	108	,	,	PUNCT
ajlm-2700	34	109	the	the	DET
ajlm-2700	34	110	recent	recent	ADJ
ajlm-2700	34	111	kdigo	kdigo	PROPN
ajlm-2700	34	112	guidelines	guideline	NOUN
ajlm-2700	34	113	proposed	propose	VERB
ajlm-2700	34	114	utilisation	utilisation	NOUN
ajlm-2700	34	115	of	of	ADP
ajlm-2700	34	116	multiples	multiple	NOUN
ajlm-2700	34	117	of	of	ADP
ajlm-2700	34	118	2–9	2–9	NOUN
ajlm-2700	34	119	-	-	ADJ
ajlm-2700	34	120	fold	fold	NOUN
ajlm-2700	34	121	of	of	ADP
ajlm-2700	34	122	the	the	DET
ajlm-2700	34	123	upper	upper	ADJ
ajlm-2700	34	124	limit	limit	NOUN
ajlm-2700	34	125	of	of	ADP
ajlm-2700	34	126	normal	normal	ADJ
ajlm-2700	34	127	for	for	ADP
ajlm-2700	34	128	a	a	DET
ajlm-2700	34	129	given	give	VERB
ajlm-2700	34	130	pth	pth	NOUN
ajlm-2700	34	131	assay	assay	NOUN
ajlm-2700	34	132	,	,	PUNCT
ajlm-2700	34	133	instead	instead	ADV
ajlm-2700	34	134	of	of	ADP
ajlm-2700	34	135	absolute	absolute	ADJ
ajlm-2700	34	136	values	value	NOUN
ajlm-2700	34	137	in	in	ADP
ajlm-2700	34	138	ckd	ckd	PROPN
ajlm-2700	34	139	patients	patient	NOUN
ajlm-2700	34	140	on	on	ADP
ajlm-2700	34	141	dialysis	dialysis	NOUN
ajlm-2700	34	142	.	.	PUNCT
ajlm-2700	35	1	in	in	ADP
ajlm-2700	35	2	patients	patient	NOUN
ajlm-2700	35	3	not	not	PART
ajlm-2700	35	4	on	on	ADP
ajlm-2700	35	5	dialysis	dialysis	NOUN
ajlm-2700	35	6	,	,	PUNCT
ajlm-2700	35	7	the	the	DET
ajlm-2700	35	8	kdigo	kdigo	PROPN
ajlm-2700	35	9	guidelines	guideline	VERB
ajlm-2700	35	10	state	state	NOUN
ajlm-2700	35	11	that	that	SCONJ
ajlm-2700	35	12	the	the	DET
ajlm-2700	35	13	target	target	NOUN
ajlm-2700	35	14	pth	pth	NOUN
ajlm-2700	35	15	concentration	concentration	NOUN
ajlm-2700	35	16	is	be	AUX
ajlm-2700	35	17	unknown	unknown	ADJ
ajlm-2700	35	18	and	and	CCONJ
ajlm-2700	35	19	thus	thus	ADV
ajlm-2700	35	20	recommend	recommend	VERB
ajlm-2700	35	21	monitoring	monitoring	NOUN
ajlm-2700	35	22	trends	trend	NOUN
ajlm-2700	35	23	rather	rather	ADV
ajlm-2700	35	24	than	than	ADP
ajlm-2700	35	25	a	a	DET
ajlm-2700	35	26	single	single	ADJ
ajlm-2700	35	27	value.15	value.15	NOUN
ajlm-2700	35	28	research	research	NOUN
ajlm-2700	35	29	has	have	AUX
ajlm-2700	35	30	shown	show	VERB
ajlm-2700	35	31	that	that	SCONJ
ajlm-2700	35	32	third	third	ADJ
ajlm-2700	35	33	-	-	PUNCT
ajlm-2700	35	34	generation	generation	NOUN
ajlm-2700	35	35	assays	assay	NOUN
ajlm-2700	35	36	produce	produce	VERB
ajlm-2700	35	37	results	result	NOUN
ajlm-2700	35	38	that	that	PRON
ajlm-2700	35	39	are	be	AUX
ajlm-2700	35	40	50	50	NUM
ajlm-2700	35	41	%	%	NOUN
ajlm-2700	35	42	–	–	PUNCT
ajlm-2700	35	43	60	60	NUM
ajlm-2700	35	44	%	%	NOUN
ajlm-2700	35	45	lower	low	ADJ
ajlm-2700	35	46	in	in	ADP
ajlm-2700	35	47	ckd	ckd	NOUN
ajlm-2700	35	48	patients	patient	NOUN
ajlm-2700	35	49	,	,	PUNCT
ajlm-2700	35	50	and	and	CCONJ
ajlm-2700	35	51	15	15	NUM
ajlm-2700	35	52	%	%	NOUN
ajlm-2700	35	53	lower	low	ADJ
ajlm-2700	35	54	in	in	ADP
ajlm-2700	35	55	non	non	ADJ
ajlm-2700	35	56	-	-	ADJ
ajlm-2700	35	57	ckd	ckd	ADJ
ajlm-2700	35	58	patients	patient	NOUN
ajlm-2700	35	59	,	,	PUNCT
ajlm-2700	35	60	when	when	SCONJ
ajlm-2700	35	61	compared	compare	VERB
ajlm-2700	35	62	to	to	ADP
ajlm-2700	35	63	second	second	ADJ
ajlm-2700	35	64	-	-	PUNCT
ajlm-2700	35	65	generation	generation	NOUN
ajlm-2700	35	66	assays.10,12	assays.10,12	NOUN
ajlm-2700	35	67	third	third	ADJ
ajlm-2700	35	68	-	-	PUNCT
ajlm-2700	35	69	generation	generation	NOUN
ajlm-2700	35	70	assays	assay	NOUN
ajlm-2700	35	71	are	be	AUX
ajlm-2700	35	72	more	more	ADV
ajlm-2700	35	73	specific	specific	ADJ
ajlm-2700	35	74	to	to	PART
ajlm-2700	35	75	bioactive	bioactive	VERB
ajlm-2700	35	76	pth	pth	NOUN
ajlm-2700	35	77	than	than	ADP
ajlm-2700	35	78	second	second	ADJ
ajlm-2700	35	79	-	-	PUNCT
ajlm-2700	35	80	generation	generation	NOUN
ajlm-2700	35	81	,	,	PUNCT
ajlm-2700	35	82	and	and	CCONJ
ajlm-2700	35	83	should	should	AUX
ajlm-2700	35	84	in	in	ADP
ajlm-2700	35	85	theory	theory	NOUN
ajlm-2700	35	86	be	be	AUX
ajlm-2700	35	87	more	more	ADV
ajlm-2700	35	88	accurate	accurate	ADJ
ajlm-2700	35	89	in	in	ADP
ajlm-2700	35	90	the	the	DET
ajlm-2700	35	91	evaluation	evaluation	NOUN
ajlm-2700	35	92	of	of	ADP
ajlm-2700	35	93	pth	pth	NOUN
ajlm-2700	35	94	status	status	NOUN
ajlm-2700	35	95	.	.	PUNCT
ajlm-2700	36	1	yet	yet	ADV
ajlm-2700	36	2	,	,	PUNCT
ajlm-2700	36	3	there	there	PRON
ajlm-2700	36	4	is	be	VERB
ajlm-2700	36	5	still	still	ADV
ajlm-2700	36	6	dispute	dispute	NOUN
ajlm-2700	36	7	as	as	ADP
ajlm-2700	36	8	to	to	ADP
ajlm-2700	36	9	which	which	PRON
ajlm-2700	36	10	assay	assay	ADV
ajlm-2700	36	11	is	be	AUX
ajlm-2700	36	12	preferable	preferable	ADJ
ajlm-2700	36	13	and	and	CCONJ
ajlm-2700	36	14	whether	whether	SCONJ
ajlm-2700	36	15	third	third	ADJ
ajlm-2700	36	16	-	-	PUNCT
ajlm-2700	36	17	generation	generation	NOUN
ajlm-2700	36	18	assays	assay	NOUN
ajlm-2700	36	19	offer	offer	VERB
ajlm-2700	36	20	improved	improve	VERB
ajlm-2700	36	21	clinical	clinical	ADJ
ajlm-2700	36	22	value.5	value.5	ADJ
ajlm-2700	36	23	second	second	ADJ
ajlm-2700	36	24	-	-	PUNCT
ajlm-2700	36	25	generation	generation	NOUN
ajlm-2700	36	26	assays	assay	NOUN
ajlm-2700	36	27	are	be	AUX
ajlm-2700	36	28	readily	readily	ADV
ajlm-2700	36	29	available	available	ADJ
ajlm-2700	36	30	,	,	PUNCT
ajlm-2700	36	31	extensively	extensively	ADV
ajlm-2700	36	32	researched	research	VERB
ajlm-2700	36	33	and	and	CCONJ
ajlm-2700	36	34	form	form	VERB
ajlm-2700	36	35	part	part	NOUN
ajlm-2700	36	36	of	of	ADP
ajlm-2700	36	37	current	current	ADJ
ajlm-2700	36	38	clinical	clinical	ADJ
ajlm-2700	36	39	guidelines.12	guidelines.12	NOUN
ajlm-2700	36	40	in	in	ADP
ajlm-2700	36	41	contrast	contrast	NOUN
ajlm-2700	36	42	,	,	PUNCT
ajlm-2700	36	43	there	there	PRON
ajlm-2700	36	44	is	be	VERB
ajlm-2700	36	45	insufficient	insufficient	ADJ
ajlm-2700	36	46	research	research	NOUN
ajlm-2700	36	47	for	for	ADP
ajlm-2700	36	48	the	the	DET
ajlm-2700	36	49	third	third	ADJ
ajlm-2700	36	50	-	-	PUNCT
ajlm-2700	36	51	generation	generation	NOUN
ajlm-2700	36	52	to	to	PART
ajlm-2700	36	53	be	be	AUX
ajlm-2700	36	54	universally	universally	ADV
ajlm-2700	36	55	adopted	adopt	VERB
ajlm-2700	36	56	in	in	ADP
ajlm-2700	36	57	clinical	clinical	ADJ
ajlm-2700	36	58	practice.12	practice.12	NOUN
ajlm-2700	36	59	in	in	ADP
ajlm-2700	36	60	our	our	PRON
ajlm-2700	36	61	setting	setting	NOUN
ajlm-2700	36	62	,	,	PUNCT
ajlm-2700	36	63	the	the	DET
ajlm-2700	36	64	national	national	PROPN
ajlm-2700	36	65	health	health	PROPN
ajlm-2700	36	66	laboratory	laboratory	PROPN
ajlm-2700	36	67	service	service	NOUN
ajlm-2700	36	68	services	service	NOUN
ajlm-2700	36	69	two	two	NUM
ajlm-2700	36	70	major	major	ADJ
ajlm-2700	36	71	academic	academic	ADJ
ajlm-2700	36	72	hospitals	hospital	NOUN
ajlm-2700	36	73	,	,	PUNCT
ajlm-2700	36	74	namely	namely	ADV
ajlm-2700	36	75	chris	chris	PROPN
ajlm-2700	36	76	hani	hani	PROPN
ajlm-2700	36	77	baragwanath	baragwanath	PROPN
ajlm-2700	36	78	academic	academic	PROPN
ajlm-2700	36	79	hospital	hospital	PROPN
ajlm-2700	36	80	and	and	CCONJ
ajlm-2700	36	81	charlotte	charlotte	PROPN
ajlm-2700	36	82	maxeke	maxeke	PROPN
ajlm-2700	36	83	johannesburg	johannesburg	PROPN
ajlm-2700	36	84	academic	academic	PROPN
ajlm-2700	36	85	hospital	hospital	PROPN
ajlm-2700	36	86	(	(	PUNCT
ajlm-2700	36	87	cmjah	cmjah	PROPN
ajlm-2700	36	88	)	)	PUNCT
ajlm-2700	36	89	,	,	PUNCT
ajlm-2700	36	90	which	which	PRON
ajlm-2700	36	91	utilise	utilise	VERB
ajlm-2700	36	92	the	the	DET
ajlm-2700	36	93	secondand	secondand	NOUN
ajlm-2700	36	94	third	third	ADJ
ajlm-2700	36	95	-	-	PUNCT
ajlm-2700	36	96	generation	generation	NOUN
ajlm-2700	36	97	pth	pth	NOUN
ajlm-2700	36	98	assays	assay	NOUN
ajlm-2700	36	99	,	,	PUNCT
ajlm-2700	36	100	respectively	respectively	ADV
ajlm-2700	36	101	,	,	PUNCT
ajlm-2700	36	102	from	from	ADP
ajlm-2700	36	103	the	the	DET
ajlm-2700	36	104	same	same	ADJ
ajlm-2700	36	105	manufacturer	manufacturer	NOUN
ajlm-2700	36	106	with	with	ADP
ajlm-2700	36	107	similar	similar	ADJ
ajlm-2700	36	108	reference	reference	NOUN
ajlm-2700	36	109	intervals	interval	NOUN
ajlm-2700	36	110	.	.	PUNCT
ajlm-2700	37	1	there	there	PRON
ajlm-2700	37	2	is	be	VERB
ajlm-2700	37	3	considerable	considerable	ADJ
ajlm-2700	37	4	movement	movement	NOUN
ajlm-2700	37	5	of	of	ADP
ajlm-2700	37	6	patients	patient	NOUN
ajlm-2700	37	7	and	and	CCONJ
ajlm-2700	37	8	blood	blood	NOUN
ajlm-2700	37	9	samples	sample	NOUN
ajlm-2700	37	10	between	between	ADP
ajlm-2700	37	11	the	the	DET
ajlm-2700	37	12	two	two	NUM
ajlm-2700	37	13	hospitals	hospital	NOUN
ajlm-2700	37	14	,	,	PUNCT
ajlm-2700	37	15	which	which	PRON
ajlm-2700	37	16	may	may	AUX
ajlm-2700	37	17	affect	affect	VERB
ajlm-2700	37	18	pth	pth	NOUN
ajlm-2700	37	19	interpretation	interpretation	NOUN
ajlm-2700	37	20	and	and	CCONJ
ajlm-2700	37	21	clinical	clinical	ADJ
ajlm-2700	37	22	decision	decision	NOUN
ajlm-2700	37	23	-	-	PUNCT
ajlm-2700	37	24	making	making	NOUN
ajlm-2700	37	25	depending	depend	VERB
ajlm-2700	37	26	on	on	ADP
ajlm-2700	37	27	the	the	DET
ajlm-2700	37	28	assay	assay	NOUN
ajlm-2700	37	29	used	use	VERB
ajlm-2700	37	30	.	.	PUNCT
ajlm-2700	38	1	the	the	DET
ajlm-2700	38	2	aim	aim	NOUN
ajlm-2700	38	3	of	of	ADP
ajlm-2700	38	4	this	this	DET
ajlm-2700	38	5	study	study	NOUN
ajlm-2700	38	6	was	be	AUX
ajlm-2700	38	7	to	to	PART
ajlm-2700	38	8	compare	compare	VERB
ajlm-2700	38	9	the	the	DET
ajlm-2700	38	10	analytical	analytical	ADJ
ajlm-2700	38	11	performance	performance	NOUN
ajlm-2700	38	12	of	of	ADP
ajlm-2700	38	13	secondand	secondand	NOUN
ajlm-2700	38	14	third	third	ADJ
ajlm-2700	38	15	-	-	PUNCT
ajlm-2700	38	16	generation	generation	NOUN
ajlm-2700	38	17	pth	pth	NOUN
ajlm-2700	38	18	assays	assay	NOUN
ajlm-2700	38	19	and	and	CCONJ
ajlm-2700	38	20	their	their	PRON
ajlm-2700	38	21	impact	impact	NOUN
ajlm-2700	38	22	on	on	ADP
ajlm-2700	38	23	clinical	clinical	ADJ
ajlm-2700	38	24	interpretation	interpretation	NOUN
ajlm-2700	38	25	of	of	ADP
ajlm-2700	38	26	hypoand	hypoand	NOUN
ajlm-2700	38	27	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	38	28	,	,	PUNCT
ajlm-2700	38	29	and	and	CCONJ
ajlm-2700	38	30	in	in	ADP
ajlm-2700	38	31	pre	pre	ADJ
ajlm-2700	38	32	-	-	NOUN
ajlm-2700	38	33	dialysis	dialysis	NOUN
ajlm-2700	38	34	and	and	CCONJ
ajlm-2700	38	35	dialysis	dialysis	NOUN
ajlm-2700	38	36	ckd	ckd	PROPN
ajlm-2700	38	37	based	base	VERB
ajlm-2700	38	38	on	on	ADP
ajlm-2700	38	39	current	current	ADJ
ajlm-2700	38	40	kdigo	kdigo	PROPN
ajlm-2700	38	41	guidelines	guideline	NOUN
ajlm-2700	38	42	.	.	PUNCT
ajlm-2700	39	1	methods	method	NOUN
ajlm-2700	39	2	ethical	ethical	ADJ
ajlm-2700	39	3	considerations	consideration	NOUN
ajlm-2700	39	4	this	this	DET
ajlm-2700	39	5	study	study	NOUN
ajlm-2700	39	6	has	have	AUX
ajlm-2700	39	7	been	be	AUX
ajlm-2700	39	8	approved	approve	VERB
ajlm-2700	39	9	by	by	ADP
ajlm-2700	39	10	the	the	DET
ajlm-2700	39	11	human	human	PROPN
ajlm-2700	39	12	research	research	PROPN
ajlm-2700	39	13	ethics	ethic	NOUN
ajlm-2700	39	14	committee	committee	PROPN
ajlm-2700	39	15	(	(	PUNCT
ajlm-2700	39	16	medical	medical	ADJ
ajlm-2700	39	17	)	)	PUNCT
ajlm-2700	39	18	of	of	ADP
ajlm-2700	39	19	the	the	DET
ajlm-2700	39	20	university	university	NOUN
ajlm-2700	39	21	of	of	ADP
ajlm-2700	39	22	the	the	DET
ajlm-2700	39	23	witwatersrand	witwatersrand	NOUN
ajlm-2700	39	24	and	and	CCONJ
ajlm-2700	39	25	performed	perform	VERB
ajlm-2700	39	26	in	in	ADP
ajlm-2700	39	27	line	line	NOUN
ajlm-2700	39	28	with	with	ADP
ajlm-2700	39	29	the	the	DET
ajlm-2700	39	30	declaration	declaration	NOUN
ajlm-2700	39	31	of	of	ADP
ajlm-2700	39	32	helsinki	helsinki	PROPN
ajlm-2700	39	33	.	.	PUNCT
ajlm-2700	40	1	the	the	DET
ajlm-2700	40	2	study	study	NOUN
ajlm-2700	40	3	made	make	VERB
ajlm-2700	40	4	use	use	NOUN
ajlm-2700	40	5	of	of	ADP
ajlm-2700	40	6	remnant	remnant	ADJ
ajlm-2700	40	7	patient	patient	NOUN
ajlm-2700	40	8	samples	sample	NOUN
ajlm-2700	40	9	on	on	ADP
ajlm-2700	40	10	which	which	PRON
ajlm-2700	40	11	routine	routine	ADJ
ajlm-2700	40	12	pth	pth	NOUN
ajlm-2700	40	13	measurement	measurement	NOUN
ajlm-2700	40	14	was	be	AUX
ajlm-2700	40	15	requested	request	VERB
ajlm-2700	40	16	.	.	PUNCT
ajlm-2700	41	1	ethics	ethic	NOUN
ajlm-2700	41	2	clearance	clearance	NOUN
ajlm-2700	41	3	(	(	PUNCT
ajlm-2700	41	4	clearance	clearance	NOUN
ajlm-2700	41	5	certificate	certificate	NOUN
ajlm-2700	41	6	number	number	NOUN
ajlm-2700	41	7	m210475	m210475	PROPN
ajlm-2700	41	8	)	)	PUNCT
ajlm-2700	41	9	was	be	AUX
ajlm-2700	41	10	obtained	obtain	VERB
ajlm-2700	41	11	for	for	ADP
ajlm-2700	41	12	use	use	NOUN
ajlm-2700	41	13	of	of	ADP
ajlm-2700	41	14	remnant	remnant	ADJ
ajlm-2700	41	15	samples	sample	NOUN
ajlm-2700	41	16	and	and	CCONJ
ajlm-2700	41	17	informed	inform	VERB
ajlm-2700	41	18	consent	consent	NOUN
ajlm-2700	41	19	was	be	AUX
ajlm-2700	41	20	not	not	PART
ajlm-2700	41	21	required	require	VERB
ajlm-2700	41	22	.	.	PUNCT
ajlm-2700	42	1	all	all	DET
ajlm-2700	42	2	patient	patient	ADJ
ajlm-2700	42	3	data	datum	NOUN
ajlm-2700	42	4	obtained	obtain	VERB
ajlm-2700	42	5	were	be	AUX
ajlm-2700	42	6	fully	fully	ADV
ajlm-2700	42	7	anonymised	anonymise	VERB
ajlm-2700	42	8	and	and	CCONJ
ajlm-2700	42	9	de	de	VERB
ajlm-2700	42	10	-	-	VERB
ajlm-2700	42	11	identified	identify	VERB
ajlm-2700	42	12	before	before	ADP
ajlm-2700	42	13	accession	accession	NOUN
ajlm-2700	42	14	.	.	PUNCT
ajlm-2700	43	1	study	study	NOUN
ajlm-2700	43	2	design	design	NOUN
ajlm-2700	43	3	this	this	DET
ajlm-2700	43	4	cross	cross	ADJ
ajlm-2700	43	5	-	-	ADJ
ajlm-2700	43	6	sectional	sectional	ADJ
ajlm-2700	43	7	study	study	NOUN
ajlm-2700	43	8	was	be	AUX
ajlm-2700	43	9	conducted	conduct	VERB
ajlm-2700	43	10	between	between	ADP
ajlm-2700	43	11	06	06	NUM
ajlm-2700	43	12	april	april	PROPN
ajlm-2700	43	13	2022	2022	NUM
ajlm-2700	43	14	and	and	CCONJ
ajlm-2700	43	15	21	21	NUM
ajlm-2700	43	16	september	september	PROPN
ajlm-2700	43	17	2022	2022	NUM
ajlm-2700	43	18	,	,	PUNCT
ajlm-2700	43	19	in	in	ADP
ajlm-2700	43	20	two	two	NUM
ajlm-2700	43	21	parts	part	NOUN
ajlm-2700	43	22	.	.	PUNCT
ajlm-2700	44	1	the	the	DET
ajlm-2700	44	2	first	first	ADJ
ajlm-2700	44	3	part	part	NOUN
ajlm-2700	44	4	was	be	AUX
ajlm-2700	44	5	a	a	DET
ajlm-2700	44	6	method	method	ADJ
ajlm-2700	44	7	comparison	comparison	NOUN
ajlm-2700	44	8	study	study	NOUN
ajlm-2700	44	9	conducted	conduct	VERB
ajlm-2700	44	10	on	on	ADP
ajlm-2700	44	11	residual	residual	ADJ
ajlm-2700	44	12	patient	patient	NOUN
ajlm-2700	44	13	samples	sample	NOUN
ajlm-2700	44	14	from	from	ADP
ajlm-2700	44	15	both	both	DET
ajlm-2700	44	16	inand	inand	ADJ
ajlm-2700	44	17	outpatients	outpatient	NOUN
ajlm-2700	44	18	on	on	ADP
ajlm-2700	44	19	which	which	PRON
ajlm-2700	44	20	a	a	DET
ajlm-2700	44	21	pth	pth	NOUN
ajlm-2700	44	22	was	be	AUX
ajlm-2700	44	23	requested	request	VERB
ajlm-2700	44	24	at	at	ADP
ajlm-2700	44	25	cmjah	cmjah	PROPN
ajlm-2700	44	26	national	national	PROPN
ajlm-2700	44	27	health	health	PROPN
ajlm-2700	44	28	laboratory	laboratory	PROPN
ajlm-2700	44	29	service	service	NOUN
ajlm-2700	44	30	.	.	PUNCT
ajlm-2700	45	1	these	these	DET
ajlm-2700	45	2	samples	sample	NOUN
ajlm-2700	45	3	were	be	AUX
ajlm-2700	45	4	tested	test	VERB
ajlm-2700	45	5	on	on	ADP
ajlm-2700	45	6	both	both	DET
ajlm-2700	45	7	secondand	secondand	NOUN
ajlm-2700	45	8	third	third	ADJ
ajlm-2700	45	9	-	-	PUNCT
ajlm-2700	45	10	generation	generation	NOUN
ajlm-2700	45	11	pth	pth	NOUN
ajlm-2700	45	12	assays	assay	NOUN
ajlm-2700	45	13	consecutively	consecutively	ADV
ajlm-2700	45	14	.	.	PUNCT
ajlm-2700	46	1	the	the	DET
ajlm-2700	46	2	second	second	ADJ
ajlm-2700	46	3	part	part	NOUN
ajlm-2700	46	4	assessed	assess	VERB
ajlm-2700	46	5	clinical	clinical	ADJ
ajlm-2700	46	6	interpretation	interpretation	NOUN
ajlm-2700	46	7	of	of	ADP
ajlm-2700	46	8	the	the	DET
ajlm-2700	46	9	assays	assay	NOUN
ajlm-2700	46	10	’	'	PUNCT
ajlm-2700	46	11	results	result	NOUN
ajlm-2700	46	12	among	among	ADP
ajlm-2700	46	13	a	a	DET
ajlm-2700	46	14	subset	subset	NOUN
ajlm-2700	46	15	of	of	ADP
ajlm-2700	46	16	the	the	DET
ajlm-2700	46	17	same	same	ADJ
ajlm-2700	46	18	group	group	NOUN
ajlm-2700	46	19	of	of	ADP
ajlm-2700	46	20	patients	patient	NOUN
ajlm-2700	46	21	,	,	PUNCT
ajlm-2700	46	22	using	use	VERB
ajlm-2700	46	23	data	datum	NOUN
ajlm-2700	46	24	from	from	ADP
ajlm-2700	46	25	the	the	DET
ajlm-2700	46	26	laboratory	laboratory	NOUN
ajlm-2700	46	27	information	information	NOUN
ajlm-2700	46	28	system	system	NOUN
ajlm-2700	46	29	.	.	PUNCT
ajlm-2700	47	1	sample	sample	NOUN
ajlm-2700	47	2	size	size	NOUN
ajlm-2700	47	3	calculations	calculation	NOUN
ajlm-2700	47	4	for	for	ADP
ajlm-2700	47	5	a	a	DET
ajlm-2700	47	6	method	method	ADJ
ajlm-2700	47	7	comparison	comparison	NOUN
ajlm-2700	47	8	study	study	NOUN
ajlm-2700	47	9	,	,	PUNCT
ajlm-2700	47	10	a	a	DET
ajlm-2700	47	11	minimum	minimum	NOUN
ajlm-2700	47	12	of	of	ADP
ajlm-2700	47	13	40	40	NUM
ajlm-2700	47	14	samples	sample	NOUN
ajlm-2700	47	15	is	be	AUX
ajlm-2700	47	16	required	require	VERB
ajlm-2700	47	17	to	to	PART
ajlm-2700	47	18	achieve	achieve	VERB
ajlm-2700	47	19	statistical	statistical	ADJ
ajlm-2700	47	20	significance	significance	NOUN
ajlm-2700	47	21	as	as	ADP
ajlm-2700	47	22	per	per	ADP
ajlm-2700	47	23	clinical	clinical	ADJ
ajlm-2700	47	24	laboratory	laboratory	NOUN
ajlm-2700	47	25	standard	standard	PROPN
ajlm-2700	47	26	institute	institute	NOUN
ajlm-2700	47	27	ep09	ep09	PROPN
ajlm-2700	47	28	-	-	PUNCT
ajlm-2700	47	29	a3	a3	NOUN
ajlm-2700	47	30	guideline.16	guideline.16	PROPN
ajlm-2700	47	31	however	however	ADV
ajlm-2700	47	32	,	,	PUNCT
ajlm-2700	47	33	more	more	ADJ
ajlm-2700	47	34	than	than	ADP
ajlm-2700	47	35	100	100	NUM
ajlm-2700	47	36	are	be	AUX
ajlm-2700	47	37	recommended	recommend	VERB
ajlm-2700	47	38	to	to	PART
ajlm-2700	47	39	improve	improve	VERB
ajlm-2700	47	40	statistical	statistical	ADJ
ajlm-2700	47	41	power	power	NOUN
ajlm-2700	47	42	.	.	PUNCT
ajlm-2700	48	1	all	all	DET
ajlm-2700	48	2	pth	pth	NOUN
ajlm-2700	48	3	samples	sample	NOUN
ajlm-2700	48	4	received	receive	VERB
ajlm-2700	48	5	during	during	ADP
ajlm-2700	48	6	the	the	DET
ajlm-2700	48	7	study	study	NOUN
ajlm-2700	48	8	period	period	NOUN
ajlm-2700	48	9	were	be	AUX
ajlm-2700	48	10	considered	consider	VERB
ajlm-2700	48	11	for	for	ADP
ajlm-2700	48	12	the	the	DET
ajlm-2700	48	13	study	study	NOUN
ajlm-2700	48	14	and	and	CCONJ
ajlm-2700	48	15	included	include	VERB
ajlm-2700	48	16	if	if	SCONJ
ajlm-2700	48	17	they	they	PRON
ajlm-2700	48	18	met	meet	VERB
ajlm-2700	48	19	the	the	DET
ajlm-2700	48	20	criteria	criterion	NOUN
ajlm-2700	48	21	.	.	PUNCT
ajlm-2700	49	1	for	for	ADP
ajlm-2700	49	2	clinical	clinical	ADJ
ajlm-2700	49	3	interpretation	interpretation	NOUN
ajlm-2700	49	4	,	,	PUNCT
ajlm-2700	49	5	the	the	DET
ajlm-2700	49	6	equation	equation	NOUN
ajlm-2700	49	7	117	117	NUM
ajlm-2700	49	8	was	be	AUX
ajlm-2700	49	9	used	use	VERB
ajlm-2700	49	10	to	to	PART
ajlm-2700	49	11	derive	derive	VERB
ajlm-2700	49	12	the	the	DET
ajlm-2700	49	13	sample	sample	NOUN
ajlm-2700	49	14	size	size	NOUN
ajlm-2700	49	15	(	(	PUNCT
ajlm-2700	49	16	n	n	CCONJ
ajlm-2700	49	17	):	):	PUNCT
ajlm-2700	49	18	utilising	utilise	VERB
ajlm-2700	49	19	a	a	DET
ajlm-2700	49	20	prevalence	prevalence	NOUN
ajlm-2700	49	21	of	of	ADP
ajlm-2700	49	22	6.4	6.4	NUM
ajlm-2700	49	23	%	%	NOUN
ajlm-2700	49	24	in	in	ADP
ajlm-2700	49	25	south	south	PROPN
ajlm-2700	49	26	africa	africa	PROPN
ajlm-2700	49	27	for	for	ADP
ajlm-2700	49	28	ckd	ckd	PROPN
ajlm-2700	49	29	;	;	PUNCT
ajlm-2700	49	30	z	z	NOUN
ajlm-2700	49	31	denotes	denote	VERB
ajlm-2700	49	32	the	the	DET
ajlm-2700	49	33	z	z	NOUN
ajlm-2700	49	34	-	-	PUNCT
ajlm-2700	49	35	score	score	NOUN
ajlm-2700	49	36	of	of	ADP
ajlm-2700	49	37	1.96	1.96	NUM
ajlm-2700	49	38	that	that	PRON
ajlm-2700	49	39	corresponds	correspond	VERB
ajlm-2700	49	40	to	to	ADP
ajlm-2700	49	41	the	the	DET
ajlm-2700	49	42	confidence	confidence	NOUN
ajlm-2700	49	43	interval	interval	NOUN
ajlm-2700	49	44	(	(	PUNCT
ajlm-2700	49	45	ci	ci	NOUN
ajlm-2700	49	46	)	)	PUNCT
ajlm-2700	49	47	of	of	ADP
ajlm-2700	49	48	95	95	NUM
ajlm-2700	49	49	%	%	NOUN
ajlm-2700	49	50	,	,	PUNCT
ajlm-2700	49	51	p	p	NOUN
ajlm-2700	49	52	is	be	AUX
ajlm-2700	49	53	expected	expect	VERB
ajlm-2700	49	54	prevalence	prevalence	NOUN
ajlm-2700	49	55	(	(	PUNCT
ajlm-2700	49	56	6.4	6.4	NUM
ajlm-2700	49	57	%	%	NOUN
ajlm-2700	49	58	)	)	PUNCT
ajlm-2700	50	1	and	and	CCONJ
ajlm-2700	50	2	d	d	PROPN
ajlm-2700	50	3	is	be	AUX
ajlm-2700	50	4	precision	precision	NOUN
ajlm-2700	50	5	,	,	PUNCT
ajlm-2700	50	6	which	which	PRON
ajlm-2700	50	7	reflects	reflect	VERB
ajlm-2700	50	8	the	the	DET
ajlm-2700	50	9	effect	effect	NOUN
ajlm-2700	50	10	size	size	NOUN
ajlm-2700	50	11	and	and	CCONJ
ajlm-2700	50	12	was	be	AUX
ajlm-2700	50	13	estimated	estimate	VERB
ajlm-2700	50	14	to	to	PART
ajlm-2700	50	15	be	be	AUX
ajlm-2700	50	16	5%.17,18	5%.17,18	NUM
ajlm-2700	50	17	a	a	DET
ajlm-2700	50	18	minimum	minimum	NOUN
ajlm-2700	50	19	of	of	ADP
ajlm-2700	50	20	92	92	NUM
ajlm-2700	50	21	samples	sample	NOUN
ajlm-2700	50	22	from	from	ADP
ajlm-2700	50	23	ckd	ckd	NOUN
ajlm-2700	50	24	patients	patient	NOUN
ajlm-2700	50	25	were	be	AUX
ajlm-2700	50	26	required	require	VERB
ajlm-2700	50	27	to	to	PART
ajlm-2700	50	28	demonstrate	demonstrate	VERB
ajlm-2700	50	29	a	a	DET
ajlm-2700	50	30	difference	difference	NOUN
ajlm-2700	50	31	between	between	ADP
ajlm-2700	50	32	the	the	DET
ajlm-2700	50	33	two	two	NUM
ajlm-2700	50	34	assays	assay	NOUN
ajlm-2700	50	35	.	.	PUNCT
ajlm-2700	51	1	method	method	ADJ
ajlm-2700	51	2	comparison	comparison	NOUN
ajlm-2700	51	3	samples	sample	NOUN
ajlm-2700	51	4	were	be	AUX
ajlm-2700	51	5	collected	collect	VERB
ajlm-2700	51	6	in	in	ADP
ajlm-2700	51	7	bd	bd	PROPN
ajlm-2700	51	8	vacutainer	vacutainer	PROPN
ajlm-2700	51	9	®	®	PROPN
ajlm-2700	51	10	ethylenediamine	ethylenediamine	NOUN
ajlm-2700	51	11	-	-	PUNCT
ajlm-2700	51	12	tetraacetic	tetraacetic	NOUN
ajlm-2700	51	13	acid	acid	NOUN
ajlm-2700	51	14	tubes	tube	NOUN
ajlm-2700	51	15	™	™	NOUN
ajlm-2700	51	16	(	(	PUNCT
ajlm-2700	51	17	becton	becton	PROPN
ajlm-2700	51	18	dickinson	dickinson	PROPN
ajlm-2700	51	19	and	and	CCONJ
ajlm-2700	51	20	company	company	NOUN
ajlm-2700	51	21	,	,	PUNCT
ajlm-2700	51	22	franklin	franklin	PROPN
ajlm-2700	51	23	lakes	lakes	PROPN
ajlm-2700	51	24	,	,	PUNCT
ajlm-2700	51	25	new	new	PROPN
ajlm-2700	51	26	jersey	jersey	PROPN
ajlm-2700	51	27	,	,	PUNCT
ajlm-2700	51	28	united	united	PROPN
ajlm-2700	51	29	states	states	PROPN
ajlm-2700	51	30	)	)	PUNCT
ajlm-2700	51	31	by	by	ADP
ajlm-2700	51	32	clinicians	clinician	NOUN
ajlm-2700	51	33	as	as	ADP
ajlm-2700	51	34	part	part	NOUN
ajlm-2700	51	35	of	of	ADP
ajlm-2700	51	36	the	the	DET
ajlm-2700	51	37	routine	routine	ADJ
ajlm-2700	51	38	clinical	clinical	ADJ
ajlm-2700	51	39	care	care	NOUN
ajlm-2700	51	40	.	.	PUNCT
ajlm-2700	52	1	samples	sample	NOUN
ajlm-2700	52	2	of	of	ADP
ajlm-2700	52	3	sufficient	sufficient	ADJ
ajlm-2700	52	4	volume	volume	NOUN
ajlm-2700	52	5	and	and	CCONJ
ajlm-2700	52	6	within	within	ADP
ajlm-2700	52	7	recommended	recommend	VERB
ajlm-2700	52	8	stability	stability	NOUN
ajlm-2700	52	9	period	period	NOUN
ajlm-2700	52	10	of	of	ADP
ajlm-2700	52	11	48	48	NUM
ajlm-2700	52	12	h	h	NOUN
ajlm-2700	52	13	when	when	SCONJ
ajlm-2700	52	14	stored	store	VERB
ajlm-2700	52	15	at	at	ADP
ajlm-2700	52	16	2	2	NUM
ajlm-2700	52	17	°	°	ADP
ajlm-2700	52	18	c	c	NOUN
ajlm-2700	52	19	–	–	PUNCT
ajlm-2700	52	20	8	8	NUM
ajlm-2700	52	21	°	°	NUM
ajlm-2700	52	22	c	c	NOUN
ajlm-2700	52	23	were	be	AUX
ajlm-2700	52	24	included	include	VERB
ajlm-2700	52	25	.	.	PUNCT
ajlm-2700	53	1	the	the	DET
ajlm-2700	53	2	samples	sample	NOUN
ajlm-2700	53	3	were	be	AUX
ajlm-2700	53	4	initially	initially	ADV
ajlm-2700	53	5	analysed	analyse	VERB
ajlm-2700	53	6	using	use	VERB
ajlm-2700	53	7	the	the	DET
ajlm-2700	53	8	third	third	ADJ
ajlm-2700	53	9	-	-	PUNCT
ajlm-2700	53	10	generation	generation	NOUN
ajlm-2700	53	11	roche	roche	NOUN
ajlm-2700	53	12	th	th	PRON
ajlm-2700	53	13	1–84	1–84	NOUN
ajlm-2700	53	14	assay	assay	VERB
ajlm-2700	53	15	on	on	ADP
ajlm-2700	53	16	the	the	DET
ajlm-2700	53	17	roche	roche	PROPN
ajlm-2700	53	18	cobas	cobas	PROPN
ajlm-2700	53	19	®	®	PROPN
ajlm-2700	53	20	e602	e602	PROPN
ajlm-2700	53	21	analyser	analyser	NOUN
ajlm-2700	53	22	(	(	PUNCT
ajlm-2700	53	23	roche	roche	NOUN
ajlm-2700	53	24	diagnostics	diagnostic	NOUN
ajlm-2700	53	25	,	,	PUNCT
ajlm-2700	53	26	mannheim	mannheim	PROPN
ajlm-2700	53	27	,	,	PUNCT
ajlm-2700	53	28	germany	germany	PROPN
ajlm-2700	53	29	)	)	PUNCT
ajlm-2700	53	30	,	,	PUNCT
ajlm-2700	53	31	the	the	DET
ajlm-2700	53	32	routine	routine	ADJ
ajlm-2700	53	33	assay	assay	VERB
ajlm-2700	53	34	at	at	ADP
ajlm-2700	53	35	cmjah	cmjah	NOUN
ajlm-2700	53	36	.	.	PUNCT
ajlm-2700	54	1	the	the	DET
ajlm-2700	54	2	second	second	ADJ
ajlm-2700	54	3	-	-	PUNCT
ajlm-2700	54	4	generation	generation	NOUN
ajlm-2700	54	5	intact	intact	ADJ
ajlm-2700	54	6	pth	pth	NOUN
ajlm-2700	54	7	assay	assay	NOUN
ajlm-2700	54	8	was	be	AUX
ajlm-2700	54	9	validated	validate	VERB
ajlm-2700	54	10	on	on	ADP
ajlm-2700	54	11	the	the	DET
ajlm-2700	54	12	same	same	ADJ
ajlm-2700	54	13	analyser	analyser	NOUN
ajlm-2700	54	14	for	for	ADP
ajlm-2700	54	15	the	the	DET
ajlm-2700	54	16	study	study	NOUN
ajlm-2700	54	17	at	at	ADP
ajlm-2700	54	18	cmjah	cmjah	PROPN
ajlm-2700	54	19	laboratory	laboratory	PROPN
ajlm-2700	54	20	,	,	PUNCT
ajlm-2700	54	21	replicating	replicate	VERB
ajlm-2700	54	22	the	the	DET
ajlm-2700	54	23	assay	assay	NOUN
ajlm-2700	54	24	used	use	VERB
ajlm-2700	54	25	at	at	ADP
ajlm-2700	54	26	chris	chris	PROPN
ajlm-2700	54	27	hani	hani	PROPN
ajlm-2700	54	28	baragwanath	baragwanath	PROPN
ajlm-2700	54	29	academic	academic	ADJ
ajlm-2700	54	30	hospital	hospital	NOUN
ajlm-2700	54	31	.	.	PUNCT
ajlm-2700	55	1	parathyroid	parathyroid	ADJ
ajlm-2700	55	2	hormone	hormone	NOUN
ajlm-2700	55	3	is	be	AUX
ajlm-2700	55	4	unstable	unstable	ADJ
ajlm-2700	55	5	in	in	ADP
ajlm-2700	55	6	blood	blood	NOUN
ajlm-2700	55	7	samples	sample	NOUN
ajlm-2700	55	8	;	;	PUNCT
ajlm-2700	55	9	to	to	PART
ajlm-2700	55	10	maintain	maintain	VERB
ajlm-2700	55	11	sample	sample	NOUN
ajlm-2700	55	12	stability	stability	NOUN
ajlm-2700	55	13	,	,	PUNCT
ajlm-2700	55	14	method	method	ADJ
ajlm-2700	55	15	comparison	comparison	NOUN
ajlm-2700	55	16	was	be	AUX
ajlm-2700	55	17	performed	perform	VERB
ajlm-2700	55	18	at	at	ADP
ajlm-2700	55	19	the	the	DET
ajlm-2700	55	20	same	same	ADJ
ajlm-2700	55	21	site	site	NOUN
ajlm-2700	55	22	.	.	PUNCT
ajlm-2700	56	1	after	after	ADP
ajlm-2700	56	2	analysing	analyse	VERB
ajlm-2700	56	3	the	the	DET
ajlm-2700	56	4	samples	sample	NOUN
ajlm-2700	56	5	on	on	ADP
ajlm-2700	56	6	the	the	DET
ajlm-2700	56	7	third	third	ADJ
ajlm-2700	56	8	-	-	PUNCT
ajlm-2700	56	9	generation	generation	NOUN
ajlm-2700	56	10	pth	pth	NOUN
ajlm-2700	56	11	assay	assay	NOUN
ajlm-2700	56	12	,	,	PUNCT
ajlm-2700	56	13	they	they	PRON
ajlm-2700	56	14	were	be	AUX
ajlm-2700	56	15	immediately	immediately	ADV
ajlm-2700	56	16	re	re	VERB
ajlm-2700	56	17	-	-	VERB
ajlm-2700	56	18	analysed	analyse	VERB
ajlm-2700	56	19	using	use	VERB
ajlm-2700	56	20	the	the	DET
ajlm-2700	56	21	newly	newly	ADV
ajlm-2700	56	22	validated	validate	VERB
ajlm-2700	56	23	second	second	ADJ
ajlm-2700	56	24	-	-	PUNCT
ajlm-2700	56	25	generation	generation	NOUN
ajlm-2700	56	26	roche	roche	NOUN
ajlm-2700	56	27	intact	intact	ADJ
ajlm-2700	56	28	pth	pth	NOUN
ajlm-2700	56	29	assay	assay	NOUN
ajlm-2700	56	30	.	.	PUNCT
ajlm-2700	57	1	laboratory	laboratory	NOUN
ajlm-2700	57	2	analysis	analysis	NOUN
ajlm-2700	57	3	a	a	DET
ajlm-2700	57	4	verification	verification	NOUN
ajlm-2700	57	5	study	study	NOUN
ajlm-2700	57	6	for	for	ADP
ajlm-2700	57	7	the	the	DET
ajlm-2700	57	8	second	second	ADJ
ajlm-2700	57	9	-	-	PUNCT
ajlm-2700	57	10	generation	generation	NOUN
ajlm-2700	57	11	pth	pth	NOUN
ajlm-2700	57	12	assay	assay	NOUN
ajlm-2700	57	13	was	be	AUX
ajlm-2700	57	14	performed	perform	VERB
ajlm-2700	57	15	according	accord	VERB
ajlm-2700	57	16	to	to	ADP
ajlm-2700	57	17	the	the	DET
ajlm-2700	57	18	clinical	clinical	ADJ
ajlm-2700	57	19	laboratory	laboratory	PROPN
ajlm-2700	57	20	standard	standard	PROPN
ajlm-2700	57	21	institute	institute	PROPN
ajlm-2700	57	22	ep15	ep15	PROPN
ajlm-2700	57	23	-	-	PUNCT
ajlm-2700	57	24	a3	a3	NOUN
ajlm-2700	57	25	guideline.19	guideline.19	NOUN
ajlm-2700	57	26	this	this	PRON
ajlm-2700	57	27	was	be	AUX
ajlm-2700	57	28	done	do	VERB
ajlm-2700	57	29	because	because	SCONJ
ajlm-2700	57	30	the	the	DET
ajlm-2700	57	31	second	second	ADJ
ajlm-2700	57	32	-	-	PUNCT
ajlm-2700	57	33	generation	generation	NOUN
ajlm-2700	57	34	pth	pth	NOUN
ajlm-2700	57	35	assay	assay	NOUN
ajlm-2700	57	36	was	be	AUX
ajlm-2700	57	37	not	not	PART
ajlm-2700	57	38	validated	validate	VERB
ajlm-2700	57	39	on	on	ADP
ajlm-2700	57	40	the	the	DET
ajlm-2700	57	41	roche	roche	PROPN
ajlm-2700	57	42	cobas	cobas	PROPN
ajlm-2700	57	43	®	®	NOUN
ajlm-2700	57	44	e602	e602	PROPN
ajlm-2700	57	45	analyser	analyser	NOUN
ajlm-2700	57	46	at	at	ADP
ajlm-2700	57	47	cmjah	cmjah	PROPN
ajlm-2700	57	48	.	.	PUNCT
ajlm-2700	58	1	assay	assay	NOUN
ajlm-2700	58	2	performance	performance	NOUN
ajlm-2700	58	3	was	be	AUX
ajlm-2700	58	4	within	within	ADP
ajlm-2700	58	5	the	the	DET
ajlm-2700	58	6	acceptable	acceptable	ADJ
ajlm-2700	58	7	limits	limit	NOUN
ajlm-2700	58	8	of	of	ADP
ajlm-2700	58	9	the	the	DET
ajlm-2700	58	10	manufacturer	manufacturer	NOUN
ajlm-2700	58	11	’s	’s	PART
ajlm-2700	58	12	claims	claim	NOUN
ajlm-2700	58	13	with	with	ADP
ajlm-2700	58	14	intra	intra	ADJ
ajlm-2700	58	15	-	-	ADJ
ajlm-2700	58	16	assay	assay	ADJ
ajlm-2700	58	17	variability	variability	NOUN
ajlm-2700	58	18	of	of	ADP
ajlm-2700	58	19	0.9	0.9	NUM
ajlm-2700	58	20	%	%	NOUN
ajlm-2700	58	21	,	,	PUNCT
ajlm-2700	58	22	and	and	CCONJ
ajlm-2700	58	23	inter	inter	ADJ
ajlm-2700	58	24	-	-	ADJ
ajlm-2700	58	25	assay	assay	ADJ
ajlm-2700	58	26	variability	variability	NOUN
ajlm-2700	58	27	of	of	ADP
ajlm-2700	58	28	2.2	2.2	NUM
ajlm-2700	58	29	%	%	NOUN
ajlm-2700	58	30	.	.	PUNCT
ajlm-2700	59	1	the	the	DET
ajlm-2700	59	2	pth	pth	NOUN
ajlm-2700	59	3	assays	assay	NOUN
ajlm-2700	59	4	’	'	PUNCT
ajlm-2700	59	5	analytical	analytical	ADJ
ajlm-2700	59	6	performance	performance	NOUN
ajlm-2700	59	7	was	be	AUX
ajlm-2700	59	8	compared	compare	VERB
ajlm-2700	59	9	as	as	ADP
ajlm-2700	59	10	per	per	ADP
ajlm-2700	59	11	the	the	DET
ajlm-2700	59	12	clinical	clinical	ADJ
ajlm-2700	59	13	laboratory	laboratory	PROPN
ajlm-2700	59	14	standard	standard	PROPN
ajlm-2700	59	15	institute	institute	PROPN
ajlm-2700	59	16	ep	ep	PROPN
ajlm-2700	59	17	09	09	NUM
ajlm-2700	59	18	-	-	PUNCT
ajlm-2700	59	19	a3	a3	NOUN
ajlm-2700	59	20	guideline.16	guideline.16	NOUN
ajlm-2700	59	21	analyses	analysis	NOUN
ajlm-2700	59	22	of	of	ADP
ajlm-2700	59	23	samples	sample	NOUN
ajlm-2700	59	24	for	for	ADP
ajlm-2700	59	25	pth	pth	NOUN
ajlm-2700	59	26	were	be	AUX
ajlm-2700	59	27	performed	perform	VERB
ajlm-2700	59	28	on	on	ADP
ajlm-2700	59	29	an	an	DET
ajlm-2700	59	30	e602	e602	PROPN
ajlm-2700	59	31	module	module	NOUN
ajlm-2700	59	32	of	of	ADP
ajlm-2700	59	33	a	a	DET
ajlm-2700	59	34	cobas	cobas	ADJ
ajlm-2700	59	35	®	®	NOUN
ajlm-2700	59	36	8000	8000	NUM
ajlm-2700	59	37	system	system	NOUN
ajlm-2700	59	38	(	(	PUNCT
ajlm-2700	59	39	roche	roche	NOUN
ajlm-2700	59	40	diagnostics	diagnostic	NOUN
ajlm-2700	59	41	,	,	PUNCT
ajlm-2700	59	42	mannheim	mannheim	PROPN
ajlm-2700	59	43	,	,	PUNCT
ajlm-2700	59	44	germany	germany	PROPN
ajlm-2700	59	45	)	)	PUNCT
ajlm-2700	59	46	.	.	PUNCT
ajlm-2700	60	1	the	the	DET
ajlm-2700	60	2	analytical	analytical	ADJ
ajlm-2700	60	3	characteristics	characteristic	NOUN
ajlm-2700	60	4	of	of	ADP
ajlm-2700	60	5	the	the	DET
ajlm-2700	60	6	pth	pth	NOUN
ajlm-2700	60	7	assays	assay	NOUN
ajlm-2700	60	8	used	use	VERB
ajlm-2700	60	9	are	be	AUX
ajlm-2700	60	10	depicted	depict	VERB
ajlm-2700	60	11	in	in	ADP
ajlm-2700	60	12	online	online	ADJ
ajlm-2700	60	13	supplementary	supplementary	ADJ
ajlm-2700	60	14	table	table	NOUN
ajlm-2700	60	15	1.20,21	1.20,21	NUM
ajlm-2700	60	16	biochemical	biochemical	ADJ
ajlm-2700	60	17	parameters	parameter	NOUN
ajlm-2700	60	18	including	include	VERB
ajlm-2700	60	19	creatinine	creatinine	NOUN
ajlm-2700	60	20	,	,	PUNCT
ajlm-2700	60	21	total	total	ADJ
ajlm-2700	60	22	calcium	calcium	NOUN
ajlm-2700	60	23	and	and	CCONJ
ajlm-2700	60	24	phosphate	phosphate	NOUN
ajlm-2700	60	25	were	be	AUX
ajlm-2700	60	26	measured	measure	VERB
ajlm-2700	60	27	using	use	VERB
ajlm-2700	60	28	standard	standard	ADJ
ajlm-2700	60	29	chemistry	chemistry	NOUN
ajlm-2700	60	30	methods	method	NOUN
ajlm-2700	60	31	on	on	ADP
ajlm-2700	60	32	the	the	DET
ajlm-2700	60	33	roche	roche	PROPN
ajlm-2700	60	34	cobas	cobas	PROPN
ajlm-2700	60	35	®	®	PROPN
ajlm-2700	60	36	8000	8000	NUM
ajlm-2700	60	37	analyser	analyser	NOUN
ajlm-2700	60	38	e702	e702	PROPN
ajlm-2700	60	39	module	module	NOUN
ajlm-2700	60	40	.	.	PUNCT
ajlm-2700	60	41	table	table	NOUN
ajlm-2700	60	42	1	1	NUM
ajlm-2700	60	43	:	:	PUNCT
ajlm-2700	60	44	 	 	SPACE
ajlm-2700	60	45	demographic	demographic	ADJ
ajlm-2700	60	46	and	and	CCONJ
ajlm-2700	60	47	biochemical	biochemical	ADJ
ajlm-2700	60	48	data	datum	NOUN
ajlm-2700	60	49	for	for	ADP
ajlm-2700	60	50	the	the	DET
ajlm-2700	60	51	patient	patient	ADJ
ajlm-2700	60	52	samples	sample	NOUN
ajlm-2700	60	53	used	use	VERB
ajlm-2700	60	54	in	in	ADP
ajlm-2700	60	55	clinical	clinical	ADJ
ajlm-2700	60	56	interpretation	interpretation	NOUN
ajlm-2700	60	57	,	,	PUNCT
ajlm-2700	60	58	johannesburg	johannesburg	PROPN
ajlm-2700	60	59	,	,	PUNCT
ajlm-2700	60	60	south	south	PROPN
ajlm-2700	60	61	africa	africa	PROPN
ajlm-2700	60	62	,	,	PUNCT
ajlm-2700	60	63	06	06	NUM
ajlm-2700	60	64	april	april	PROPN
ajlm-2700	60	65	2022	2022	NUM
ajlm-2700	60	66	to	to	ADP
ajlm-2700	60	67	21	21	NUM
ajlm-2700	60	68	september	september	PROPN
ajlm-2700	60	69	2022	2022	NUM
ajlm-2700	60	70	.	.	PUNCT
ajlm-2700	61	1	clinical	clinical	ADJ
ajlm-2700	61	2	interpretation	interpretation	NOUN
ajlm-2700	61	3	the	the	DET
ajlm-2700	61	4	same	same	ADJ
ajlm-2700	61	5	data	datum	NOUN
ajlm-2700	61	6	set	set	VERB
ajlm-2700	61	7	used	use	VERB
ajlm-2700	61	8	in	in	ADP
ajlm-2700	61	9	the	the	DET
ajlm-2700	61	10	method	method	ADJ
ajlm-2700	61	11	comparison	comparison	NOUN
ajlm-2700	61	12	study	study	NOUN
ajlm-2700	61	13	was	be	AUX
ajlm-2700	61	14	considered	consider	VERB
ajlm-2700	61	15	for	for	ADP
ajlm-2700	61	16	the	the	DET
ajlm-2700	61	17	clinical	clinical	ADJ
ajlm-2700	61	18	performance	performance	NOUN
ajlm-2700	61	19	study	study	NOUN
ajlm-2700	61	20	,	,	PUNCT
ajlm-2700	61	21	and	and	CCONJ
ajlm-2700	61	22	those	those	PRON
ajlm-2700	61	23	that	that	PRON
ajlm-2700	61	24	met	meet	VERB
ajlm-2700	61	25	criteria	criterion	NOUN
ajlm-2700	61	26	were	be	AUX
ajlm-2700	61	27	included	include	VERB
ajlm-2700	61	28	.	.	PUNCT
ajlm-2700	62	1	the	the	DET
ajlm-2700	62	2	clinical	clinical	ADJ
ajlm-2700	62	3	performance	performance	NOUN
ajlm-2700	62	4	of	of	ADP
ajlm-2700	62	5	the	the	DET
ajlm-2700	62	6	two	two	NUM
ajlm-2700	62	7	assays	assay	NOUN
ajlm-2700	62	8	was	be	AUX
ajlm-2700	62	9	assessed	assess	VERB
ajlm-2700	62	10	for	for	ADP
ajlm-2700	62	11	their	their	PRON
ajlm-2700	62	12	performance	performance	NOUN
ajlm-2700	62	13	in	in	ADP
ajlm-2700	62	14	the	the	DET
ajlm-2700	62	15	diagnosis	diagnosis	NOUN
ajlm-2700	62	16	of	of	ADP
ajlm-2700	62	17	hypoparathyroidism	hypoparathyroidism	NOUN
ajlm-2700	62	18	and	and	CCONJ
ajlm-2700	62	19	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	62	20	and	and	CCONJ
ajlm-2700	62	21	in	in	ADP
ajlm-2700	62	22	ckd	ckd	PROPN
ajlm-2700	62	23	patients	patient	NOUN
ajlm-2700	62	24	,	,	PUNCT
ajlm-2700	62	25	including	include	VERB
ajlm-2700	62	26	those	those	PRON
ajlm-2700	62	27	on	on	ADP
ajlm-2700	62	28	dialysis	dialysis	NOUN
ajlm-2700	62	29	.	.	PUNCT
ajlm-2700	63	1	data	datum	NOUN
ajlm-2700	63	2	were	be	AUX
ajlm-2700	63	3	collected	collect	VERB
ajlm-2700	63	4	from	from	ADP
ajlm-2700	63	5	the	the	DET
ajlm-2700	63	6	national	national	PROPN
ajlm-2700	63	7	health	health	PROPN
ajlm-2700	63	8	laboratory	laboratory	PROPN
ajlm-2700	63	9	service	service	PROPN
ajlm-2700	63	10	trakcaretm	trakcaretm	NOUN
ajlm-2700	63	11	(	(	PUNCT
ajlm-2700	63	12	intersystems	intersystem	NOUN
ajlm-2700	63	13	,	,	PUNCT
ajlm-2700	63	14	cambridge	cambridge	PROPN
ajlm-2700	63	15	,	,	PUNCT
ajlm-2700	63	16	massachusetts	massachusetts	PROPN
ajlm-2700	63	17	,	,	PUNCT
ajlm-2700	63	18	united	united	PROPN
ajlm-2700	63	19	states	states	PROPN
ajlm-2700	63	20	)	)	PUNCT
ajlm-2700	63	21	laboratory	laboratory	NOUN
ajlm-2700	63	22	information	information	NOUN
ajlm-2700	63	23	system	system	NOUN
ajlm-2700	63	24	during	during	ADP
ajlm-2700	63	25	the	the	DET
ajlm-2700	63	26	study	study	NOUN
ajlm-2700	63	27	period	period	NOUN
ajlm-2700	63	28	(	(	PUNCT
ajlm-2700	63	29	06	06	NUM
ajlm-2700	63	30	april	april	PROPN
ajlm-2700	63	31	2022	2022	NUM
ajlm-2700	63	32	and	and	CCONJ
ajlm-2700	63	33	21	21	NUM
ajlm-2700	63	34	september	september	PROPN
ajlm-2700	63	35	2022	2022	NUM
ajlm-2700	63	36	)	)	PUNCT
ajlm-2700	63	37	and	and	CCONJ
ajlm-2700	63	38	included	include	VERB
ajlm-2700	63	39	:	:	PUNCT
ajlm-2700	63	40	age	age	NOUN
ajlm-2700	63	41	,	,	PUNCT
ajlm-2700	63	42	gender	gender	NOUN
ajlm-2700	63	43	,	,	PUNCT
ajlm-2700	63	44	calcium	calcium	NOUN
ajlm-2700	63	45	,	,	PUNCT
ajlm-2700	63	46	phosphate	phosphate	NOUN
ajlm-2700	63	47	,	,	PUNCT
ajlm-2700	63	48	creatinine	creatinine	NOUN
ajlm-2700	63	49	,	,	PUNCT
ajlm-2700	63	50	and	and	CCONJ
ajlm-2700	63	51	25	25	NUM
ajlm-2700	63	52	(	(	PUNCT
ajlm-2700	63	53	oh	oh	INTJ
ajlm-2700	63	54	)	)	PUNCT
ajlm-2700	63	55	vitamin	vitamin	NOUN
ajlm-2700	63	56	d.	d.	NOUN
ajlm-2700	63	57	the	the	DET
ajlm-2700	63	58	glomerular	glomerular	ADJ
ajlm-2700	63	59	filtration	filtration	NOUN
ajlm-2700	63	60	rate	rate	NOUN
ajlm-2700	63	61	(	(	PUNCT
ajlm-2700	63	62	gfr	gfr	NOUN
ajlm-2700	63	63	)	)	PUNCT
ajlm-2700	63	64	was	be	AUX
ajlm-2700	63	65	estimated	estimate	VERB
ajlm-2700	63	66	using	use	VERB
ajlm-2700	63	67	the	the	DET
ajlm-2700	63	68	chronic	chronic	ADJ
ajlm-2700	63	69	kidney	kidney	NOUN
ajlm-2700	63	70	disease	disease	NOUN
ajlm-2700	63	71	epidemiology	epidemiology	NOUN
ajlm-2700	63	72	collaboration	collaboration	NOUN
ajlm-2700	63	73	2009	2009	NUM
ajlm-2700	63	74	equation	equation	NOUN
ajlm-2700	63	75	without	without	ADP
ajlm-2700	63	76	the	the	DET
ajlm-2700	63	77	race	race	NOUN
ajlm-2700	63	78	factor.22	factor.22	NOUN
ajlm-2700	63	79	samples	sample	NOUN
ajlm-2700	63	80	within	within	ADP
ajlm-2700	63	81	storage	storage	NOUN
ajlm-2700	63	82	stability	stability	NOUN
ajlm-2700	63	83	limits	limit	NOUN
ajlm-2700	63	84	,	,	PUNCT
ajlm-2700	63	85	those	those	PRON
ajlm-2700	63	86	with	with	ADP
ajlm-2700	63	87	all	all	DET
ajlm-2700	63	88	required	require	VERB
ajlm-2700	63	89	biochemical	biochemical	ADJ
ajlm-2700	63	90	data	datum	NOUN
ajlm-2700	63	91	and	and	CCONJ
ajlm-2700	63	92	patients	patient	NOUN
ajlm-2700	63	93	18	18	NUM
ajlm-2700	63	94	years	year	NOUN
ajlm-2700	63	95	old	old	ADJ
ajlm-2700	63	96	and	and	CCONJ
ajlm-2700	63	97	above	above	ADV
ajlm-2700	63	98	were	be	AUX
ajlm-2700	63	99	included	include	VERB
ajlm-2700	63	100	for	for	ADP
ajlm-2700	63	101	the	the	DET
ajlm-2700	63	102	clinical	clinical	ADJ
ajlm-2700	63	103	interpretation	interpretation	NOUN
ajlm-2700	63	104	(	(	PUNCT
ajlm-2700	63	105	online	online	ADJ
ajlm-2700	63	106	supplementary	supplementary	ADJ
ajlm-2700	63	107	figure	figure	NOUN
ajlm-2700	63	108	5b	5b	NUM
ajlm-2700	63	109	)	)	PUNCT
ajlm-2700	63	110	.	.	PUNCT
ajlm-2700	64	1	statistical	statistical	ADJ
ajlm-2700	64	2	analysis	analysis	NOUN
ajlm-2700	64	3	the	the	DET
ajlm-2700	64	4	data	datum	NOUN
ajlm-2700	64	5	obtained	obtain	VERB
ajlm-2700	64	6	were	be	AUX
ajlm-2700	64	7	captured	capture	VERB
ajlm-2700	64	8	onto	onto	ADP
ajlm-2700	64	9	microsoft	microsoft	PROPN
ajlm-2700	64	10	excel	excel	PROPN
ajlm-2700	64	11	®	®	PROPN
ajlm-2700	64	12	(	(	PUNCT
ajlm-2700	64	13	microsoft	microsoft	PROPN
ajlm-2700	64	14	,	,	PUNCT
ajlm-2700	64	15	seattle	seattle	PROPN
ajlm-2700	64	16	,	,	PUNCT
ajlm-2700	64	17	washington	washington	PROPN
ajlm-2700	64	18	,	,	PUNCT
ajlm-2700	64	19	united	united	PROPN
ajlm-2700	64	20	states	states	PROPN
ajlm-2700	64	21	)	)	PUNCT
ajlm-2700	64	22	and	and	CCONJ
ajlm-2700	64	23	analysed	analyse	VERB
ajlm-2700	64	24	using	use	VERB
ajlm-2700	64	25	medcalc	medcalc	PROPN
ajlm-2700	64	26	®	®	PROPN
ajlm-2700	64	27	,	,	PUNCT
ajlm-2700	64	28	version	version	NOUN
ajlm-2700	64	29	200218	200218	NUM
ajlm-2700	64	30	(	(	PUNCT
ajlm-2700	64	31	medcalc	medcalc	PROPN
ajlm-2700	64	32	software	software	PROPN
ajlm-2700	64	33	,	,	PUNCT
ajlm-2700	64	34	ostend	ostend	PROPN
ajlm-2700	64	35	,	,	PUNCT
ajlm-2700	64	36	belgium	belgium	PROPN
ajlm-2700	64	37	)	)	PUNCT
ajlm-2700	64	38	.	.	PUNCT
ajlm-2700	65	1	the	the	DET
ajlm-2700	65	2	shapiro	shapiro	PROPN
ajlm-2700	65	3	-	-	PUNCT
ajlm-2700	65	4	wilks	wilks	PROPN
ajlm-2700	65	5	test	test	NOUN
ajlm-2700	65	6	was	be	AUX
ajlm-2700	65	7	used	use	VERB
ajlm-2700	65	8	to	to	PART
ajlm-2700	65	9	assess	assess	VERB
ajlm-2700	65	10	for	for	ADP
ajlm-2700	65	11	normality	normality	NOUN
ajlm-2700	65	12	.	.	PUNCT
ajlm-2700	66	1	data	datum	NOUN
ajlm-2700	66	2	were	be	AUX
ajlm-2700	66	3	demonstrated	demonstrate	VERB
ajlm-2700	66	4	to	to	PART
ajlm-2700	66	5	be	be	AUX
ajlm-2700	66	6	not	not	PART
ajlm-2700	66	7	normally	normally	ADV
ajlm-2700	66	8	distributed	distribute	VERB
ajlm-2700	66	9	and	and	CCONJ
ajlm-2700	66	10	expressed	express	VERB
ajlm-2700	66	11	as	as	ADP
ajlm-2700	66	12	median	median	NOUN
ajlm-2700	66	13	and	and	CCONJ
ajlm-2700	66	14	interquartile	interquartile	ADJ
ajlm-2700	66	15	range	range	NOUN
ajlm-2700	66	16	.	.	PUNCT
ajlm-2700	67	1	categorical	categorical	ADJ
ajlm-2700	67	2	data	datum	NOUN
ajlm-2700	67	3	were	be	AUX
ajlm-2700	67	4	expressed	express	VERB
ajlm-2700	67	5	as	as	ADP
ajlm-2700	67	6	proportion	proportion	NOUN
ajlm-2700	67	7	and	and	CCONJ
ajlm-2700	67	8	percentage	percentage	NOUN
ajlm-2700	67	9	.	.	PUNCT
ajlm-2700	68	1	the	the	DET
ajlm-2700	68	2	wilcoxon	wilcoxon	ADJ
ajlm-2700	68	3	test	test	NOUN
ajlm-2700	68	4	was	be	AUX
ajlm-2700	68	5	used	use	VERB
ajlm-2700	68	6	to	to	PART
ajlm-2700	68	7	compare	compare	VERB
ajlm-2700	68	8	pth	pth	NOUN
ajlm-2700	68	9	concentrations	concentration	NOUN
ajlm-2700	68	10	between	between	ADP
ajlm-2700	68	11	the	the	DET
ajlm-2700	68	12	two	two	NUM
ajlm-2700	68	13	assays	assay	NOUN
ajlm-2700	68	14	.	.	PUNCT
ajlm-2700	69	1	a	a	DET
ajlm-2700	69	2	mann	mann	PROPN
ajlm-2700	69	3	-	-	PUNCT
ajlm-2700	69	4	whitney	whitney	PROPN
ajlm-2700	69	5	test	test	NOUN
ajlm-2700	69	6	was	be	AUX
ajlm-2700	69	7	used	use	VERB
ajlm-2700	69	8	to	to	PART
ajlm-2700	69	9	compare	compare	VERB
ajlm-2700	69	10	the	the	DET
ajlm-2700	69	11	median	median	ADJ
ajlm-2700	69	12	age	age	NOUN
ajlm-2700	69	13	between	between	ADP
ajlm-2700	69	14	the	the	DET
ajlm-2700	69	15	ckd	ckd	PROPN
ajlm-2700	69	16	and	and	CCONJ
ajlm-2700	69	17	non	non	ADJ
ajlm-2700	69	18	-	-	ADJ
ajlm-2700	69	19	ckd	ckd	ADJ
ajlm-2700	69	20	groups	group	NOUN
ajlm-2700	69	21	.	.	PUNCT
ajlm-2700	70	1	intact	intact	ADJ
ajlm-2700	70	2	pth	pth	NOUN
ajlm-2700	70	3	was	be	AUX
ajlm-2700	70	4	used	use	VERB
ajlm-2700	70	5	as	as	ADP
ajlm-2700	70	6	the	the	DET
ajlm-2700	70	7	comparative	comparative	ADJ
ajlm-2700	70	8	method	method	NOUN
ajlm-2700	70	9	(	(	PUNCT
ajlm-2700	70	10	x	x	NOUN
ajlm-2700	70	11	)	)	PUNCT
ajlm-2700	70	12	and	and	CCONJ
ajlm-2700	70	13	pth	pth	NOUN
ajlm-2700	70	14	1–84	1–84	NOUN
ajlm-2700	70	15	as	as	ADP
ajlm-2700	70	16	the	the	DET
ajlm-2700	70	17	test	test	NOUN
ajlm-2700	70	18	method	method	NOUN
ajlm-2700	70	19	(	(	PUNCT
ajlm-2700	70	20	y	y	NOUN
ajlm-2700	70	21	)	)	PUNCT
ajlm-2700	70	22	.	.	PUNCT
ajlm-2700	71	1	passing	pass	VERB
ajlm-2700	71	2	-	-	PUNCT
ajlm-2700	71	3	bablok	bablok	NOUN
ajlm-2700	71	4	regression	regression	NOUN
ajlm-2700	71	5	was	be	AUX
ajlm-2700	71	6	used	use	VERB
ajlm-2700	71	7	to	to	PART
ajlm-2700	71	8	assess	assess	VERB
ajlm-2700	71	9	method	method	NOUN
ajlm-2700	71	10	agreement	agreement	NOUN
ajlm-2700	71	11	,	,	PUNCT
ajlm-2700	71	12	and	and	CCONJ
ajlm-2700	71	13	the	the	DET
ajlm-2700	71	14	bland	bland	ADJ
ajlm-2700	71	15	-	-	PUNCT
ajlm-2700	71	16	altman	altman	NOUN
ajlm-2700	71	17	difference	difference	NOUN
ajlm-2700	71	18	plot	plot	NOUN
ajlm-2700	71	19	was	be	AUX
ajlm-2700	71	20	used	use	VERB
ajlm-2700	71	21	to	to	PART
ajlm-2700	71	22	determine	determine	VERB
ajlm-2700	71	23	the	the	DET
ajlm-2700	71	24	magnitude	magnitude	NOUN
ajlm-2700	71	25	of	of	ADP
ajlm-2700	71	26	bias	bias	NOUN
ajlm-2700	71	27	(	(	PUNCT
ajlm-2700	71	28	observed	observe	VERB
ajlm-2700	71	29	differences	difference	NOUN
ajlm-2700	71	30	)	)	PUNCT
ajlm-2700	71	31	between	between	ADP
ajlm-2700	71	32	the	the	DET
ajlm-2700	71	33	two	two	NUM
ajlm-2700	71	34	methods	method	NOUN
ajlm-2700	71	35	.	.	PUNCT
ajlm-2700	72	1	the	the	DET
ajlm-2700	72	2	observed	observed	ADJ
ajlm-2700	72	3	inter	inter	ADJ
ajlm-2700	72	4	-	-	ADJ
ajlm-2700	72	5	assay	assay	ADJ
ajlm-2700	72	6	bias	bias	NOUN
ajlm-2700	72	7	was	be	AUX
ajlm-2700	72	8	compared	compare	VERB
ajlm-2700	72	9	with	with	ADP
ajlm-2700	72	10	desirable	desirable	ADJ
ajlm-2700	72	11	analytical	analytical	ADJ
ajlm-2700	72	12	performance	performance	NOUN
ajlm-2700	72	13	specifications	specification	NOUN
ajlm-2700	72	14	(	(	PUNCT
ajlm-2700	72	15	bias	bias	VERB
ajlm-2700	72	16	±7.1	±7.1	NOUN
ajlm-2700	72	17	%	%	NOUN
ajlm-2700	72	18	)	)	PUNCT
ajlm-2700	72	19	for	for	ADP
ajlm-2700	72	20	pth	pth	NOUN
ajlm-2700	72	21	derived	derive	VERB
ajlm-2700	72	22	from	from	ADP
ajlm-2700	72	23	the	the	DET
ajlm-2700	72	24	european	european	PROPN
ajlm-2700	72	25	federation	federation	PROPN
ajlm-2700	72	26	of	of	ADP
ajlm-2700	72	27	clinical	clinical	ADJ
ajlm-2700	72	28	chemistry	chemistry	NOUN
ajlm-2700	72	29	and	and	CCONJ
ajlm-2700	72	30	laboratory	laboratory	NOUN
ajlm-2700	72	31	medicine	medicine	NOUN
ajlm-2700	72	32	biological	biological	ADJ
ajlm-2700	72	33	variation	variation	NOUN
ajlm-2700	72	34	database.23	database.23	PROPN
ajlm-2700	72	35	the	the	DET
ajlm-2700	72	36	mcnemar	mcnemar	PROPN
ajlm-2700	72	37	test	test	NOUN
ajlm-2700	72	38	was	be	AUX
ajlm-2700	72	39	used	use	VERB
ajlm-2700	72	40	to	to	PART
ajlm-2700	72	41	determine	determine	VERB
ajlm-2700	72	42	if	if	SCONJ
ajlm-2700	72	43	there	there	PRON
ajlm-2700	72	44	were	be	VERB
ajlm-2700	72	45	significant	significant	ADJ
ajlm-2700	72	46	differences	difference	NOUN
ajlm-2700	72	47	in	in	ADP
ajlm-2700	72	48	the	the	DET
ajlm-2700	72	49	classification	classification	NOUN
ajlm-2700	72	50	of	of	ADP
ajlm-2700	72	51	patients	patient	NOUN
ajlm-2700	72	52	and	and	CCONJ
ajlm-2700	72	53	if	if	SCONJ
ajlm-2700	72	54	the	the	DET
ajlm-2700	72	55	clinical	clinical	ADJ
ajlm-2700	72	56	interpretation	interpretation	NOUN
ajlm-2700	72	57	changes	change	NOUN
ajlm-2700	72	58	when	when	SCONJ
ajlm-2700	72	59	one	one	NUM
ajlm-2700	72	60	assay	assay	NOUN
ajlm-2700	72	61	is	be	AUX
ajlm-2700	72	62	used	use	VERB
ajlm-2700	72	63	over	over	ADP
ajlm-2700	72	64	the	the	DET
ajlm-2700	72	65	other	other	ADJ
ajlm-2700	72	66	.	.	PUNCT
ajlm-2700	73	1	a	a	DET
ajlm-2700	73	2	p	p	NOUN
ajlm-2700	73	3	-	-	PUNCT
ajlm-2700	73	4	value	value	NOUN
ajlm-2700	73	5	of	of	ADP
ajlm-2700	73	6	<	<	X
ajlm-2700	73	7	0.05	0.05	NUM
ajlm-2700	73	8	was	be	AUX
ajlm-2700	73	9	considered	consider	VERB
ajlm-2700	73	10	statistically	statistically	ADV
ajlm-2700	73	11	significant	significant	ADJ
ajlm-2700	73	12	.	.	PUNCT
ajlm-2700	74	1	chronic	chronic	ADJ
ajlm-2700	74	2	kidney	kidney	NOUN
ajlm-2700	74	3	disease	disease	NOUN
ajlm-2700	74	4	patients	patient	NOUN
ajlm-2700	74	5	on	on	ADP
ajlm-2700	74	6	dialysis	dialysis	NOUN
ajlm-2700	74	7	were	be	AUX
ajlm-2700	74	8	classified	classify	VERB
ajlm-2700	74	9	as	as	ADP
ajlm-2700	74	10	above	above	ADV
ajlm-2700	74	11	,	,	PUNCT
ajlm-2700	74	12	below	below	ADV
ajlm-2700	74	13	,	,	PUNCT
ajlm-2700	74	14	or	or	CCONJ
ajlm-2700	74	15	within	within	ADP
ajlm-2700	74	16	the	the	DET
ajlm-2700	74	17	pth	pth	NOUN
ajlm-2700	74	18	target	target	NOUN
ajlm-2700	74	19	range	range	NOUN
ajlm-2700	74	20	of	of	ADP
ajlm-2700	74	21	2–9	2–9	NUM
ajlm-2700	74	22	times	time	NOUN
ajlm-2700	74	23	the	the	DET
ajlm-2700	74	24	upper	upper	ADJ
ajlm-2700	74	25	limit	limit	NOUN
ajlm-2700	74	26	of	of	ADP
ajlm-2700	74	27	normal	normal	ADJ
ajlm-2700	74	28	as	as	SCONJ
ajlm-2700	74	29	recommended	recommend	VERB
ajlm-2700	74	30	by	by	ADP
ajlm-2700	74	31	the	the	DET
ajlm-2700	74	32	kdigo	kdigo	PROPN
ajlm-2700	74	33	guidelines	guideline	NOUN
ajlm-2700	74	34	,	,	PUNCT
ajlm-2700	74	35	using	use	VERB
ajlm-2700	74	36	the	the	DET
ajlm-2700	74	37	two	two	NUM
ajlm-2700	74	38	pth	pth	NOUN
ajlm-2700	74	39	assays	assay	NOUN
ajlm-2700	74	40	.	.	PUNCT
ajlm-2700	75	1	a	a	DET
ajlm-2700	75	2	kappa	kappa	PROPN
ajlm-2700	75	3	statistic	statistic	NOUN
ajlm-2700	75	4	was	be	AUX
ajlm-2700	75	5	used	use	VERB
ajlm-2700	75	6	to	to	PART
ajlm-2700	75	7	assess	assess	VERB
ajlm-2700	75	8	the	the	DET
ajlm-2700	75	9	performance	performance	NOUN
ajlm-2700	75	10	of	of	ADP
ajlm-2700	75	11	the	the	DET
ajlm-2700	75	12	classification	classification	NOUN
ajlm-2700	75	13	using	use	VERB
ajlm-2700	75	14	both	both	DET
ajlm-2700	75	15	assays	assay	NOUN
ajlm-2700	75	16	,	,	PUNCT
ajlm-2700	75	17	with	with	ADP
ajlm-2700	75	18	a	a	DET
ajlm-2700	75	19	value	value	NOUN
ajlm-2700	75	20	of	of	ADP
ajlm-2700	75	21	≥	≥	NOUN
ajlm-2700	75	22	0.60	0.60	NUM
ajlm-2700	75	23	representing	represent	VERB
ajlm-2700	75	24	acceptable	acceptable	ADJ
ajlm-2700	75	25	agreement.24	agreement.24	NOUN
ajlm-2700	75	26	results	result	NOUN
ajlm-2700	75	27	method	method	VERB
ajlm-2700	75	28	comparison	comparison	NOUN
ajlm-2700	75	29	a	a	DET
ajlm-2700	75	30	total	total	NOUN
ajlm-2700	75	31	of	of	ADP
ajlm-2700	75	32	505	505	NUM
ajlm-2700	75	33	residual	residual	ADJ
ajlm-2700	75	34	patient	patient	NOUN
ajlm-2700	75	35	samples	sample	NOUN
ajlm-2700	75	36	were	be	AUX
ajlm-2700	75	37	initially	initially	ADV
ajlm-2700	75	38	identified	identify	VERB
ajlm-2700	75	39	for	for	ADP
ajlm-2700	75	40	the	the	DET
ajlm-2700	75	41	study	study	NOUN
ajlm-2700	75	42	.	.	PUNCT
ajlm-2700	76	1	however	however	ADV
ajlm-2700	76	2	,	,	PUNCT
ajlm-2700	76	3	24	24	NUM
ajlm-2700	76	4	samples	sample	NOUN
ajlm-2700	76	5	were	be	AUX
ajlm-2700	76	6	excluded	exclude	VERB
ajlm-2700	76	7	:	:	PUNCT
ajlm-2700	76	8	17	17	NUM
ajlm-2700	76	9	had	have	VERB
ajlm-2700	76	10	results	result	NOUN
ajlm-2700	76	11	exceeding	exceed	VERB
ajlm-2700	76	12	the	the	DET
ajlm-2700	76	13	measuring	measure	VERB
ajlm-2700	76	14	range	range	NOUN
ajlm-2700	76	15	of	of	ADP
ajlm-2700	76	16	the	the	DET
ajlm-2700	76	17	elecsys	elecsys	PROPN
ajlm-2700	76	18	pth	pth	PROPN
ajlm-2700	76	19	1–84	1–84	NOUN
ajlm-2700	76	20	assay	assay	VERB
ajlm-2700	76	21	and	and	CCONJ
ajlm-2700	76	22	seven	seven	NUM
ajlm-2700	76	23	had	have	AUX
ajlm-2700	76	24	exceeded	exceed	VERB
ajlm-2700	76	25	the	the	DET
ajlm-2700	76	26	stability	stability	NOUN
ajlm-2700	76	27	period	period	NOUN
ajlm-2700	76	28	.	.	PUNCT
ajlm-2700	77	1	thus	thus	ADV
ajlm-2700	77	2	,	,	PUNCT
ajlm-2700	77	3	481	481	NUM
ajlm-2700	77	4	samples	sample	NOUN
ajlm-2700	77	5	were	be	AUX
ajlm-2700	77	6	analysed	analyse	VERB
ajlm-2700	77	7	and	and	CCONJ
ajlm-2700	77	8	utilised	utilise	VERB
ajlm-2700	77	9	for	for	ADP
ajlm-2700	77	10	the	the	DET
ajlm-2700	77	11	method	method	ADJ
ajlm-2700	77	12	comparison	comparison	NOUN
ajlm-2700	77	13	study	study	NOUN
ajlm-2700	77	14	as	as	SCONJ
ajlm-2700	77	15	shown	show	VERB
ajlm-2700	77	16	in	in	ADP
ajlm-2700	77	17	online	online	ADJ
ajlm-2700	77	18	supplementary	supplementary	ADJ
ajlm-2700	77	19	figure	figure	NOUN
ajlm-2700	77	20	5a	5a	NUM
ajlm-2700	77	21	.	.	PUNCT
ajlm-2700	78	1	the	the	DET
ajlm-2700	78	2	median	median	ADJ
ajlm-2700	78	3	pth	pth	NOUN
ajlm-2700	78	4	concentration	concentration	NOUN
ajlm-2700	78	5	for	for	ADP
ajlm-2700	78	6	the	the	DET
ajlm-2700	78	7	third	third	ADJ
ajlm-2700	78	8	-	-	PUNCT
ajlm-2700	78	9	generation	generation	NOUN
ajlm-2700	78	10	assay	assay	NOUN
ajlm-2700	78	11	was	be	AUX
ajlm-2700	78	12	lower	low	ADJ
ajlm-2700	78	13	,	,	PUNCT
ajlm-2700	78	14	at	at	ADP
ajlm-2700	78	15	8.51	8.51	NUM
ajlm-2700	78	16	pmol	pmol	NOUN
ajlm-2700	78	17	/	/	SYM
ajlm-2700	78	18	l	l	NOUN
ajlm-2700	78	19	(	(	PUNCT
ajlm-2700	78	20	interquartile	interquartile	NOUN
ajlm-2700	78	21	range	range	NOUN
ajlm-2700	78	22	:	:	PUNCT
ajlm-2700	78	23	4.30	4.30	NUM
ajlm-2700	78	24	–	–	PUNCT
ajlm-2700	78	25	25.5	25.5	NUM
ajlm-2700	78	26	)	)	PUNCT
ajlm-2700	78	27	compared	compare	VERB
ajlm-2700	78	28	to	to	ADP
ajlm-2700	78	29	the	the	DET
ajlm-2700	78	30	second	second	ADJ
ajlm-2700	78	31	-	-	PUNCT
ajlm-2700	78	32	generation	generation	NOUN
ajlm-2700	78	33	median	median	NOUN
ajlm-2700	78	34	of	of	ADP
ajlm-2700	78	35	9.85	9.85	NUM
ajlm-2700	78	36	pmol	pmol	NOUN
ajlm-2700	78	37	/	/	SYM
ajlm-2700	78	38	l	l	NOUN
ajlm-2700	78	39	(	(	PUNCT
ajlm-2700	78	40	interquartile	interquartile	NOUN
ajlm-2700	78	41	range	range	NOUN
ajlm-2700	78	42	:	:	PUNCT
ajlm-2700	78	43	4.53	4.53	NUM
ajlm-2700	78	44	–	–	PUNCT
ajlm-2700	78	45	33.58	33.58	NUM
ajlm-2700	78	46	)	)	PUNCT
ajlm-2700	78	47	,	,	PUNCT
ajlm-2700	78	48	and	and	CCONJ
ajlm-2700	78	49	the	the	DET
ajlm-2700	78	50	difference	difference	NOUN
ajlm-2700	78	51	was	be	AUX
ajlm-2700	78	52	statistically	statistically	ADV
ajlm-2700	78	53	significant	significant	ADJ
ajlm-2700	78	54	(	(	PUNCT
ajlm-2700	78	55	p	p	X
ajlm-2700	78	56	<	<	X
ajlm-2700	78	57	0.0001	0.0001	NUM
ajlm-2700	78	58	)	)	PUNCT
ajlm-2700	78	59	.	.	PUNCT
ajlm-2700	79	1	the	the	DET
ajlm-2700	79	2	regression	regression	NOUN
ajlm-2700	79	3	analysis	analysis	NOUN
ajlm-2700	79	4	equation	equation	NOUN
ajlm-2700	79	5	was	be	AUX
ajlm-2700	79	6	calculated	calculate	VERB
ajlm-2700	79	7	as	as	ADP
ajlm-2700	79	8	y	y	PROPN
ajlm-2700	79	9	=	=	PROPN
ajlm-2700	79	10	0.713x	0.713x	PROPN
ajlm-2700	79	11	+	+	CCONJ
ajlm-2700	79	12	0.887	0.887	NUM
ajlm-2700	79	13	(	(	PUNCT
ajlm-2700	79	14	figure	figure	NOUN
ajlm-2700	79	15	1	1	NUM
ajlm-2700	79	16	)	)	PUNCT
ajlm-2700	79	17	.	.	PUNCT
ajlm-2700	80	1	there	there	PRON
ajlm-2700	80	2	was	be	VERB
ajlm-2700	80	3	good	good	ADJ
ajlm-2700	80	4	correlation	correlation	NOUN
ajlm-2700	80	5	between	between	ADP
ajlm-2700	80	6	the	the	DET
ajlm-2700	80	7	two	two	NUM
ajlm-2700	80	8	methods	method	NOUN
ajlm-2700	80	9	,	,	PUNCT
ajlm-2700	80	10	with	with	ADP
ajlm-2700	80	11	a	a	DET
ajlm-2700	80	12	coefficient	coefficient	NOUN
ajlm-2700	80	13	correlation	correlation	NOUN
ajlm-2700	80	14	(	(	PUNCT
ajlm-2700	80	15	r	r	NOUN
ajlm-2700	80	16	)	)	PUNCT
ajlm-2700	80	17	=	=	NOUN
ajlm-2700	80	18	0.994	0.994	NUM
ajlm-2700	80	19	and	and	CCONJ
ajlm-2700	80	20	p	p	X
ajlm-2700	80	21	<	<	X
ajlm-2700	80	22	0.0001	0.0001	NUM
ajlm-2700	80	23	.	.	PUNCT
ajlm-2700	81	1	the	the	DET
ajlm-2700	81	2	intercept	intercept	NOUN
ajlm-2700	81	3	was	be	AUX
ajlm-2700	81	4	calculated	calculate	VERB
ajlm-2700	81	5	at	at	ADP
ajlm-2700	81	6	0.887	0.887	NUM
ajlm-2700	81	7	pmol	pmol	NOUN
ajlm-2700	81	8	/	/	SYM
ajlm-2700	81	9	l	l	NOUN
ajlm-2700	81	10	(	(	PUNCT
ajlm-2700	81	11	95	95	NUM
ajlm-2700	81	12	%	%	NOUN
ajlm-2700	81	13	ci	ci	NOUN
ajlm-2700	81	14	:	:	PUNCT
ajlm-2700	81	15	0.788	0.788	NUM
ajlm-2700	81	16	–	–	PUNCT
ajlm-2700	81	17	1.005	1.005	NUM
ajlm-2700	81	18	)	)	PUNCT
ajlm-2700	81	19	and	and	CCONJ
ajlm-2700	81	20	the	the	DET
ajlm-2700	81	21	slope	slope	NOUN
ajlm-2700	81	22	at	at	ADP
ajlm-2700	81	23	0.713	0.713	NUM
ajlm-2700	81	24	pmol	pmol	NOUN
ajlm-2700	81	25	/	/	SYM
ajlm-2700	81	26	l	l	NOUN
ajlm-2700	81	27	(	(	PUNCT
ajlm-2700	81	28	95	95	NUM
ajlm-2700	81	29	%	%	NOUN
ajlm-2700	81	30	ci	ci	NOUN
ajlm-2700	81	31	:	:	PUNCT
ajlm-2700	81	32	0.703	0.703	NUM
ajlm-2700	81	33	–	–	PUNCT
ajlm-2700	81	34	0.723	0.723	NUM
ajlm-2700	81	35	)	)	PUNCT
ajlm-2700	81	36	,	,	PUNCT
ajlm-2700	81	37	indicating	indicate	VERB
ajlm-2700	81	38	that	that	SCONJ
ajlm-2700	81	39	there	there	PRON
ajlm-2700	81	40	were	be	VERB
ajlm-2700	81	41	systematic	systematic	ADJ
ajlm-2700	81	42	and	and	CCONJ
ajlm-2700	81	43	proportional	proportional	ADJ
ajlm-2700	81	44	differences	difference	NOUN
ajlm-2700	81	45	between	between	ADP
ajlm-2700	81	46	the	the	DET
ajlm-2700	81	47	two	two	NUM
ajlm-2700	81	48	methods	method	NOUN
ajlm-2700	81	49	.	.	PUNCT
ajlm-2700	82	1	figure	figure	VERB
ajlm-2700	82	2	1	1	NUM
ajlm-2700	82	3	:	:	PUNCT
ajlm-2700	82	4	distribution	distribution	NOUN
ajlm-2700	82	5	of	of	ADP
ajlm-2700	82	6	results	result	NOUN
ajlm-2700	82	7	across	across	ADP
ajlm-2700	82	8	all	all	DET
ajlm-2700	82	9	measured	measured	ADJ
ajlm-2700	82	10	concentrations	concentration	NOUN
ajlm-2700	82	11	comparing	compare	VERB
ajlm-2700	82	12	intact	intact	ADJ
ajlm-2700	82	13	parathyroid	parathyroid	ADJ
ajlm-2700	82	14	hormone	hormone	NOUN
ajlm-2700	82	15	and	and	CCONJ
ajlm-2700	82	16	parathyroid	parathyroid	ADJ
ajlm-2700	82	17	hormone	hormone	NOUN
ajlm-2700	82	18	1–84	1–84	NOUN
ajlm-2700	82	19	assays	assay	VERB
ajlm-2700	82	20	(	(	PUNCT
ajlm-2700	82	21	y	y	NOUN
ajlm-2700	82	22	=	=	PUNCT
ajlm-2700	82	23	0.713x	0.713x	PROPN
ajlm-2700	83	1	+	+	CCONJ
ajlm-2700	83	2	0.887	0.887	NUM
ajlm-2700	83	3	;	;	PUNCT
ajlm-2700	83	4	n	n	PROPN
ajlm-2700	83	5	=	=	SYM
ajlm-2700	83	6	481	481	NUM
ajlm-2700	83	7	)	)	PUNCT
ajlm-2700	83	8	,	,	PUNCT
ajlm-2700	83	9	johannesburg	johannesburg	PROPN
ajlm-2700	83	10	,	,	PUNCT
ajlm-2700	83	11	south	south	PROPN
ajlm-2700	83	12	africa	africa	PROPN
ajlm-2700	83	13	,	,	PUNCT
ajlm-2700	83	14	06	06	NUM
ajlm-2700	83	15	april	april	PROPN
ajlm-2700	83	16	to	to	ADP
ajlm-2700	83	17	21	21	NUM
ajlm-2700	83	18	september	september	PROPN
ajlm-2700	83	19	2022	2022	NUM
ajlm-2700	83	20	.	.	PUNCT
ajlm-2700	84	1	the	the	DET
ajlm-2700	84	2	bland	bland	ADJ
ajlm-2700	84	3	-	-	PUNCT
ajlm-2700	84	4	altman	altman	NOUN
ajlm-2700	84	5	analysis	analysis	NOUN
ajlm-2700	84	6	showed	show	VERB
ajlm-2700	84	7	an	an	DET
ajlm-2700	84	8	average	average	ADJ
ajlm-2700	84	9	overall	overall	ADJ
ajlm-2700	84	10	difference	difference	NOUN
ajlm-2700	84	11	between	between	ADP
ajlm-2700	84	12	the	the	DET
ajlm-2700	84	13	pth	pth	NOUN
ajlm-2700	84	14	assays	assay	NOUN
ajlm-2700	84	15	of	of	ADP
ajlm-2700	84	16	9.00	9.00	NUM
ajlm-2700	84	17	pmol	pmol	NOUN
ajlm-2700	84	18	/	/	SYM
ajlm-2700	84	19	l	l	NOUN
ajlm-2700	84	20	(	(	PUNCT
ajlm-2700	84	21	18.5	18.5	NUM
ajlm-2700	84	22	%	%	NOUN
ajlm-2700	84	23	,	,	PUNCT
ajlm-2700	84	24	p	p	X
ajlm-2700	84	25	<	<	X
ajlm-2700	84	26	0.0001	0.0001	NUM
ajlm-2700	84	27	)	)	PUNCT
ajlm-2700	84	28	among	among	ADP
ajlm-2700	84	29	all	all	DET
ajlm-2700	84	30	samples	sample	NOUN
ajlm-2700	84	31	analysed	analyse	VERB
ajlm-2700	84	32	,	,	PUNCT
ajlm-2700	84	33	with	with	ADP
ajlm-2700	84	34	increased	increase	VERB
ajlm-2700	84	35	deviations	deviation	NOUN
ajlm-2700	84	36	observed	observe	VERB
ajlm-2700	84	37	at	at	ADP
ajlm-2700	84	38	higher	high	ADJ
ajlm-2700	84	39	pth	pth	NOUN
ajlm-2700	84	40	concentrations	concentration	NOUN
ajlm-2700	84	41	(	(	PUNCT
ajlm-2700	84	42	figure	figure	NOUN
ajlm-2700	84	43	2	2	NUM
ajlm-2700	84	44	and	and	CCONJ
ajlm-2700	84	45	figure	figure	VERB
ajlm-2700	84	46	3	3	NUM
ajlm-2700	84	47	)	)	PUNCT
ajlm-2700	84	48	.	.	PUNCT
ajlm-2700	85	1	the	the	DET
ajlm-2700	85	2	bias	bias	NOUN
ajlm-2700	85	3	in	in	ADP
ajlm-2700	85	4	the	the	DET
ajlm-2700	85	5	entire	entire	ADJ
ajlm-2700	85	6	ckd	ckd	PROPN
ajlm-2700	85	7	group	group	NOUN
ajlm-2700	85	8	was	be	AUX
ajlm-2700	85	9	27.2	27.2	NUM
ajlm-2700	85	10	%	%	NOUN
ajlm-2700	85	11	,	,	PUNCT
ajlm-2700	85	12	and	and	CCONJ
ajlm-2700	85	13	25.3	25.3	NUM
ajlm-2700	85	14	%	%	NOUN
ajlm-2700	85	15	in	in	ADP
ajlm-2700	85	16	the	the	DET
ajlm-2700	85	17	pre	pre	NOUN
ajlm-2700	85	18	-	-	ADJ
ajlm-2700	85	19	dialysis	dialysis	ADJ
ajlm-2700	85	20	ckd	ckd	PROPN
ajlm-2700	85	21	group	group	NOUN
ajlm-2700	85	22	(	(	PUNCT
ajlm-2700	85	23	p	p	X
ajlm-2700	85	24	<	<	X
ajlm-2700	85	25	0.0001	0.0001	NUM
ajlm-2700	85	26	)	)	PUNCT
ajlm-2700	85	27	.	.	PUNCT
ajlm-2700	86	1	the	the	DET
ajlm-2700	86	2	dialysis	dialysis	NOUN
ajlm-2700	86	3	group	group	NOUN
ajlm-2700	86	4	,	,	PUNCT
ajlm-2700	86	5	however	however	ADV
ajlm-2700	86	6	,	,	PUNCT
ajlm-2700	86	7	demonstrated	demonstrate	VERB
ajlm-2700	86	8	the	the	DET
ajlm-2700	86	9	highest	high	ADJ
ajlm-2700	86	10	bias	bias	NOUN
ajlm-2700	86	11	of	of	ADP
ajlm-2700	86	12	35.2	35.2	NUM
ajlm-2700	86	13	%	%	NOUN
ajlm-2700	86	14	(	(	PUNCT
ajlm-2700	86	15	p	p	X
ajlm-2700	86	16	<	<	X
ajlm-2700	86	17	0.0001	0.0001	NUM
ajlm-2700	86	18	)	)	PUNCT
ajlm-2700	86	19	.	.	PUNCT
ajlm-2700	87	1	this	this	PRON
ajlm-2700	87	2	is	be	AUX
ajlm-2700	87	3	in	in	ADP
ajlm-2700	87	4	stark	stark	ADJ
ajlm-2700	87	5	contrast	contrast	NOUN
ajlm-2700	87	6	to	to	ADP
ajlm-2700	87	7	the	the	DET
ajlm-2700	87	8	difference	difference	NOUN
ajlm-2700	87	9	observed	observe	VERB
ajlm-2700	87	10	within	within	ADP
ajlm-2700	87	11	the	the	DET
ajlm-2700	87	12	non	non	ADJ
ajlm-2700	87	13	-	-	ADJ
ajlm-2700	87	14	ckd	ckd	ADJ
ajlm-2700	87	15	group	group	NOUN
ajlm-2700	87	16	with	with	ADP
ajlm-2700	87	17	estimated	estimate	VERB
ajlm-2700	87	18	gfr	gfr	NOUN
ajlm-2700	87	19	(	(	PUNCT
ajlm-2700	87	20	egfr	egfr	X
ajlm-2700	87	21	)	)	PUNCT
ajlm-2700	87	22	>	>	X
ajlm-2700	88	1	60	60	NUM
ajlm-2700	88	2	ml	ml	NOUN
ajlm-2700	88	3	/	/	SYM
ajlm-2700	88	4	min/1.73	min/1.73	NOUN
ajlm-2700	88	5	m2	m2	PROPN
ajlm-2700	88	6	,	,	PUNCT
ajlm-2700	88	7	which	which	PRON
ajlm-2700	88	8	was	be	AUX
ajlm-2700	88	9	demonstrated	demonstrate	VERB
ajlm-2700	88	10	to	to	PART
ajlm-2700	88	11	be	be	AUX
ajlm-2700	88	12	5.7	5.7	NUM
ajlm-2700	88	13	%	%	NOUN
ajlm-2700	88	14	(	(	PUNCT
ajlm-2700	88	15	p	p	X
ajlm-2700	88	16	<	<	X
ajlm-2700	88	17	0.0001	0.0001	NUM
ajlm-2700	88	18	)	)	PUNCT
ajlm-2700	88	19	(	(	PUNCT
ajlm-2700	88	20	online	online	PROPN
ajlm-2700	88	21	supplementary	supplementary	ADJ
ajlm-2700	88	22	figures	figure	NOUN
ajlm-2700	88	23	1–4	1–4	NUM
ajlm-2700	88	24	)	)	PUNCT
ajlm-2700	88	25	.	.	PUNCT
ajlm-2700	89	1	figure	figure	VERB
ajlm-2700	89	2	2	2	NUM
ajlm-2700	89	3	:	:	PUNCT
ajlm-2700	89	4	absolute	absolute	ADJ
ajlm-2700	89	5	differences	difference	NOUN
ajlm-2700	89	6	in	in	ADP
ajlm-2700	89	7	parathyroid	parathyroid	ADJ
ajlm-2700	89	8	hormone	hormone	NOUN
ajlm-2700	89	9	(	(	PUNCT
ajlm-2700	89	10	pth	pth	NOUN
ajlm-2700	89	11	)	)	PUNCT
ajlm-2700	89	12	results	result	NOUN
ajlm-2700	89	13	across	across	ADP
ajlm-2700	89	14	concentrations	concentration	NOUN
ajlm-2700	89	15	levels	level	NOUN
ajlm-2700	89	16	comparing	compare	VERB
ajlm-2700	89	17	intact	intact	ADJ
ajlm-2700	89	18	pth	pth	NOUN
ajlm-2700	89	19	and	and	CCONJ
ajlm-2700	89	20	pth	pth	NOUN
ajlm-2700	89	21	1–84	1–84	NOUN
ajlm-2700	89	22	assays	assay	NOUN
ajlm-2700	89	23	,	,	PUNCT
ajlm-2700	89	24	johannesburg	johannesburg	PROPN
ajlm-2700	89	25	,	,	PUNCT
ajlm-2700	89	26	south	south	PROPN
ajlm-2700	89	27	africa	africa	PROPN
ajlm-2700	89	28	,	,	PUNCT
ajlm-2700	90	1	06	06	NUM
ajlm-2700	90	2	april	april	PROPN
ajlm-2700	90	3	2022	2022	NUM
ajlm-2700	90	4	to	to	ADP
ajlm-2700	90	5	21	21	NUM
ajlm-2700	90	6	september	september	PROPN
ajlm-2700	90	7	2022	2022	NUM
ajlm-2700	90	8	.	.	PUNCT
ajlm-2700	91	1	figure	figure	VERB
ajlm-2700	91	2	3	3	NUM
ajlm-2700	91	3	:	:	PUNCT
ajlm-2700	91	4	percentage	percentage	NOUN
ajlm-2700	91	5	difference	difference	NOUN
ajlm-2700	91	6	in	in	ADP
ajlm-2700	91	7	parathyroid	parathyroid	ADJ
ajlm-2700	91	8	hormone	hormone	NOUN
ajlm-2700	91	9	(	(	PUNCT
ajlm-2700	91	10	pth	pth	NOUN
ajlm-2700	91	11	)	)	PUNCT
ajlm-2700	91	12	results	result	NOUN
ajlm-2700	91	13	across	across	ADP
ajlm-2700	91	14	concentration	concentration	NOUN
ajlm-2700	91	15	levels	level	NOUN
ajlm-2700	91	16	comparing	compare	VERB
ajlm-2700	91	17	intact	intact	ADJ
ajlm-2700	91	18	pth	pth	NOUN
ajlm-2700	91	19	and	and	CCONJ
ajlm-2700	91	20	pth	pth	NOUN
ajlm-2700	91	21	1–84	1–84	NOUN
ajlm-2700	91	22	assays	assay	NOUN
ajlm-2700	91	23	,	,	PUNCT
ajlm-2700	91	24	johannesburg	johannesburg	PROPN
ajlm-2700	91	25	,	,	PUNCT
ajlm-2700	91	26	south	south	PROPN
ajlm-2700	91	27	africa	africa	PROPN
ajlm-2700	91	28	,	,	PUNCT
ajlm-2700	92	1	06	06	NUM
ajlm-2700	92	2	april	april	PROPN
ajlm-2700	92	3	2022	2022	NUM
ajlm-2700	92	4	to	to	ADP
ajlm-2700	92	5	21	21	NUM
ajlm-2700	92	6	september	september	PROPN
ajlm-2700	92	7	2022	2022	NUM
ajlm-2700	92	8	.	.	PUNCT
ajlm-2700	93	1	clinical	clinical	ADJ
ajlm-2700	93	2	interpretation	interpretation	NOUN
ajlm-2700	93	3	the	the	DET
ajlm-2700	93	4	clinical	clinical	ADJ
ajlm-2700	93	5	performance	performance	NOUN
ajlm-2700	93	6	of	of	ADP
ajlm-2700	93	7	the	the	DET
ajlm-2700	93	8	two	two	NUM
ajlm-2700	93	9	assays	assay	NOUN
ajlm-2700	93	10	was	be	AUX
ajlm-2700	93	11	assessed	assess	VERB
ajlm-2700	93	12	in	in	ADP
ajlm-2700	93	13	the	the	DET
ajlm-2700	93	14	diagnosis	diagnosis	NOUN
ajlm-2700	93	15	of	of	ADP
ajlm-2700	93	16	hypoparathyroidism	hypoparathyroidism	NOUN
ajlm-2700	93	17	and	and	CCONJ
ajlm-2700	93	18	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	93	19	and	and	CCONJ
ajlm-2700	93	20	in	in	ADP
ajlm-2700	93	21	ckd	ckd	PROPN
ajlm-2700	93	22	patients	patient	NOUN
ajlm-2700	93	23	,	,	PUNCT
ajlm-2700	93	24	including	include	VERB
ajlm-2700	93	25	those	those	PRON
ajlm-2700	93	26	on	on	ADP
ajlm-2700	93	27	dialysis	dialysis	NOUN
ajlm-2700	93	28	.	.	PUNCT
ajlm-2700	94	1	the	the	DET
ajlm-2700	94	2	same	same	ADJ
ajlm-2700	94	3	505	505	NUM
ajlm-2700	94	4	residual	residual	ADJ
ajlm-2700	94	5	samples	sample	NOUN
ajlm-2700	94	6	considered	consider	VERB
ajlm-2700	94	7	for	for	ADP
ajlm-2700	94	8	the	the	DET
ajlm-2700	94	9	method	method	ADJ
ajlm-2700	94	10	comparison	comparison	NOUN
ajlm-2700	94	11	study	study	NOUN
ajlm-2700	94	12	were	be	AUX
ajlm-2700	94	13	reviewed	review	VERB
ajlm-2700	94	14	for	for	ADP
ajlm-2700	94	15	the	the	DET
ajlm-2700	94	16	clinical	clinical	ADJ
ajlm-2700	94	17	interpretation	interpretation	NOUN
ajlm-2700	94	18	arm	arm	NOUN
ajlm-2700	94	19	of	of	ADP
ajlm-2700	94	20	the	the	DET
ajlm-2700	94	21	study	study	NOUN
ajlm-2700	94	22	.	.	PUNCT
ajlm-2700	95	1	sixteen	sixteen	NUM
ajlm-2700	95	2	(	(	PUNCT
ajlm-2700	95	3	16	16	NUM
ajlm-2700	95	4	)	)	PUNCT
ajlm-2700	95	5	were	be	AUX
ajlm-2700	95	6	excluded	exclude	VERB
ajlm-2700	95	7	because	because	SCONJ
ajlm-2700	95	8	they	they	PRON
ajlm-2700	95	9	exceeded	exceed	VERB
ajlm-2700	95	10	the	the	DET
ajlm-2700	95	11	stability	stability	NOUN
ajlm-2700	95	12	period	period	NOUN
ajlm-2700	95	13	and	and	CCONJ
ajlm-2700	95	14	had	have	AUX
ajlm-2700	95	15	missing	miss	VERB
ajlm-2700	95	16	demographics	demographic	NOUN
ajlm-2700	95	17	,	,	PUNCT
ajlm-2700	95	18	110	110	NUM
ajlm-2700	95	19	were	be	AUX
ajlm-2700	95	20	from	from	ADP
ajlm-2700	95	21	patients	patient	NOUN
ajlm-2700	95	22	with	with	ADP
ajlm-2700	95	23	an	an	DET
ajlm-2700	95	24	age	age	NOUN
ajlm-2700	95	25	less	less	ADJ
ajlm-2700	95	26	than	than	ADP
ajlm-2700	95	27	18	18	NUM
ajlm-2700	95	28	years	year	NOUN
ajlm-2700	95	29	old	old	ADJ
ajlm-2700	95	30	,	,	PUNCT
ajlm-2700	95	31	and	and	CCONJ
ajlm-2700	95	32	103	103	NUM
ajlm-2700	95	33	had	have	AUX
ajlm-2700	95	34	missing	miss	VERB
ajlm-2700	95	35	biochemical	biochemical	ADJ
ajlm-2700	95	36	data	datum	NOUN
ajlm-2700	95	37	.	.	PUNCT
ajlm-2700	96	1	a	a	DET
ajlm-2700	96	2	total	total	NOUN
ajlm-2700	96	3	of	of	ADP
ajlm-2700	96	4	276	276	NUM
ajlm-2700	96	5	patients	patient	NOUN
ajlm-2700	96	6	(	(	PUNCT
ajlm-2700	96	7	170	170	NUM
ajlm-2700	96	8	women	woman	NOUN
ajlm-2700	96	9	,	,	PUNCT
ajlm-2700	96	10	106	106	NUM
ajlm-2700	96	11	men	man	NOUN
ajlm-2700	96	12	,	,	PUNCT
ajlm-2700	96	13	age	age	NOUN
ajlm-2700	96	14	range	range	NOUN
ajlm-2700	96	15	:	:	PUNCT
ajlm-2700	96	16	18	18	NUM
ajlm-2700	96	17	–	–	SYM
ajlm-2700	96	18	89	89	NUM
ajlm-2700	96	19	years	year	NOUN
ajlm-2700	96	20	)	)	PUNCT
ajlm-2700	96	21	were	be	AUX
ajlm-2700	96	22	included	include	VERB
ajlm-2700	96	23	in	in	ADP
ajlm-2700	96	24	the	the	DET
ajlm-2700	96	25	clinical	clinical	ADJ
ajlm-2700	96	26	interpretation	interpretation	NOUN
ajlm-2700	96	27	part	part	NOUN
ajlm-2700	96	28	of	of	ADP
ajlm-2700	96	29	the	the	DET
ajlm-2700	96	30	study	study	NOUN
ajlm-2700	96	31	as	as	SCONJ
ajlm-2700	96	32	depicted	depict	VERB
ajlm-2700	96	33	in	in	ADP
ajlm-2700	96	34	the	the	DET
ajlm-2700	96	35	flow	flow	NOUN
ajlm-2700	96	36	diagram	diagram	NOUN
ajlm-2700	96	37	(	(	PUNCT
ajlm-2700	96	38	online	online	ADJ
ajlm-2700	96	39	supplementary	supplementary	ADJ
ajlm-2700	96	40	figure	figure	NOUN
ajlm-2700	96	41	5b	5b	NUM
ajlm-2700	96	42	)	)	PUNCT
ajlm-2700	96	43	.	.	PUNCT
ajlm-2700	97	1	the	the	DET
ajlm-2700	97	2	overall	overall	ADJ
ajlm-2700	97	3	median	median	ADJ
ajlm-2700	97	4	age	age	NOUN
ajlm-2700	97	5	was	be	AUX
ajlm-2700	97	6	52	52	NUM
ajlm-2700	97	7	years	year	NOUN
ajlm-2700	97	8	with	with	ADP
ajlm-2700	97	9	the	the	DET
ajlm-2700	97	10	majority	majority	NOUN
ajlm-2700	97	11	being	be	AUX
ajlm-2700	97	12	women	woman	NOUN
ajlm-2700	97	13	(	(	PUNCT
ajlm-2700	97	14	62	62	NUM
ajlm-2700	97	15	%	%	NOUN
ajlm-2700	97	16	)	)	PUNCT
ajlm-2700	97	17	.	.	PUNCT
ajlm-2700	98	1	the	the	DET
ajlm-2700	98	2	median	median	ADJ
ajlm-2700	98	3	age	age	NOUN
ajlm-2700	98	4	for	for	ADP
ajlm-2700	98	5	ckd	ckd	PROPN
ajlm-2700	98	6	patients	patient	NOUN
ajlm-2700	98	7	was	be	AUX
ajlm-2700	98	8	lower	low	ADJ
ajlm-2700	98	9	than	than	ADP
ajlm-2700	98	10	the	the	DET
ajlm-2700	98	11	non	non	PROPN
ajlm-2700	98	12	-	-	NOUN
ajlm-2700	98	13	ckd	ckd	ADJ
ajlm-2700	98	14	;	;	PUNCT
ajlm-2700	98	15	however	however	ADV
ajlm-2700	98	16	,	,	PUNCT
ajlm-2700	98	17	the	the	DET
ajlm-2700	98	18	difference	difference	NOUN
ajlm-2700	98	19	was	be	AUX
ajlm-2700	98	20	not	not	PART
ajlm-2700	98	21	statistically	statistically	ADV
ajlm-2700	98	22	significant	significant	ADJ
ajlm-2700	98	23	(	(	PUNCT
ajlm-2700	98	24	p	p	X
ajlm-2700	98	25	=	=	NOUN
ajlm-2700	98	26	0.1032	0.1032	NUM
ajlm-2700	98	27	)	)	PUNCT
ajlm-2700	98	28	(	(	PUNCT
ajlm-2700	98	29	table	table	NOUN
ajlm-2700	98	30	1	1	NUM
ajlm-2700	98	31	)	)	PUNCT
ajlm-2700	98	32	.	.	PUNCT
ajlm-2700	99	1	vitamin	vitamin	NOUN
ajlm-2700	99	2	d	d	NOUN
ajlm-2700	99	3	results	result	NOUN
ajlm-2700	99	4	were	be	AUX
ajlm-2700	99	5	not	not	PART
ajlm-2700	99	6	included	include	VERB
ajlm-2700	99	7	,	,	PUNCT
ajlm-2700	99	8	as	as	SCONJ
ajlm-2700	99	9	very	very	ADV
ajlm-2700	99	10	few	few	ADJ
ajlm-2700	99	11	patients	patient	NOUN
ajlm-2700	99	12	had	have	VERB
ajlm-2700	99	13	results	result	NOUN
ajlm-2700	99	14	available	available	ADJ
ajlm-2700	99	15	on	on	ADP
ajlm-2700	99	16	the	the	DET
ajlm-2700	99	17	laboratory	laboratory	NOUN
ajlm-2700	99	18	information	information	NOUN
ajlm-2700	99	19	system	system	NOUN
ajlm-2700	99	20	.	.	PUNCT
ajlm-2700	100	1	the	the	DET
ajlm-2700	100	2	mcnemar	mcnemar	PROPN
ajlm-2700	100	3	test	test	NOUN
ajlm-2700	100	4	did	do	AUX
ajlm-2700	100	5	not	not	PART
ajlm-2700	100	6	demonstrate	demonstrate	VERB
ajlm-2700	100	7	any	any	DET
ajlm-2700	100	8	statistically	statistically	ADV
ajlm-2700	100	9	significant	significant	ADJ
ajlm-2700	100	10	differences	difference	NOUN
ajlm-2700	100	11	in	in	ADP
ajlm-2700	100	12	clinical	clinical	ADJ
ajlm-2700	100	13	interpretation	interpretation	NOUN
ajlm-2700	100	14	,	,	PUNCT
ajlm-2700	100	15	as	as	SCONJ
ajlm-2700	100	16	shown	show	VERB
ajlm-2700	100	17	by	by	ADP
ajlm-2700	100	18	p	p	NOUN
ajlm-2700	100	19	-	-	PUNCT
ajlm-2700	100	20	values	value	NOUN
ajlm-2700	100	21	above	above	ADP
ajlm-2700	100	22	0.05	0.05	NUM
ajlm-2700	100	23	in	in	ADP
ajlm-2700	100	24	the	the	DET
ajlm-2700	100	25	detection	detection	NOUN
ajlm-2700	100	26	of	of	ADP
ajlm-2700	100	27	low	low	ADJ
ajlm-2700	100	28	,	,	PUNCT
ajlm-2700	100	29	normal	normal	ADJ
ajlm-2700	100	30	,	,	PUNCT
ajlm-2700	100	31	and	and	CCONJ
ajlm-2700	100	32	high	high	ADJ
ajlm-2700	100	33	pth	pth	NOUN
ajlm-2700	100	34	using	use	VERB
ajlm-2700	100	35	both	both	DET
ajlm-2700	100	36	assays	assay	NOUN
ajlm-2700	100	37	.	.	PUNCT
ajlm-2700	101	1	in	in	ADP
ajlm-2700	101	2	both	both	CCONJ
ajlm-2700	101	3	the	the	DET
ajlm-2700	101	4	ckd	ckd	PROPN
ajlm-2700	101	5	and	and	CCONJ
ajlm-2700	101	6	dialysis	dialysis	NOUN
ajlm-2700	101	7	group	group	NOUN
ajlm-2700	101	8	,	,	PUNCT
ajlm-2700	101	9	no	no	DET
ajlm-2700	101	10	statistically	statistically	ADV
ajlm-2700	101	11	significant	significant	ADJ
ajlm-2700	101	12	(	(	PUNCT
ajlm-2700	101	13	p	p	X
ajlm-2700	101	14	=	=	NOUN
ajlm-2700	101	15	0.500	0.500	NUM
ajlm-2700	101	16	)	)	PUNCT
ajlm-2700	101	17	differences	difference	NOUN
ajlm-2700	101	18	in	in	ADP
ajlm-2700	101	19	interpretation	interpretation	NOUN
ajlm-2700	101	20	were	be	AUX
ajlm-2700	101	21	found	find	VERB
ajlm-2700	101	22	using	use	VERB
ajlm-2700	101	23	mcnemar	mcnemar	NOUN
ajlm-2700	101	24	,	,	PUNCT
ajlm-2700	101	25	as	as	SCONJ
ajlm-2700	101	26	is	be	AUX
ajlm-2700	101	27	shown	show	VERB
ajlm-2700	101	28	in	in	ADP
ajlm-2700	101	29	table	table	NOUN
ajlm-2700	101	30	2	2	NUM
ajlm-2700	101	31	.	.	PUNCT
ajlm-2700	101	32	table	table	NOUN
ajlm-2700	101	33	2	2	NUM
ajlm-2700	101	34	:	:	PUNCT
ajlm-2700	101	35	 	 	SPACE
ajlm-2700	101	36	differences	difference	NOUN
ajlm-2700	101	37	in	in	ADP
ajlm-2700	101	38	clinical	clinical	ADJ
ajlm-2700	101	39	interpretation	interpretation	NOUN
ajlm-2700	101	40	using	use	VERB
ajlm-2700	101	41	manufacturer	manufacturer	NOUN
ajlm-2700	101	42	reference	reference	NOUN
ajlm-2700	101	43	interval	interval	NOUN
ajlm-2700	101	44	,	,	PUNCT
ajlm-2700	101	45	johannesburg	johannesburg	PROPN
ajlm-2700	101	46	,	,	PUNCT
ajlm-2700	101	47	south	south	PROPN
ajlm-2700	101	48	africa	africa	PROPN
ajlm-2700	101	49	,	,	PUNCT
ajlm-2700	101	50	06	06	NUM
ajlm-2700	101	51	april	april	PROPN
ajlm-2700	101	52	2022	2022	NUM
ajlm-2700	101	53	to	to	ADP
ajlm-2700	101	54	21	21	NUM
ajlm-2700	101	55	september	september	PROPN
ajlm-2700	101	56	2022	2022	NUM
ajlm-2700	101	57	.	.	PUNCT
ajlm-2700	102	1	there	there	PRON
ajlm-2700	102	2	were	be	VERB
ajlm-2700	102	3	29	29	NUM
ajlm-2700	102	4	patients	patient	NOUN
ajlm-2700	102	5	with	with	ADP
ajlm-2700	102	6	ckd	ckd	PROPN
ajlm-2700	102	7	on	on	ADP
ajlm-2700	102	8	dialysis	dialysis	NOUN
ajlm-2700	102	9	.	.	PUNCT
ajlm-2700	103	1	classification	classification	NOUN
ajlm-2700	103	2	according	accord	VERB
ajlm-2700	103	3	to	to	ADP
ajlm-2700	103	4	kdigo	kdigo	PROPN
ajlm-2700	103	5	guidelines	guideline	NOUN
ajlm-2700	103	6	revealed	reveal	VERB
ajlm-2700	103	7	minimal	minimal	ADJ
ajlm-2700	103	8	discordance	discordance	NOUN
ajlm-2700	103	9	between	between	ADP
ajlm-2700	103	10	the	the	DET
ajlm-2700	103	11	two	two	NUM
ajlm-2700	103	12	pth	pth	NOUN
ajlm-2700	103	13	assays	assay	NOUN
ajlm-2700	103	14	,	,	PUNCT
ajlm-2700	103	15	with	with	ADP
ajlm-2700	103	16	a	a	DET
ajlm-2700	103	17	weighted	weight	VERB
ajlm-2700	103	18	ҡ	ҡ	PRON
ajlm-2700	103	19	coefficient	coefficient	NOUN
ajlm-2700	103	20	of	of	ADP
ajlm-2700	103	21	0.797	0.797	NUM
ajlm-2700	103	22	(	(	PUNCT
ajlm-2700	103	23	0.594–1.000	0.594–1.000	NUM
ajlm-2700	103	24	)	)	PUNCT
ajlm-2700	103	25	(	(	PUNCT
ajlm-2700	103	26	table	table	NOUN
ajlm-2700	103	27	3	3	NUM
ajlm-2700	103	28	)	)	PUNCT
ajlm-2700	103	29	.	.	PUNCT
ajlm-2700	104	1	table	table	NOUN
ajlm-2700	104	2	3	3	NUM
ajlm-2700	104	3	:	:	PUNCT
ajlm-2700	104	4	 	 	SPACE
ajlm-2700	104	5	classification	classification	NOUN
ajlm-2700	104	6	according	accord	VERB
ajlm-2700	104	7	to	to	ADP
ajlm-2700	104	8	kidney	kidney	NOUN
ajlm-2700	104	9	disease	disease	NOUN
ajlm-2700	104	10	:	:	PUNCT
ajlm-2700	104	11	improving	improve	VERB
ajlm-2700	104	12	global	global	ADJ
ajlm-2700	104	13	outcomes	outcome	NOUN
ajlm-2700	104	14	guidelines	guideline	NOUN
ajlm-2700	104	15	for	for	ADP
ajlm-2700	104	16	intact	intact	ADJ
ajlm-2700	104	17	parathyroid	parathyroid	ADJ
ajlm-2700	104	18	hormone	hormone	NOUN
ajlm-2700	104	19	and	and	CCONJ
ajlm-2700	104	20	parathyroid	parathyroid	ADJ
ajlm-2700	104	21	hormone	hormone	NOUN
ajlm-2700	104	22	1–84	1–84	NOUN
ajlm-2700	104	23	assays	assay	NOUN
ajlm-2700	104	24	,	,	PUNCT
ajlm-2700	104	25	johannesburg	johannesburg	PROPN
ajlm-2700	104	26	,	,	PUNCT
ajlm-2700	104	27	south	south	PROPN
ajlm-2700	104	28	africa	africa	PROPN
ajlm-2700	104	29	,	,	PUNCT
ajlm-2700	104	30	06	06	NUM
ajlm-2700	104	31	april	april	PROPN
ajlm-2700	104	32	2022	2022	NUM
ajlm-2700	104	33	to	to	ADP
ajlm-2700	104	34	21	21	NUM
ajlm-2700	104	35	september	september	PROPN
ajlm-2700	104	36	2022	2022	NUM
ajlm-2700	104	37	.	.	PUNCT
ajlm-2700	105	1	discussion	discussion	NOUN
ajlm-2700	105	2	the	the	DET
ajlm-2700	105	3	study	study	NOUN
ajlm-2700	105	4	conducted	conduct	VERB
ajlm-2700	105	5	at	at	ADP
ajlm-2700	105	6	a	a	DET
ajlm-2700	105	7	tertiary	tertiary	ADJ
ajlm-2700	105	8	hospital	hospital	NOUN
ajlm-2700	105	9	in	in	ADP
ajlm-2700	105	10	johannesburg	johannesburg	PROPN
ajlm-2700	105	11	,	,	PUNCT
ajlm-2700	105	12	south	south	PROPN
ajlm-2700	105	13	africa	africa	PROPN
ajlm-2700	105	14	,	,	PUNCT
ajlm-2700	105	15	between	between	ADP
ajlm-2700	105	16	06	06	NUM
ajlm-2700	105	17	april	april	PROPN
ajlm-2700	105	18	2022	2022	NUM
ajlm-2700	105	19	and	and	CCONJ
ajlm-2700	105	20	21	21	NUM
ajlm-2700	105	21	september	september	PROPN
ajlm-2700	105	22	2022	2022	NUM
ajlm-2700	105	23	found	find	VERB
ajlm-2700	105	24	that	that	SCONJ
ajlm-2700	105	25	there	there	PRON
ajlm-2700	105	26	was	be	VERB
ajlm-2700	105	27	a	a	DET
ajlm-2700	105	28	difference	difference	NOUN
ajlm-2700	105	29	(	(	PUNCT
ajlm-2700	105	30	inter	inter	ADJ
ajlm-2700	105	31	-	-	ADJ
ajlm-2700	105	32	assay	assay	ADJ
ajlm-2700	105	33	bias	bias	NOUN
ajlm-2700	105	34	)	)	PUNCT
ajlm-2700	105	35	between	between	ADP
ajlm-2700	105	36	the	the	DET
ajlm-2700	105	37	secondand	secondand	NOUN
ajlm-2700	105	38	third	third	ADJ
ajlm-2700	105	39	-	-	PUNCT
ajlm-2700	105	40	generation	generation	NOUN
ajlm-2700	105	41	pth	pth	NOUN
ajlm-2700	105	42	assays	assay	NOUN
ajlm-2700	105	43	.	.	PUNCT
ajlm-2700	106	1	however	however	ADV
ajlm-2700	106	2	,	,	PUNCT
ajlm-2700	106	3	there	there	PRON
ajlm-2700	106	4	was	be	VERB
ajlm-2700	106	5	no	no	DET
ajlm-2700	106	6	clinically	clinically	ADV
ajlm-2700	106	7	significant	significant	ADJ
ajlm-2700	106	8	change	change	NOUN
ajlm-2700	106	9	in	in	ADP
ajlm-2700	106	10	the	the	DET
ajlm-2700	106	11	classification	classification	NOUN
ajlm-2700	106	12	of	of	ADP
ajlm-2700	106	13	hypoparathyroidism	hypoparathyroidism	NOUN
ajlm-2700	106	14	,	,	PUNCT
ajlm-2700	106	15	primary	primary	ADJ
ajlm-2700	106	16	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	106	17	,	,	PUNCT
ajlm-2700	106	18	and	and	CCONJ
ajlm-2700	106	19	secondary	secondary	ADJ
ajlm-2700	106	20	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	106	21	in	in	ADP
ajlm-2700	106	22	pre	pre	ADJ
ajlm-2700	106	23	-	-	NOUN
ajlm-2700	106	24	dialysis	dialysis	NOUN
ajlm-2700	106	25	and	and	CCONJ
ajlm-2700	106	26	dialysis	dialysis	NOUN
ajlm-2700	106	27	ckd	ckd	NOUN
ajlm-2700	106	28	patients	patient	NOUN
ajlm-2700	106	29	when	when	SCONJ
ajlm-2700	106	30	one	one	NUM
ajlm-2700	106	31	assay	assay	NOUN
ajlm-2700	106	32	was	be	AUX
ajlm-2700	106	33	used	use	VERB
ajlm-2700	106	34	over	over	ADP
ajlm-2700	106	35	the	the	DET
ajlm-2700	106	36	other	other	ADJ
ajlm-2700	106	37	.	.	PUNCT
ajlm-2700	107	1	with	with	ADP
ajlm-2700	107	2	regard	regard	NOUN
ajlm-2700	107	3	to	to	ADP
ajlm-2700	107	4	analytical	analytical	ADJ
ajlm-2700	107	5	performance	performance	NOUN
ajlm-2700	107	6	,	,	PUNCT
ajlm-2700	107	7	the	the	DET
ajlm-2700	107	8	methods	method	NOUN
ajlm-2700	107	9	were	be	AUX
ajlm-2700	107	10	strongly	strongly	ADV
ajlm-2700	107	11	correlated	correlate	VERB
ajlm-2700	107	12	.	.	PUNCT
ajlm-2700	108	1	however	however	ADV
ajlm-2700	108	2	,	,	PUNCT
ajlm-2700	108	3	as	as	SCONJ
ajlm-2700	108	4	the	the	DET
ajlm-2700	108	5	percentage	percentage	NOUN
ajlm-2700	108	6	mean	mean	NOUN
ajlm-2700	108	7	bias	bias	NOUN
ajlm-2700	108	8	surpassed	surpass	VERB
ajlm-2700	108	9	the	the	DET
ajlm-2700	108	10	european	european	PROPN
ajlm-2700	108	11	federation	federation	PROPN
ajlm-2700	108	12	of	of	ADP
ajlm-2700	108	13	clinical	clinical	ADJ
ajlm-2700	108	14	chemistry	chemistry	NOUN
ajlm-2700	108	15	and	and	CCONJ
ajlm-2700	108	16	laboratory	laboratory	NOUN
ajlm-2700	108	17	medicine	medicine	NOUN
ajlm-2700	108	18	biological	biological	ADJ
ajlm-2700	108	19	variation	variation	NOUN
ajlm-2700	108	20	goal	goal	NOUN
ajlm-2700	108	21	,	,	PUNCT
ajlm-2700	108	22	this	this	PRON
ajlm-2700	108	23	implies	imply	VERB
ajlm-2700	108	24	that	that	SCONJ
ajlm-2700	108	25	these	these	DET
ajlm-2700	108	26	assays	assay	NOUN
ajlm-2700	108	27	are	be	AUX
ajlm-2700	108	28	neither	neither	CCONJ
ajlm-2700	108	29	interchangeable	interchangeable	ADJ
ajlm-2700	108	30	nor	nor	CCONJ
ajlm-2700	108	31	comparable	comparable	ADJ
ajlm-2700	108	32	.	.	PUNCT
ajlm-2700	109	1	our	our	PRON
ajlm-2700	109	2	study	study	NOUN
ajlm-2700	109	3	showed	show	VERB
ajlm-2700	109	4	that	that	SCONJ
ajlm-2700	109	5	for	for	ADP
ajlm-2700	109	6	the	the	DET
ajlm-2700	109	7	entire	entire	ADJ
ajlm-2700	109	8	patient	patient	NOUN
ajlm-2700	109	9	group	group	NOUN
ajlm-2700	109	10	,	,	PUNCT
ajlm-2700	109	11	the	the	DET
ajlm-2700	109	12	third	third	ADJ
ajlm-2700	109	13	-	-	PUNCT
ajlm-2700	109	14	generation	generation	NOUN
ajlm-2700	109	15	pth	pth	NOUN
ajlm-2700	109	16	assay	assay	NOUN
ajlm-2700	109	17	produced	produce	VERB
ajlm-2700	109	18	results	result	NOUN
ajlm-2700	109	19	that	that	PRON
ajlm-2700	109	20	were	be	AUX
ajlm-2700	109	21	,	,	PUNCT
ajlm-2700	109	22	on	on	ADP
ajlm-2700	109	23	average	average	ADJ
ajlm-2700	109	24	,	,	PUNCT
ajlm-2700	109	25	approximately	approximately	ADV
ajlm-2700	109	26	20	20	NUM
ajlm-2700	109	27	%	%	NOUN
ajlm-2700	109	28	lower	low	ADJ
ajlm-2700	109	29	than	than	ADP
ajlm-2700	109	30	the	the	DET
ajlm-2700	109	31	second	second	ADJ
ajlm-2700	109	32	-	-	PUNCT
ajlm-2700	109	33	generation	generation	NOUN
ajlm-2700	109	34	assay	assay	NOUN
ajlm-2700	109	35	,	,	PUNCT
ajlm-2700	109	36	and	and	CCONJ
ajlm-2700	109	37	even	even	ADV
ajlm-2700	109	38	lower	low	ADJ
ajlm-2700	109	39	in	in	ADP
ajlm-2700	109	40	ckd	ckd	PROPN
ajlm-2700	109	41	(	(	PUNCT
ajlm-2700	109	42	27	27	NUM
ajlm-2700	109	43	%	%	NOUN
ajlm-2700	109	44	)	)	PUNCT
ajlm-2700	109	45	and	and	CCONJ
ajlm-2700	109	46	dialysis	dialysis	NOUN
ajlm-2700	109	47	(	(	PUNCT
ajlm-2700	109	48	35	35	NUM
ajlm-2700	109	49	%	%	NOUN
ajlm-2700	109	50	)	)	PUNCT
ajlm-2700	109	51	patients	patient	NOUN
ajlm-2700	109	52	.	.	PUNCT
ajlm-2700	110	1	this	this	PRON
ajlm-2700	110	2	is	be	AUX
ajlm-2700	110	3	in	in	ADP
ajlm-2700	110	4	keeping	keep	VERB
ajlm-2700	110	5	with	with	ADP
ajlm-2700	110	6	other	other	ADJ
ajlm-2700	110	7	reported	report	VERB
ajlm-2700	110	8	research.3,14,15,25,26,27	research.3,14,15,25,26,27	NUM
ajlm-2700	110	9	studies	study	NOUN
ajlm-2700	110	10	by	by	ADP
ajlm-2700	110	11	hashim	hashim	PROPN
ajlm-2700	110	12	et	et	PROPN
ajlm-2700	110	13	al	al	PROPN
ajlm-2700	110	14	.	.	PROPN
ajlm-2700	110	15	conducted	conduct	VERB
ajlm-2700	110	16	in	in	ADP
ajlm-2700	110	17	a	a	DET
ajlm-2700	110	18	malaysian	malaysian	ADJ
ajlm-2700	110	19	population	population	NOUN
ajlm-2700	110	20	in	in	ADP
ajlm-2700	110	21	2020	2020	NUM
ajlm-2700	110	22	and	and	CCONJ
ajlm-2700	110	23	o’flaherty	o’flaherty	NUM
ajlm-2700	111	1	et	et	PROPN
ajlm-2700	111	2	al	al	PROPN
ajlm-2700	111	3	.	.	PROPN
ajlm-2700	111	4	published	publish	VERB
ajlm-2700	111	5	in	in	ADP
ajlm-2700	111	6	2013	2013	NUM
ajlm-2700	111	7	from	from	ADP
ajlm-2700	111	8	the	the	DET
ajlm-2700	111	9	united	united	ADJ
ajlm-2700	111	10	kingdom	kingdom	NOUN
ajlm-2700	111	11	,	,	PUNCT
ajlm-2700	111	12	both	both	PRON
ajlm-2700	111	13	using	use	VERB
ajlm-2700	111	14	roche	roche	NOUN
ajlm-2700	111	15	pth	pth	NOUN
ajlm-2700	111	16	assays	assay	NOUN
ajlm-2700	111	17	,	,	PUNCT
ajlm-2700	111	18	found	find	VERB
ajlm-2700	111	19	that	that	SCONJ
ajlm-2700	111	20	third	third	ADJ
ajlm-2700	111	21	-	-	PUNCT
ajlm-2700	111	22	generation	generation	NOUN
ajlm-2700	111	23	assays	assay	NOUN
ajlm-2700	111	24	were	be	AUX
ajlm-2700	111	25	lower	low	ADJ
ajlm-2700	111	26	by	by	ADP
ajlm-2700	111	27	30	30	NUM
ajlm-2700	111	28	%	%	NOUN
ajlm-2700	111	29	and	and	CCONJ
ajlm-2700	111	30	40	40	NUM
ajlm-2700	111	31	%	%	NOUN
ajlm-2700	111	32	compared	compare	VERB
ajlm-2700	111	33	to	to	ADP
ajlm-2700	111	34	second	second	ADJ
ajlm-2700	111	35	-	-	PUNCT
ajlm-2700	111	36	generation	generation	NOUN
ajlm-2700	111	37	assays	assay	NOUN
ajlm-2700	111	38	,	,	PUNCT
ajlm-2700	111	39	respectively.28,29	respectively.28,29	VERB
ajlm-2700	111	40	in	in	ADP
ajlm-2700	111	41	contrast	contrast	NOUN
ajlm-2700	111	42	,	,	PUNCT
ajlm-2700	111	43	in	in	ADP
ajlm-2700	111	44	the	the	DET
ajlm-2700	111	45	non	non	ADJ
ajlm-2700	111	46	-	-	ADJ
ajlm-2700	111	47	ckd	ckd	ADJ
ajlm-2700	111	48	group	group	NOUN
ajlm-2700	111	49	with	with	ADP
ajlm-2700	111	50	egfr	egfr	NOUN
ajlm-2700	111	51	above	above	ADP
ajlm-2700	111	52	60	60	NUM
ajlm-2700	111	53	ml	ml	NOUN
ajlm-2700	111	54	/	/	SYM
ajlm-2700	111	55	min/1.73	min/1.73	NOUN
ajlm-2700	111	56	m2	m2	PROPN
ajlm-2700	111	57	,	,	PUNCT
ajlm-2700	111	58	the	the	DET
ajlm-2700	111	59	observed	observed	ADJ
ajlm-2700	111	60	bias	bias	NOUN
ajlm-2700	111	61	was	be	AUX
ajlm-2700	111	62	5.7	5.7	NUM
ajlm-2700	111	63	%	%	NOUN
ajlm-2700	111	64	.	.	PUNCT
ajlm-2700	112	1	this	this	PRON
ajlm-2700	112	2	indicates	indicate	VERB
ajlm-2700	112	3	that	that	SCONJ
ajlm-2700	112	4	in	in	ADP
ajlm-2700	112	5	patients	patient	NOUN
ajlm-2700	112	6	with	with	ADP
ajlm-2700	112	7	normal	normal	ADJ
ajlm-2700	112	8	gfr	gfr	NOUN
ajlm-2700	112	9	,	,	PUNCT
ajlm-2700	112	10	there	there	PRON
ajlm-2700	112	11	are	be	VERB
ajlm-2700	112	12	minimal	minimal	ADJ
ajlm-2700	112	13	differences	difference	NOUN
ajlm-2700	112	14	between	between	ADP
ajlm-2700	112	15	secondand	secondand	NOUN
ajlm-2700	112	16	third	third	ADJ
ajlm-2700	112	17	-	-	PUNCT
ajlm-2700	112	18	generation	generation	NOUN
ajlm-2700	112	19	assays	assay	NOUN
ajlm-2700	112	20	,	,	PUNCT
ajlm-2700	112	21	which	which	PRON
ajlm-2700	112	22	is	be	AUX
ajlm-2700	112	23	in	in	ADP
ajlm-2700	112	24	keeping	keeping	NOUN
ajlm-2700	112	25	with	with	ADP
ajlm-2700	112	26	other	other	ADJ
ajlm-2700	112	27	reported	report	VERB
ajlm-2700	112	28	studies	study	NOUN
ajlm-2700	112	29	conducted	conduct	VERB
ajlm-2700	112	30	in	in	ADP
ajlm-2700	112	31	france	france	PROPN
ajlm-2700	112	32	and	and	CCONJ
ajlm-2700	112	33	malaysia.26,28	malaysia.26,28	NOUN
ajlm-2700	112	34	although	although	SCONJ
ajlm-2700	112	35	the	the	DET
ajlm-2700	112	36	observed	observed	ADJ
ajlm-2700	112	37	differences	difference	NOUN
ajlm-2700	112	38	between	between	ADP
ajlm-2700	112	39	the	the	DET
ajlm-2700	112	40	two	two	NUM
ajlm-2700	112	41	pth	pth	NOUN
ajlm-2700	112	42	assays	assay	NOUN
ajlm-2700	112	43	were	be	AUX
ajlm-2700	112	44	higher	high	ADJ
ajlm-2700	112	45	in	in	ADP
ajlm-2700	112	46	both	both	CCONJ
ajlm-2700	112	47	the	the	DET
ajlm-2700	112	48	pre	pre	NOUN
ajlm-2700	112	49	-	-	NOUN
ajlm-2700	112	50	dialysis	dialysis	NOUN
ajlm-2700	112	51	and	and	CCONJ
ajlm-2700	112	52	dialysis	dialysis	NOUN
ajlm-2700	112	53	ckd	ckd	NOUN
ajlm-2700	112	54	groups	group	NOUN
ajlm-2700	112	55	,	,	PUNCT
ajlm-2700	112	56	there	there	PRON
ajlm-2700	112	57	was	be	VERB
ajlm-2700	112	58	no	no	DET
ajlm-2700	112	59	change	change	NOUN
ajlm-2700	112	60	in	in	ADP
ajlm-2700	112	61	interpretation	interpretation	NOUN
ajlm-2700	112	62	of	of	ADP
ajlm-2700	112	63	secondary	secondary	ADJ
ajlm-2700	112	64	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	112	65	with	with	ADP
ajlm-2700	112	66	either	either	DET
ajlm-2700	112	67	assay	assay	NOUN
ajlm-2700	112	68	.	.	PUNCT
ajlm-2700	113	1	the	the	DET
ajlm-2700	113	2	kdigo	kdigo	PROPN
ajlm-2700	113	3	guidelines	guideline	NOUN
ajlm-2700	113	4	do	do	AUX
ajlm-2700	113	5	not	not	PART
ajlm-2700	113	6	state	state	VERB
ajlm-2700	113	7	the	the	DET
ajlm-2700	113	8	target	target	NOUN
ajlm-2700	113	9	pth	pth	NOUN
ajlm-2700	113	10	range	range	NOUN
ajlm-2700	113	11	in	in	ADP
ajlm-2700	113	12	pre	pre	ADJ
ajlm-2700	113	13	-	-	ADJ
ajlm-2700	113	14	dialysis	dialysis	ADJ
ajlm-2700	113	15	ckd	ckd	PROPN
ajlm-2700	113	16	patients.15	patients.15	PROPN
ajlm-2700	113	17	furthermore	furthermore	ADV
ajlm-2700	113	18	,	,	PUNCT
ajlm-2700	113	19	we	we	PRON
ajlm-2700	113	20	did	do	AUX
ajlm-2700	113	21	not	not	PART
ajlm-2700	113	22	find	find	VERB
ajlm-2700	113	23	studies	study	NOUN
ajlm-2700	113	24	that	that	PRON
ajlm-2700	113	25	assessed	assess	VERB
ajlm-2700	113	26	the	the	DET
ajlm-2700	113	27	impact	impact	NOUN
ajlm-2700	113	28	on	on	ADP
ajlm-2700	113	29	clinical	clinical	ADJ
ajlm-2700	113	30	interpretation	interpretation	NOUN
ajlm-2700	113	31	in	in	ADP
ajlm-2700	113	32	this	this	DET
ajlm-2700	113	33	group	group	NOUN
ajlm-2700	113	34	.	.	PUNCT
ajlm-2700	114	1	there	there	PRON
ajlm-2700	114	2	is	be	VERB
ajlm-2700	114	3	a	a	DET
ajlm-2700	114	4	paucity	paucity	NOUN
ajlm-2700	114	5	of	of	ADP
ajlm-2700	114	6	studies	study	NOUN
ajlm-2700	114	7	that	that	PRON
ajlm-2700	114	8	have	have	AUX
ajlm-2700	114	9	compared	compare	VERB
ajlm-2700	114	10	secondand	secondand	NOUN
ajlm-2700	114	11	third	third	ADJ
ajlm-2700	114	12	-	-	PUNCT
ajlm-2700	114	13	generation	generation	NOUN
ajlm-2700	114	14	pth	pth	NOUN
ajlm-2700	114	15	assays	assay	NOUN
ajlm-2700	114	16	in	in	ADP
ajlm-2700	114	17	dialysis	dialysis	NOUN
ajlm-2700	114	18	patients	patient	NOUN
ajlm-2700	114	19	using	use	VERB
ajlm-2700	114	20	the	the	DET
ajlm-2700	114	21	kdigo	kdigo	ADJ
ajlm-2700	114	22	classification	classification	NOUN
ajlm-2700	114	23	of	of	ADP
ajlm-2700	114	24	2–9	2–9	NUM
ajlm-2700	114	25	times	time	NOUN
ajlm-2700	114	26	the	the	DET
ajlm-2700	114	27	upper	upper	ADJ
ajlm-2700	114	28	limit	limit	NOUN
ajlm-2700	114	29	of	of	ADP
ajlm-2700	114	30	normal.26,30	normal.26,30	NOUN
ajlm-2700	114	31	in	in	ADP
ajlm-2700	114	32	the	the	DET
ajlm-2700	114	33	dialysis	dialysis	NOUN
ajlm-2700	114	34	group	group	NOUN
ajlm-2700	114	35	,	,	PUNCT
ajlm-2700	114	36	using	use	VERB
ajlm-2700	114	37	the	the	DET
ajlm-2700	114	38	manufacturer	manufacturer	NOUN
ajlm-2700	114	39	’s	’s	PART
ajlm-2700	114	40	upper	upper	ADJ
ajlm-2700	114	41	limit	limit	NOUN
ajlm-2700	114	42	of	of	ADP
ajlm-2700	114	43	normal	normal	ADJ
ajlm-2700	114	44	,	,	PUNCT
ajlm-2700	114	45	classification	classification	NOUN
ajlm-2700	114	46	using	use	VERB
ajlm-2700	114	47	kdigo	kdigo	PROPN
ajlm-2700	114	48	did	do	AUX
ajlm-2700	114	49	not	not	PART
ajlm-2700	114	50	demonstrate	demonstrate	VERB
ajlm-2700	114	51	statistically	statistically	ADV
ajlm-2700	114	52	significant	significant	ADJ
ajlm-2700	114	53	discordance	discordance	NOUN
ajlm-2700	114	54	between	between	ADP
ajlm-2700	114	55	the	the	DET
ajlm-2700	114	56	two	two	NUM
ajlm-2700	114	57	assays	assay	NOUN
ajlm-2700	114	58	.	.	PUNCT
ajlm-2700	115	1	this	this	DET
ajlm-2700	115	2	study	study	NOUN
ajlm-2700	115	3	was	be	AUX
ajlm-2700	115	4	limited	limit	VERB
ajlm-2700	115	5	by	by	ADP
ajlm-2700	115	6	a	a	DET
ajlm-2700	115	7	small	small	ADJ
ajlm-2700	115	8	sample	sample	NOUN
ajlm-2700	115	9	size	size	NOUN
ajlm-2700	115	10	of	of	ADP
ajlm-2700	115	11	confirmed	confirm	VERB
ajlm-2700	115	12	dialysis	dialysis	NOUN
ajlm-2700	115	13	patients	patient	NOUN
ajlm-2700	115	14	which	which	PRON
ajlm-2700	115	15	reflects	reflect	VERB
ajlm-2700	115	16	the	the	DET
ajlm-2700	115	17	limited	limited	ADJ
ajlm-2700	115	18	dialysis	dialysis	NOUN
ajlm-2700	115	19	resources	resource	NOUN
ajlm-2700	115	20	in	in	ADP
ajlm-2700	115	21	our	our	PRON
ajlm-2700	115	22	country	country	NOUN
ajlm-2700	115	23	.	.	PUNCT
ajlm-2700	116	1	however	however	ADV
ajlm-2700	116	2	,	,	PUNCT
ajlm-2700	116	3	our	our	PRON
ajlm-2700	116	4	finding	finding	NOUN
ajlm-2700	116	5	contrasted	contrast	VERB
ajlm-2700	116	6	with	with	ADP
ajlm-2700	116	7	a	a	DET
ajlm-2700	116	8	few	few	ADJ
ajlm-2700	116	9	published	publish	VERB
ajlm-2700	116	10	studies	study	NOUN
ajlm-2700	116	11	,	,	PUNCT
ajlm-2700	116	12	including	include	VERB
ajlm-2700	116	13	that	that	PRON
ajlm-2700	116	14	by	by	ADP
ajlm-2700	116	15	dupuy	dupuy	PROPN
ajlm-2700	116	16	et	et	PROPN
ajlm-2700	116	17	al	al	PROPN
ajlm-2700	116	18	.	.	PROPN
ajlm-2700	116	19	conducted	conduct	VERB
ajlm-2700	116	20	in	in	ADP
ajlm-2700	116	21	france	france	PROPN
ajlm-2700	116	22	and	and	CCONJ
ajlm-2700	116	23	published	publish	VERB
ajlm-2700	116	24	in	in	ADP
ajlm-2700	116	25	2018	2018	NUM
ajlm-2700	116	26	,	,	PUNCT
ajlm-2700	116	27	which	which	PRON
ajlm-2700	116	28	demonstrated	demonstrate	VERB
ajlm-2700	116	29	a	a	DET
ajlm-2700	116	30	high	high	ADJ
ajlm-2700	116	31	percentage	percentage	NOUN
ajlm-2700	116	32	of	of	ADP
ajlm-2700	116	33	discordant	discordant	ADJ
ajlm-2700	116	34	results	result	NOUN
ajlm-2700	116	35	in	in	ADP
ajlm-2700	116	36	dialysis	dialysis	NOUN
ajlm-2700	116	37	patients	patient	NOUN
ajlm-2700	116	38	,	,	PUNCT
ajlm-2700	116	39	with	with	ADP
ajlm-2700	116	40	a	a	DET
ajlm-2700	116	41	ҡ	ҡ	NOUN
ajlm-2700	116	42	coefficient	coefficient	NOUN
ajlm-2700	116	43	of	of	ADP
ajlm-2700	116	44	<	<	X
ajlm-2700	116	45	0.20.26	0.20.26	PROPN
ajlm-2700	116	46	in	in	ADP
ajlm-2700	116	47	addition	addition	NOUN
ajlm-2700	116	48	,	,	PUNCT
ajlm-2700	116	49	a	a	DET
ajlm-2700	116	50	study	study	NOUN
ajlm-2700	116	51	by	by	ADP
ajlm-2700	116	52	beko	beko	PROPN
ajlm-2700	116	53	et	et	PROPN
ajlm-2700	116	54	al	al	PROPN
ajlm-2700	116	55	.	.	PROPN
ajlm-2700	116	56	,	,	PUNCT
ajlm-2700	116	57	published	publish	VERB
ajlm-2700	116	58	in	in	ADP
ajlm-2700	116	59	2012	2012	NUM
ajlm-2700	116	60	from	from	ADP
ajlm-2700	116	61	hungary	hungary	PROPN
ajlm-2700	116	62	,	,	PUNCT
ajlm-2700	116	63	found	find	VERB
ajlm-2700	116	64	that	that	SCONJ
ajlm-2700	116	65	using	use	VERB
ajlm-2700	116	66	the	the	DET
ajlm-2700	116	67	manufacturer	manufacturer	NOUN
ajlm-2700	116	68	’s	’s	PART
ajlm-2700	116	69	upper	upper	ADJ
ajlm-2700	116	70	limit	limit	NOUN
ajlm-2700	116	71	of	of	ADP
ajlm-2700	116	72	normal	normal	ADJ
ajlm-2700	116	73	,	,	PUNCT
ajlm-2700	116	74	the	the	DET
ajlm-2700	116	75	clinical	clinical	ADJ
ajlm-2700	116	76	classification	classification	NOUN
ajlm-2700	116	77	was	be	AUX
ajlm-2700	116	78	altered	alter	VERB
ajlm-2700	116	79	in	in	ADP
ajlm-2700	116	80	up	up	ADP
ajlm-2700	116	81	to	to	PART
ajlm-2700	116	82	23	23	NUM
ajlm-2700	116	83	%	%	NOUN
ajlm-2700	116	84	of	of	ADP
ajlm-2700	116	85	dialysis	dialysis	NOUN
ajlm-2700	116	86	patients	patient	NOUN
ajlm-2700	116	87	because	because	SCONJ
ajlm-2700	116	88	of	of	ADP
ajlm-2700	116	89	the	the	DET
ajlm-2700	116	90	switch	switch	NOUN
ajlm-2700	116	91	from	from	ADP
ajlm-2700	116	92	secondto	secondto	ADJ
ajlm-2700	116	93	third	third	ADJ
ajlm-2700	116	94	-	-	PUNCT
ajlm-2700	116	95	generation	generation	NOUN
ajlm-2700	116	96	pth	pth	NOUN
ajlm-2700	116	97	assay.30	assay.30	ADJ
ajlm-2700	116	98	presence	presence	NOUN
ajlm-2700	116	99	of	of	ADP
ajlm-2700	116	100	discordance	discordance	NOUN
ajlm-2700	116	101	is	be	AUX
ajlm-2700	116	102	important	important	ADJ
ajlm-2700	116	103	,	,	PUNCT
ajlm-2700	116	104	as	as	SCONJ
ajlm-2700	116	105	pth	pth	NOUN
ajlm-2700	116	106	concentrations	concentration	NOUN
ajlm-2700	116	107	are	be	AUX
ajlm-2700	116	108	used	use	VERB
ajlm-2700	116	109	in	in	ADP
ajlm-2700	116	110	the	the	DET
ajlm-2700	116	111	management	management	NOUN
ajlm-2700	116	112	of	of	ADP
ajlm-2700	116	113	ckd	ckd	PROPN
ajlm-2700	116	114	-	-	PUNCT
ajlm-2700	116	115	mbd	mbd	PROPN
ajlm-2700	116	116	.	.	PUNCT
ajlm-2700	117	1	hence	hence	ADV
ajlm-2700	117	2	,	,	PUNCT
ajlm-2700	117	3	the	the	DET
ajlm-2700	117	4	use	use	NOUN
ajlm-2700	117	5	of	of	ADP
ajlm-2700	117	6	secondover	secondover	ADJ
ajlm-2700	117	7	third	third	ADJ
ajlm-2700	117	8	-	-	PUNCT
ajlm-2700	117	9	generation	generation	NOUN
ajlm-2700	117	10	pth	pth	NOUN
ajlm-2700	117	11	assays	assay	NOUN
ajlm-2700	117	12	may	may	AUX
ajlm-2700	117	13	result	result	VERB
ajlm-2700	117	14	in	in	ADP
ajlm-2700	117	15	misclassification	misclassification	NOUN
ajlm-2700	117	16	,	,	PUNCT
ajlm-2700	117	17	leading	lead	VERB
ajlm-2700	117	18	to	to	ADP
ajlm-2700	117	19	inadequate	inadequate	ADJ
ajlm-2700	117	20	management	management	NOUN
ajlm-2700	117	21	.	.	PUNCT
ajlm-2700	118	1	there	there	PRON
ajlm-2700	118	2	have	have	AUX
ajlm-2700	118	3	been	be	AUX
ajlm-2700	118	4	various	various	ADJ
ajlm-2700	118	5	attempts	attempt	NOUN
ajlm-2700	118	6	to	to	PART
ajlm-2700	118	7	reduce	reduce	VERB
ajlm-2700	118	8	the	the	DET
ajlm-2700	118	9	discrepancies	discrepancy	NOUN
ajlm-2700	118	10	between	between	ADP
ajlm-2700	118	11	the	the	DET
ajlm-2700	118	12	secondand	secondand	NOUN
ajlm-2700	118	13	third	third	ADJ
ajlm-2700	118	14	-	-	PUNCT
ajlm-2700	118	15	generation	generation	NOUN
ajlm-2700	118	16	pth	pth	NOUN
ajlm-2700	118	17	assays	assay	NOUN
ajlm-2700	118	18	in	in	ADP
ajlm-2700	118	19	dialysis	dialysis	NOUN
ajlm-2700	118	20	patients	patient	NOUN
ajlm-2700	118	21	,	,	PUNCT
ajlm-2700	118	22	by	by	ADP
ajlm-2700	118	23	applying	apply	VERB
ajlm-2700	118	24	a	a	DET
ajlm-2700	118	25	correction	correction	NOUN
ajlm-2700	118	26	factor	factor	NOUN
ajlm-2700	118	27	or	or	CCONJ
ajlm-2700	118	28	deriving	derive	VERB
ajlm-2700	118	29	an	an	DET
ajlm-2700	118	30	equation	equation	NOUN
ajlm-2700	118	31	to	to	PART
ajlm-2700	118	32	allow	allow	VERB
ajlm-2700	118	33	interconversion	interconversion	NOUN
ajlm-2700	118	34	between	between	ADP
ajlm-2700	118	35	the	the	DET
ajlm-2700	118	36	two	two	NUM
ajlm-2700	118	37	assays.31	assays.31	NOUN
ajlm-2700	118	38	a	a	DET
ajlm-2700	118	39	study	study	NOUN
ajlm-2700	118	40	by	by	ADP
ajlm-2700	118	41	wójtowicz	wójtowicz	NOUN
ajlm-2700	118	42	et	et	PROPN
ajlm-2700	118	43	al	al	PROPN
ajlm-2700	118	44	.	.	PROPN
ajlm-2700	118	45	conducted	conduct	VERB
ajlm-2700	118	46	in	in	ADP
ajlm-2700	118	47	2016	2016	NUM
ajlm-2700	118	48	in	in	ADP
ajlm-2700	118	49	poland	poland	PROPN
ajlm-2700	118	50	suggested	suggest	VERB
ajlm-2700	118	51	the	the	DET
ajlm-2700	118	52	use	use	NOUN
ajlm-2700	118	53	of	of	ADP
ajlm-2700	118	54	1–84/7–84	1–84/7–84	NUM
ajlm-2700	118	55	pth	pth	NOUN
ajlm-2700	118	56	ratio	ratio	NOUN
ajlm-2700	118	57	to	to	PART
ajlm-2700	118	58	report	report	VERB
ajlm-2700	118	59	pth	pth	NOUN
ajlm-2700	118	60	results	result	NOUN
ajlm-2700	118	61	to	to	PART
ajlm-2700	118	62	minimise	minimise	VERB
ajlm-2700	118	63	potential	potential	ADJ
ajlm-2700	118	64	misdiagnosis	misdiagnosis	NOUN
ajlm-2700	118	65	of	of	ADP
ajlm-2700	118	66	ckd	ckd	PROPN
ajlm-2700	118	67	-	-	PROPN
ajlm-2700	118	68	bmd	bmd	PROPN
ajlm-2700	118	69	in	in	ADP
ajlm-2700	118	70	ckd	ckd	PROPN
ajlm-2700	118	71	patients.31	patients.31	PROPN
ajlm-2700	118	72	however	however	ADV
ajlm-2700	118	73	,	,	PUNCT
ajlm-2700	118	74	further	further	ADJ
ajlm-2700	118	75	validation	validation	NOUN
ajlm-2700	118	76	studies	study	NOUN
ajlm-2700	118	77	are	be	AUX
ajlm-2700	118	78	needed	need	VERB
ajlm-2700	118	79	,	,	PUNCT
ajlm-2700	118	80	and	and	CCONJ
ajlm-2700	118	81	these	these	DET
ajlm-2700	118	82	efforts	effort	NOUN
ajlm-2700	118	83	are	be	AUX
ajlm-2700	118	84	not	not	PART
ajlm-2700	118	85	currently	currently	ADV
ajlm-2700	118	86	adopted	adopt	VERB
ajlm-2700	118	87	by	by	ADP
ajlm-2700	118	88	clinical	clinical	ADJ
ajlm-2700	118	89	guidelines	guideline	NOUN
ajlm-2700	118	90	.	.	PUNCT
ajlm-2700	119	1	overestimation	overestimation	NOUN
ajlm-2700	119	2	of	of	ADP
ajlm-2700	119	3	pth	pth	NOUN
ajlm-2700	119	4	by	by	ADP
ajlm-2700	119	5	second	second	ADJ
ajlm-2700	119	6	-	-	PUNCT
ajlm-2700	119	7	generation	generation	NOUN
ajlm-2700	119	8	assays	assay	NOUN
ajlm-2700	119	9	because	because	SCONJ
ajlm-2700	119	10	of	of	ADP
ajlm-2700	119	11	pth	pth	NOUN
ajlm-2700	119	12	fragment	fragment	NOUN
ajlm-2700	119	13	cross	cross	NOUN
ajlm-2700	119	14	reactivity	reactivity	NOUN
ajlm-2700	119	15	is	be	AUX
ajlm-2700	119	16	of	of	ADP
ajlm-2700	119	17	negligible	negligible	ADJ
ajlm-2700	119	18	consequence	consequence	NOUN
ajlm-2700	119	19	in	in	ADP
ajlm-2700	119	20	patients	patient	NOUN
ajlm-2700	119	21	with	with	ADP
ajlm-2700	119	22	primary	primary	ADJ
ajlm-2700	119	23	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	119	24	.	.	PUNCT
ajlm-2700	120	1	nonetheless	nonetheless	ADV
ajlm-2700	120	2	,	,	PUNCT
ajlm-2700	120	3	the	the	DET
ajlm-2700	120	4	question	question	NOUN
ajlm-2700	120	5	regarding	regard	VERB
ajlm-2700	120	6	whether	whether	SCONJ
ajlm-2700	120	7	third	third	ADJ
ajlm-2700	120	8	-	-	PUNCT
ajlm-2700	120	9	generation	generation	NOUN
ajlm-2700	120	10	pth	pth	NOUN
ajlm-2700	120	11	assays	assay	NOUN
ajlm-2700	120	12	offer	offer	VERB
ajlm-2700	120	13	superior	superior	ADJ
ajlm-2700	120	14	diagnostic	diagnostic	ADJ
ajlm-2700	120	15	efficacy	efficacy	NOUN
ajlm-2700	120	16	remains	remain	VERB
ajlm-2700	120	17	.	.	PUNCT
ajlm-2700	121	1	in	in	ADP
ajlm-2700	121	2	our	our	PRON
ajlm-2700	121	3	study	study	NOUN
ajlm-2700	121	4	,	,	PUNCT
ajlm-2700	121	5	there	there	PRON
ajlm-2700	121	6	were	be	VERB
ajlm-2700	121	7	no	no	DET
ajlm-2700	121	8	differences	difference	NOUN
ajlm-2700	121	9	in	in	ADP
ajlm-2700	121	10	interpretation	interpretation	NOUN
ajlm-2700	121	11	between	between	ADP
ajlm-2700	121	12	the	the	DET
ajlm-2700	121	13	two	two	NUM
ajlm-2700	121	14	assays	assay	NOUN
ajlm-2700	121	15	with	with	ADP
ajlm-2700	121	16	regard	regard	NOUN
ajlm-2700	121	17	to	to	ADP
ajlm-2700	121	18	diagnosis	diagnosis	NOUN
ajlm-2700	121	19	of	of	ADP
ajlm-2700	121	20	primary	primary	ADJ
ajlm-2700	121	21	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	121	22	.	.	PUNCT
ajlm-2700	122	1	this	this	PRON
ajlm-2700	122	2	is	be	AUX
ajlm-2700	122	3	consistent	consistent	ADJ
ajlm-2700	122	4	with	with	ADP
ajlm-2700	122	5	other	other	ADJ
ajlm-2700	122	6	published	publish	VERB
ajlm-2700	122	7	studies	study	NOUN
ajlm-2700	122	8	:	:	PUNCT
ajlm-2700	122	9	boudou	boudou	NOUN
ajlm-2700	122	10	et	et	PROPN
ajlm-2700	122	11	al	al	PROPN
ajlm-2700	122	12	.	.	PROPN
ajlm-2700	123	1	from	from	ADP
ajlm-2700	123	2	france,32	france,32	PROPN
ajlm-2700	123	3	and	and	CCONJ
ajlm-2700	123	4	bonansea	bonansea	ADJ
ajlm-2700	123	5	et	et	PROPN
ajlm-2700	123	6	al	al	PROPN
ajlm-2700	123	7	.	.	PROPN
ajlm-2700	124	1	from	from	ADP
ajlm-2700	124	2	brazil.33	brazil.33	NOUN
ajlm-2700	124	3	taking	take	VERB
ajlm-2700	124	4	into	into	ADP
ajlm-2700	124	5	consideration	consideration	NOUN
ajlm-2700	124	6	published	publish	VERB
ajlm-2700	124	7	evidence	evidence	NOUN
ajlm-2700	124	8	,	,	PUNCT
ajlm-2700	124	9	the	the	DET
ajlm-2700	124	10	recent	recent	ADJ
ajlm-2700	124	11	international	international	ADJ
ajlm-2700	124	12	guideline	guideline	NOUN
ajlm-2700	124	13	on	on	ADP
ajlm-2700	124	14	evaluation	evaluation	NOUN
ajlm-2700	124	15	and	and	CCONJ
ajlm-2700	124	16	management	management	NOUN
ajlm-2700	124	17	of	of	ADP
ajlm-2700	124	18	primary	primary	ADJ
ajlm-2700	124	19	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	124	20	recommend	recommend	VERB
ajlm-2700	124	21	the	the	DET
ajlm-2700	124	22	use	use	NOUN
ajlm-2700	124	23	of	of	ADP
ajlm-2700	124	24	either	either	DET
ajlm-2700	124	25	secondor	secondor	VERB
ajlm-2700	124	26	third	third	ADJ
ajlm-2700	124	27	-	-	PUNCT
ajlm-2700	124	28	generation	generation	NOUN
ajlm-2700	124	29	pth	pth	NOUN
ajlm-2700	124	30	assays.34	assays.34	NOUN
ajlm-2700	124	31	the	the	DET
ajlm-2700	124	32	international	international	PROPN
ajlm-2700	124	33	federation	federation	PROPN
ajlm-2700	124	34	of	of	ADP
ajlm-2700	124	35	clinical	clinical	ADJ
ajlm-2700	124	36	chemistry	chemistry	NOUN
ajlm-2700	124	37	and	and	CCONJ
ajlm-2700	124	38	laboratory	laboratory	NOUN
ajlm-2700	124	39	medicine	medicine	PROPN
ajlm-2700	124	40	committee	committee	PROPN
ajlm-2700	124	41	for	for	ADP
ajlm-2700	124	42	bone	bone	NOUN
ajlm-2700	124	43	metabolism	metabolism	NOUN
ajlm-2700	124	44	has	have	AUX
ajlm-2700	124	45	established	establish	VERB
ajlm-2700	124	46	a	a	DET
ajlm-2700	124	47	working	work	VERB
ajlm-2700	124	48	group	group	NOUN
ajlm-2700	124	49	for	for	ADP
ajlm-2700	124	50	the	the	DET
ajlm-2700	124	51	purpose	purpose	NOUN
ajlm-2700	124	52	of	of	ADP
ajlm-2700	124	53	creating	create	VERB
ajlm-2700	124	54	pth	pth	NOUN
ajlm-2700	124	55	standardisation	standardisation	NOUN
ajlm-2700	124	56	to	to	PART
ajlm-2700	124	57	make	make	VERB
ajlm-2700	124	58	the	the	DET
ajlm-2700	124	59	results	result	NOUN
ajlm-2700	124	60	comparable	comparable	ADJ
ajlm-2700	124	61	among	among	ADP
ajlm-2700	124	62	different	different	ADJ
ajlm-2700	124	63	assays.35	assays.35	NOUN
ajlm-2700	124	64	in	in	ADP
ajlm-2700	124	65	the	the	DET
ajlm-2700	124	66	absence	absence	NOUN
ajlm-2700	124	67	of	of	ADP
ajlm-2700	124	68	a	a	DET
ajlm-2700	124	69	reference	reference	NOUN
ajlm-2700	124	70	measurement	measurement	NOUN
ajlm-2700	124	71	method	method	NOUN
ajlm-2700	124	72	,	,	PUNCT
ajlm-2700	124	73	the	the	DET
ajlm-2700	124	74	international	international	PROPN
ajlm-2700	124	75	federation	federation	PROPN
ajlm-2700	124	76	of	of	ADP
ajlm-2700	124	77	clinical	clinical	ADJ
ajlm-2700	124	78	chemistry	chemistry	NOUN
ajlm-2700	124	79	and	and	CCONJ
ajlm-2700	124	80	laboratory	laboratory	NOUN
ajlm-2700	124	81	medicine	medicine	NOUN
ajlm-2700	124	82	has	have	AUX
ajlm-2700	124	83	recommended	recommend	VERB
ajlm-2700	124	84	the	the	DET
ajlm-2700	124	85	use	use	NOUN
ajlm-2700	124	86	of	of	ADP
ajlm-2700	124	87	the	the	DET
ajlm-2700	124	88	world	world	PROPN
ajlm-2700	124	89	health	health	PROPN
ajlm-2700	124	90	organization	organization	PROPN
ajlm-2700	124	91	standard	standard	NOUN
ajlm-2700	124	92	,	,	PUNCT
ajlm-2700	124	93	but	but	CCONJ
ajlm-2700	124	94	this	this	PRON
ajlm-2700	124	95	has	have	AUX
ajlm-2700	124	96	not	not	PART
ajlm-2700	124	97	been	be	AUX
ajlm-2700	124	98	completely	completely	ADV
ajlm-2700	124	99	implemented	implement	VERB
ajlm-2700	124	100	because	because	SCONJ
ajlm-2700	124	101	of	of	ADP
ajlm-2700	124	102	a	a	DET
ajlm-2700	124	103	lack	lack	NOUN
ajlm-2700	124	104	of	of	ADP
ajlm-2700	124	105	commutability.9,10	commutability.9,10	NOUN
ajlm-2700	124	106	even	even	ADV
ajlm-2700	124	107	though	though	SCONJ
ajlm-2700	124	108	second	second	ADJ
ajlm-2700	124	109	-	-	PUNCT
ajlm-2700	124	110	generation	generation	NOUN
ajlm-2700	124	111	pth	pth	NOUN
ajlm-2700	124	112	assays	assay	NOUN
ajlm-2700	124	113	are	be	AUX
ajlm-2700	124	114	the	the	DET
ajlm-2700	124	115	most	most	ADV
ajlm-2700	124	116	utilised	utilise	VERB
ajlm-2700	124	117	assays	assay	NOUN
ajlm-2700	124	118	,	,	PUNCT
ajlm-2700	124	119	third	third	ADJ
ajlm-2700	124	120	-	-	PUNCT
ajlm-2700	124	121	generation	generation	NOUN
ajlm-2700	124	122	pth	pth	NOUN
ajlm-2700	124	123	assays	assay	NOUN
ajlm-2700	124	124	offer	offer	VERB
ajlm-2700	124	125	the	the	DET
ajlm-2700	124	126	best	good	ADJ
ajlm-2700	124	127	hope	hope	NOUN
ajlm-2700	124	128	for	for	ADP
ajlm-2700	124	129	harmonisation	harmonisation	NOUN
ajlm-2700	124	130	of	of	ADP
ajlm-2700	124	131	pth	pth	NOUN
ajlm-2700	124	132	because	because	SCONJ
ajlm-2700	124	133	the	the	DET
ajlm-2700	124	134	majority	majority	NOUN
ajlm-2700	124	135	are	be	AUX
ajlm-2700	124	136	traceable	traceable	ADJ
ajlm-2700	124	137	to	to	ADP
ajlm-2700	124	138	the	the	DET
ajlm-2700	124	139	world	world	PROPN
ajlm-2700	124	140	health	health	PROPN
ajlm-2700	124	141	organization	organization	NOUN
ajlm-2700	124	142	standard.35	standard.35	NOUN
ajlm-2700	124	143	to	to	ADP
ajlm-2700	124	144	the	the	DET
ajlm-2700	124	145	best	good	ADJ
ajlm-2700	124	146	of	of	ADP
ajlm-2700	124	147	our	our	PRON
ajlm-2700	124	148	knowledge	knowledge	NOUN
ajlm-2700	124	149	,	,	PUNCT
ajlm-2700	124	150	this	this	PRON
ajlm-2700	124	151	is	be	AUX
ajlm-2700	124	152	the	the	DET
ajlm-2700	124	153	first	first	ADJ
ajlm-2700	124	154	study	study	NOUN
ajlm-2700	124	155	in	in	ADP
ajlm-2700	124	156	africa	africa	PROPN
ajlm-2700	124	157	to	to	PART
ajlm-2700	124	158	evaluate	evaluate	VERB
ajlm-2700	124	159	the	the	DET
ajlm-2700	124	160	differences	difference	NOUN
ajlm-2700	124	161	in	in	ADP
ajlm-2700	124	162	analytical	analytical	ADJ
ajlm-2700	124	163	performance	performance	NOUN
ajlm-2700	124	164	and	and	CCONJ
ajlm-2700	124	165	impact	impact	NOUN
ajlm-2700	124	166	on	on	ADP
ajlm-2700	124	167	clinical	clinical	ADJ
ajlm-2700	124	168	interpretation	interpretation	NOUN
ajlm-2700	124	169	of	of	ADP
ajlm-2700	124	170	secondand	secondand	NOUN
ajlm-2700	124	171	third	third	ADJ
ajlm-2700	124	172	-	-	PUNCT
ajlm-2700	124	173	generation	generation	NOUN
ajlm-2700	124	174	pth	pth	NOUN
ajlm-2700	124	175	assays	assay	NOUN
ajlm-2700	124	176	.	.	PUNCT
ajlm-2700	125	1	limitations	limitation	NOUN
ajlm-2700	125	2	our	our	PRON
ajlm-2700	125	3	study	study	NOUN
ajlm-2700	125	4	had	have	VERB
ajlm-2700	125	5	some	some	DET
ajlm-2700	125	6	limitations	limitation	NOUN
ajlm-2700	125	7	.	.	PUNCT
ajlm-2700	126	1	firstly	firstly	ADV
ajlm-2700	126	2	,	,	PUNCT
ajlm-2700	126	3	we	we	PRON
ajlm-2700	126	4	had	have	VERB
ajlm-2700	126	5	a	a	DET
ajlm-2700	126	6	small	small	ADJ
ajlm-2700	126	7	sample	sample	NOUN
ajlm-2700	126	8	size	size	NOUN
ajlm-2700	126	9	of	of	ADP
ajlm-2700	126	10	patients	patient	NOUN
ajlm-2700	126	11	on	on	ADP
ajlm-2700	126	12	dialysis	dialysis	NOUN
ajlm-2700	126	13	.	.	PUNCT
ajlm-2700	127	1	secondly	secondly	ADV
ajlm-2700	127	2	,	,	PUNCT
ajlm-2700	127	3	not	not	PART
ajlm-2700	127	4	all	all	DET
ajlm-2700	127	5	patients	patient	NOUN
ajlm-2700	127	6	had	have	VERB
ajlm-2700	127	7	laboratory	laboratory	NOUN
ajlm-2700	127	8	results	result	NOUN
ajlm-2700	127	9	of	of	ADP
ajlm-2700	127	10	tests	test	NOUN
ajlm-2700	127	11	used	use	VERB
ajlm-2700	127	12	in	in	ADP
ajlm-2700	127	13	the	the	DET
ajlm-2700	127	14	evaluation	evaluation	NOUN
ajlm-2700	127	15	of	of	ADP
ajlm-2700	127	16	ckd	ckd	PROPN
ajlm-2700	127	17	,	,	PUNCT
ajlm-2700	127	18	for	for	ADP
ajlm-2700	127	19	example	example	NOUN
ajlm-2700	127	20	urine	urine	NOUN
ajlm-2700	127	21	albumin	albumin	NOUN
ajlm-2700	127	22	.	.	PUNCT
ajlm-2700	128	1	finally	finally	ADV
ajlm-2700	128	2	,	,	PUNCT
ajlm-2700	128	3	the	the	DET
ajlm-2700	128	4	study	study	NOUN
ajlm-2700	128	5	was	be	AUX
ajlm-2700	128	6	based	base	VERB
ajlm-2700	128	7	on	on	ADP
ajlm-2700	128	8	information	information	NOUN
ajlm-2700	128	9	available	available	ADJ
ajlm-2700	128	10	on	on	ADP
ajlm-2700	128	11	the	the	DET
ajlm-2700	128	12	laboratory	laboratory	NOUN
ajlm-2700	128	13	information	information	NOUN
ajlm-2700	128	14	system	system	NOUN
ajlm-2700	128	15	,	,	PUNCT
ajlm-2700	128	16	with	with	ADP
ajlm-2700	128	17	limited	limited	ADJ
ajlm-2700	128	18	clinical	clinical	ADJ
ajlm-2700	128	19	information	information	NOUN
ajlm-2700	128	20	.	.	PUNCT
ajlm-2700	129	1	conclusion	conclusion	VERB
ajlm-2700	129	2	the	the	DET
ajlm-2700	129	3	secondand	secondand	NOUN
ajlm-2700	129	4	third	third	ADJ
ajlm-2700	129	5	-	-	PUNCT
ajlm-2700	129	6	generation	generation	NOUN
ajlm-2700	129	7	pth	pth	NOUN
ajlm-2700	129	8	assays	assay	NOUN
ajlm-2700	129	9	correlate	correlate	VERB
ajlm-2700	129	10	very	very	ADV
ajlm-2700	129	11	well	well	ADV
ajlm-2700	129	12	,	,	PUNCT
ajlm-2700	129	13	though	though	SCONJ
ajlm-2700	129	14	there	there	PRON
ajlm-2700	129	15	was	be	VERB
ajlm-2700	129	16	a	a	DET
ajlm-2700	129	17	bias	bias	NOUN
ajlm-2700	129	18	observed	observe	VERB
ajlm-2700	129	19	between	between	ADP
ajlm-2700	129	20	the	the	DET
ajlm-2700	129	21	two	two	NUM
ajlm-2700	129	22	methods	method	NOUN
ajlm-2700	129	23	which	which	PRON
ajlm-2700	129	24	increases	increase	VERB
ajlm-2700	129	25	with	with	ADP
ajlm-2700	129	26	rising	rise	VERB
ajlm-2700	129	27	pth	pth	NOUN
ajlm-2700	129	28	concentrations	concentration	NOUN
ajlm-2700	129	29	that	that	PRON
ajlm-2700	129	30	prevail	prevail	VERB
ajlm-2700	129	31	in	in	ADP
ajlm-2700	129	32	ckd	ckd	PROPN
ajlm-2700	129	33	patients	patient	NOUN
ajlm-2700	129	34	.	.	PUNCT
ajlm-2700	130	1	however	however	ADV
ajlm-2700	130	2	,	,	PUNCT
ajlm-2700	130	3	using	use	VERB
ajlm-2700	130	4	the	the	DET
ajlm-2700	130	5	manufacturer	manufacturer	NOUN
ajlm-2700	130	6	’s	’s	PART
ajlm-2700	130	7	assay	assay	NOUN
ajlm-2700	130	8	-	-	PUNCT
ajlm-2700	130	9	specific	specific	ADJ
ajlm-2700	130	10	reference	reference	NOUN
ajlm-2700	130	11	intervals	interval	NOUN
ajlm-2700	130	12	and	and	CCONJ
ajlm-2700	130	13	kdigo	kdigo	PROPN
ajlm-2700	130	14	guideline	guideline	NOUN
ajlm-2700	130	15	on	on	ADP
ajlm-2700	130	16	pth	pth	NOUN
ajlm-2700	130	17	classification	classification	NOUN
ajlm-2700	130	18	,	,	PUNCT
ajlm-2700	130	19	there	there	PRON
ajlm-2700	130	20	were	be	VERB
ajlm-2700	130	21	no	no	DET
ajlm-2700	130	22	major	major	ADJ
ajlm-2700	130	23	changes	change	NOUN
ajlm-2700	130	24	in	in	ADP
ajlm-2700	130	25	clinical	clinical	ADJ
ajlm-2700	130	26	interpretation	interpretation	NOUN
ajlm-2700	130	27	when	when	SCONJ
ajlm-2700	130	28	either	either	CCONJ
ajlm-2700	130	29	assay	assay	NOUN
ajlm-2700	130	30	was	be	AUX
ajlm-2700	130	31	used	use	VERB
ajlm-2700	130	32	.	.	PUNCT
ajlm-2700	131	1	thus	thus	ADV
ajlm-2700	131	2	,	,	PUNCT
ajlm-2700	131	3	the	the	DET
ajlm-2700	131	4	decision	decision	NOUN
ajlm-2700	131	5	to	to	PART
ajlm-2700	131	6	use	use	VERB
ajlm-2700	131	7	thirdover	thirdover	NOUN
ajlm-2700	131	8	second	second	ADJ
ajlm-2700	131	9	-	-	PUNCT
ajlm-2700	131	10	generation	generation	NOUN
ajlm-2700	131	11	pth	pth	NOUN
ajlm-2700	131	12	should	should	AUX
ajlm-2700	131	13	take	take	VERB
ajlm-2700	131	14	all	all	PRON
ajlm-2700	131	15	of	of	ADP
ajlm-2700	131	16	this	this	PRON
ajlm-2700	131	17	into	into	ADP
ajlm-2700	131	18	account	account	NOUN
ajlm-2700	131	19	.	.	PUNCT
ajlm-2700	132	1	we	we	PRON
ajlm-2700	132	2	recommend	recommend	VERB
ajlm-2700	132	3	that	that	SCONJ
ajlm-2700	132	4	assays	assay	NOUN
ajlm-2700	132	5	not	not	PART
ajlm-2700	132	6	be	be	AUX
ajlm-2700	132	7	used	use	VERB
ajlm-2700	132	8	interchangeably	interchangeably	ADV
ajlm-2700	132	9	.	.	PUNCT
ajlm-2700	133	1	therefore	therefore	ADV
ajlm-2700	133	2	,	,	PUNCT
ajlm-2700	133	3	as	as	SCONJ
ajlm-2700	133	4	stated	state	VERB
ajlm-2700	133	5	by	by	ADP
ajlm-2700	133	6	the	the	DET
ajlm-2700	133	7	manufacturer	manufacturer	NOUN
ajlm-2700	133	8	and	and	CCONJ
ajlm-2700	133	9	in	in	ADP
ajlm-2700	133	10	accordance	accordance	NOUN
ajlm-2700	133	11	with	with	ADP
ajlm-2700	133	12	the	the	DET
ajlm-2700	133	13	kdigo	kdigo	ADJ
ajlm-2700	133	14	recommendations	recommendation	NOUN
ajlm-2700	133	15	,	,	PUNCT
ajlm-2700	133	16	clinical	clinical	ADJ
ajlm-2700	133	17	laboratories	laboratory	NOUN
ajlm-2700	133	18	should	should	AUX
ajlm-2700	133	19	state	state	VERB
ajlm-2700	133	20	the	the	DET
ajlm-2700	133	21	generation	generation	NOUN
ajlm-2700	133	22	of	of	ADP
ajlm-2700	133	23	pth	pth	NOUN
ajlm-2700	133	24	assay	assay	NOUN
ajlm-2700	133	25	employed	employ	VERB
ajlm-2700	133	26	and	and	CCONJ
ajlm-2700	133	27	inform	inform	VERB
ajlm-2700	133	28	clinicians	clinician	NOUN
ajlm-2700	133	29	of	of	ADP
ajlm-2700	133	30	any	any	DET
ajlm-2700	133	31	change	change	NOUN
ajlm-2700	133	32	in	in	ADP
ajlm-2700	133	33	clinical	clinical	ADJ
ajlm-2700	133	34	methods	method	NOUN
ajlm-2700	133	35	to	to	PART
ajlm-2700	133	36	facilitate	facilitate	VERB
ajlm-2700	133	37	appropriate	appropriate	ADJ
ajlm-2700	133	38	interpretation	interpretation	NOUN
ajlm-2700	133	39	of	of	ADP
ajlm-2700	133	40	pth	pth	NOUN
ajlm-2700	133	41	results	result	NOUN
ajlm-2700	133	42	.	.	PUNCT
ajlm-2700	134	1	acknowledgements	acknowledgement	NOUN
ajlm-2700	134	2	we	we	PRON
ajlm-2700	134	3	would	would	AUX
ajlm-2700	134	4	like	like	VERB
ajlm-2700	134	5	to	to	PART
ajlm-2700	134	6	acknowledge	acknowledge	VERB
ajlm-2700	134	7	all	all	DET
ajlm-2700	134	8	the	the	DET
ajlm-2700	134	9	national	national	PROPN
ajlm-2700	134	10	health	health	PROPN
ajlm-2700	134	11	laboratory	laboratory	PROPN
ajlm-2700	134	12	services	services	PROPN
ajlm-2700	134	13	technical	technical	ADJ
ajlm-2700	134	14	staff	staff	NOUN
ajlm-2700	134	15	at	at	ADP
ajlm-2700	134	16	charlotte	charlotte	PROPN
ajlm-2700	134	17	maxeke	maxeke	PROPN
ajlm-2700	134	18	johannesburg	johannesburg	PROPN
ajlm-2700	134	19	academic	academic	ADJ
ajlm-2700	134	20	hospital	hospital	NOUN
ajlm-2700	134	21	for	for	ADP
ajlm-2700	134	22	their	their	PRON
ajlm-2700	134	23	assistance	assistance	NOUN
ajlm-2700	134	24	in	in	ADP
ajlm-2700	134	25	analysing	analyse	VERB
ajlm-2700	134	26	samples	sample	NOUN
ajlm-2700	134	27	.	.	PUNCT
ajlm-2700	135	1	this	this	DET
ajlm-2700	135	2	article	article	NOUN
ajlm-2700	135	3	is	be	AUX
ajlm-2700	135	4	partially	partially	ADV
ajlm-2700	135	5	based	base	VERB
ajlm-2700	135	6	on	on	ADP
ajlm-2700	135	7	the	the	DET
ajlm-2700	135	8	n.n	n.n	PROPN
ajlm-2700	135	9	.	.	PROPN
ajlm-2700	135	10	’s	’s	PART
ajlm-2700	135	11	thesis	thesis	NOUN
ajlm-2700	135	12	entitled	entitle	VERB
ajlm-2700	135	13	‘	'	PUNCT
ajlm-2700	135	14	comparison	comparison	NOUN
ajlm-2700	135	15	of	of	ADP
ajlm-2700	135	16	second	second	ADJ
ajlm-2700	135	17	and	and	CCONJ
ajlm-2700	135	18	third	third	ADJ
ajlm-2700	135	19	generation	generation	NOUN
ajlm-2700	135	20	parathyroid	parathyroid	ADJ
ajlm-2700	135	21	hormone	hormone	NOUN
ajlm-2700	135	22	(	(	PUNCT
ajlm-2700	135	23	pth	pth	NOUN
ajlm-2700	135	24	)	)	PUNCT
ajlm-2700	135	25	assays	assay	NOUN
ajlm-2700	135	26	performed	perform	VERB
ajlm-2700	135	27	at	at	ADP
ajlm-2700	135	28	charlotte	charlotte	PROPN
ajlm-2700	135	29	maxeke	maxeke	PROPN
ajlm-2700	135	30	johannesburg	johannesburg	PROPN
ajlm-2700	135	31	academic	academic	PROPN
ajlm-2700	135	32	hospital	hospital	NOUN
ajlm-2700	135	33	–	–	PUNCT
ajlm-2700	135	34	are	be	AUX
ajlm-2700	135	35	they	they	PRON
ajlm-2700	135	36	fit	fit	ADJ
ajlm-2700	135	37	for	for	ADP
ajlm-2700	135	38	purpose	purpose	NOUN
ajlm-2700	135	39	?	?	PUNCT
ajlm-2700	135	40	’	'	PUNCT
ajlm-2700	135	41	towards	towards	ADP
ajlm-2700	135	42	the	the	DET
ajlm-2700	135	43	degree	degree	NOUN
ajlm-2700	135	44	of	of	ADP
ajlm-2700	135	45	master	master	NOUN
ajlm-2700	135	46	of	of	ADP
ajlm-2700	135	47	medicine	medicine	NOUN
ajlm-2700	135	48	in	in	ADP
ajlm-2700	135	49	the	the	DET
ajlm-2700	135	50	department	department	NOUN
ajlm-2700	135	51	of	of	ADP
ajlm-2700	135	52	chemical	chemical	PROPN
ajlm-2700	135	53	pathology	pathology	PROPN
ajlm-2700	135	54	,	,	PUNCT
ajlm-2700	135	55	university	university	NOUN
ajlm-2700	135	56	of	of	ADP
ajlm-2700	135	57	the	the	DET
ajlm-2700	135	58	witwatersrand	witwatersrand	NOUN
ajlm-2700	135	59	,	,	PUNCT
ajlm-2700	135	60	south	south	PROPN
ajlm-2700	135	61	africa	africa	PROPN
ajlm-2700	135	62	,	,	PUNCT
ajlm-2700	135	63	november	november	PROPN
ajlm-2700	135	64	,	,	PUNCT
ajlm-2700	135	65	2023	2023	NUM
ajlm-2700	135	66	,	,	PUNCT
ajlm-2700	135	67	with	with	ADP
ajlm-2700	135	68	supervisors	supervisor	NOUN
ajlm-2700	135	69	m.m	m.m	PROPN
ajlm-2700	135	70	.	.	PROPN
ajlm-2700	135	71	and	and	CCONJ
ajlm-2700	135	72	d.j	d.j	PROPN
ajlm-2700	135	73	.	.	PROPN
ajlm-2700	136	1	it	it	PRON
ajlm-2700	136	2	is	be	AUX
ajlm-2700	136	3	available	available	ADJ
ajlm-2700	136	4	here	here	ADV
ajlm-2700	136	5	:	:	PUNCT
ajlm-2700	137	1	https://hdl.handle.net/10539/44544	https://hdl.handle.net/10539/44544	X
ajlm-2700	137	2	.	.	PUNCT
ajlm-2700	138	1	competing	compete	VERB
ajlm-2700	138	2	interests	interest	NOUN
ajlm-2700	138	3	the	the	DET
ajlm-2700	138	4	author	author	NOUN
ajlm-2700	138	5	reported	report	VERB
ajlm-2700	138	6	that	that	SCONJ
ajlm-2700	138	7	they	they	PRON
ajlm-2700	138	8	received	receive	VERB
ajlm-2700	138	9	funding	funding	NOUN
ajlm-2700	138	10	from	from	ADP
ajlm-2700	138	11	national	national	PROPN
ajlm-2700	138	12	health	health	PROPN
ajlm-2700	138	13	laboratory	laboratory	PROPN
ajlm-2700	138	14	service	service	PROPN
ajlm-2700	138	15	k	k	PROPN
ajlm-2700	138	16	-	-	NOUN
ajlm-2700	138	17	funding	funding	NOUN
ajlm-2700	138	18	and	and	CCONJ
ajlm-2700	138	19	university	university	NOUN
ajlm-2700	138	20	of	of	ADP
ajlm-2700	138	21	the	the	DET
ajlm-2700	138	22	witwatersrand	witwatersrand	NOUN
ajlm-2700	138	23	research	research	NOUN
ajlm-2700	138	24	grants	grant	NOUN
ajlm-2700	138	25	,	,	PUNCT
ajlm-2700	138	26	which	which	PRON
ajlm-2700	138	27	may	may	AUX
ajlm-2700	138	28	be	be	AUX
ajlm-2700	138	29	affected	affect	VERB
ajlm-2700	138	30	by	by	ADP
ajlm-2700	138	31	the	the	DET
ajlm-2700	138	32	research	research	NOUN
ajlm-2700	138	33	reported	report	VERB
ajlm-2700	138	34	in	in	ADP
ajlm-2700	138	35	the	the	DET
ajlm-2700	138	36	enclosed	enclose	VERB
ajlm-2700	138	37	publication	publication	NOUN
ajlm-2700	138	38	.	.	PUNCT
ajlm-2700	139	1	the	the	DET
ajlm-2700	139	2	author	author	NOUN
ajlm-2700	139	3	has	have	AUX
ajlm-2700	139	4	disclosed	disclose	VERB
ajlm-2700	139	5	those	those	DET
ajlm-2700	139	6	interests	interest	NOUN
ajlm-2700	139	7	fully	fully	ADV
ajlm-2700	139	8	and	and	CCONJ
ajlm-2700	139	9	has	have	AUX
ajlm-2700	139	10	implemented	implement	VERB
ajlm-2700	139	11	an	an	DET
ajlm-2700	139	12	approved	approve	VERB
ajlm-2700	139	13	plan	plan	NOUN
ajlm-2700	139	14	for	for	ADP
ajlm-2700	139	15	managing	manage	VERB
ajlm-2700	139	16	any	any	DET
ajlm-2700	139	17	potential	potential	ADJ
ajlm-2700	139	18	conflicts	conflict	NOUN
ajlm-2700	139	19	arising	arise	VERB
ajlm-2700	139	20	from	from	ADP
ajlm-2700	139	21	their	their	PRON
ajlm-2700	139	22	involvement	involvement	NOUN
ajlm-2700	139	23	.	.	PUNCT
ajlm-2700	140	1	the	the	DET
ajlm-2700	140	2	terms	term	NOUN
ajlm-2700	140	3	of	of	ADP
ajlm-2700	140	4	these	these	DET
ajlm-2700	140	5	funding	funding	NOUN
ajlm-2700	140	6	arrangements	arrangement	NOUN
ajlm-2700	140	7	have	have	AUX
ajlm-2700	140	8	been	be	AUX
ajlm-2700	140	9	reviewed	review	VERB
ajlm-2700	140	10	and	and	CCONJ
ajlm-2700	140	11	approved	approve	VERB
ajlm-2700	140	12	by	by	ADP
ajlm-2700	140	13	the	the	DET
ajlm-2700	140	14	affiliated	affiliated	ADJ
ajlm-2700	140	15	university	university	NOUN
ajlm-2700	140	16	in	in	ADP
ajlm-2700	140	17	accordance	accordance	NOUN
ajlm-2700	140	18	with	with	ADP
ajlm-2700	140	19	its	its	PRON
ajlm-2700	140	20	policy	policy	NOUN
ajlm-2700	140	21	on	on	ADP
ajlm-2700	140	22	objectivity	objectivity	NOUN
ajlm-2700	140	23	in	in	ADP
ajlm-2700	140	24	research	research	NOUN
ajlm-2700	140	25	.	.	PUNCT
ajlm-2700	141	1	authors	author	NOUN
ajlm-2700	141	2	’	’	PART
ajlm-2700	141	3	contributions	contribution	NOUN
ajlm-2700	141	4	n.n	n.n	PROPN
ajlm-2700	141	5	.	.	PROPN
ajlm-2700	141	6	collected	collect	VERB
ajlm-2700	141	7	and	and	CCONJ
ajlm-2700	141	8	analysed	analyse	VERB
ajlm-2700	141	9	the	the	DET
ajlm-2700	141	10	samples	sample	NOUN
ajlm-2700	141	11	,	,	PUNCT
ajlm-2700	141	12	conducted	conduct	VERB
ajlm-2700	141	13	data	datum	NOUN
ajlm-2700	141	14	analysis	analysis	NOUN
ajlm-2700	141	15	,	,	PUNCT
ajlm-2700	141	16	and	and	CCONJ
ajlm-2700	141	17	drafted	draft	VERB
ajlm-2700	141	18	the	the	DET
ajlm-2700	141	19	first	first	ADJ
ajlm-2700	141	20	manuscript	manuscript	NOUN
ajlm-2700	141	21	.	.	PUNCT
ajlm-2700	142	1	d.j	d.j	PROPN
ajlm-2700	142	2	.	.	PROPN
ajlm-2700	142	3	and	and	CCONJ
ajlm-2700	142	4	s.k	s.k	PROPN
ajlm-2700	142	5	.	.	PROPN
ajlm-2700	142	6	supervised	supervise	VERB
ajlm-2700	142	7	the	the	DET
ajlm-2700	142	8	study	study	NOUN
ajlm-2700	142	9	,	,	PUNCT
ajlm-2700	142	10	and	and	CCONJ
ajlm-2700	142	11	were	be	AUX
ajlm-2700	142	12	involved	involve	VERB
ajlm-2700	142	13	in	in	ADP
ajlm-2700	142	14	project	project	NOUN
ajlm-2700	142	15	management	management	NOUN
ajlm-2700	142	16	,	,	PUNCT
ajlm-2700	142	17	data	datum	NOUN
ajlm-2700	142	18	analysis	analysis	NOUN
ajlm-2700	142	19	,	,	PUNCT
ajlm-2700	142	20	and	and	CCONJ
ajlm-2700	142	21	reviewing	review	VERB
ajlm-2700	142	22	and	and	CCONJ
ajlm-2700	142	23	editing	editing	NOUN
ajlm-2700	142	24	of	of	ADP
ajlm-2700	142	25	the	the	DET
ajlm-2700	142	26	article	article	NOUN
ajlm-2700	142	27	.	.	PUNCT
ajlm-2700	143	1	m.r.m	m.r.m	PROPN
ajlm-2700	143	2	.	.	PROPN
ajlm-2700	143	3	conceptualised	conceptualise	VERB
ajlm-2700	143	4	the	the	DET
ajlm-2700	143	5	study	study	NOUN
ajlm-2700	143	6	,	,	PUNCT
ajlm-2700	143	7	and	and	CCONJ
ajlm-2700	143	8	was	be	AUX
ajlm-2700	143	9	involved	involve	VERB
ajlm-2700	143	10	in	in	ADP
ajlm-2700	143	11	methodology	methodology	NOUN
ajlm-2700	143	12	,	,	PUNCT
ajlm-2700	143	13	supervision	supervision	NOUN
ajlm-2700	143	14	,	,	PUNCT
ajlm-2700	143	15	funding	funding	NOUN
ajlm-2700	143	16	acquisition	acquisition	NOUN
ajlm-2700	143	17	,	,	PUNCT
ajlm-2700	143	18	and	and	CCONJ
ajlm-2700	143	19	reviewing	review	VERB
ajlm-2700	143	20	and	and	CCONJ
ajlm-2700	143	21	editing	editing	NOUN
ajlm-2700	143	22	of	of	ADP
ajlm-2700	143	23	the	the	DET
ajlm-2700	143	24	article	article	NOUN
ajlm-2700	143	25	.	.	PUNCT
ajlm-2700	144	1	sources	source	NOUN
ajlm-2700	144	2	of	of	ADP
ajlm-2700	144	3	support	support	NOUN
ajlm-2700	144	4	national	national	PROPN
ajlm-2700	144	5	health	health	PROPN
ajlm-2700	144	6	laboratory	laboratory	PROPN
ajlm-2700	144	7	service	service	PROPN
ajlm-2700	144	8	k	k	PROPN
ajlm-2700	144	9	-	-	NOUN
ajlm-2700	144	10	funding	funding	NOUN
ajlm-2700	144	11	and	and	CCONJ
ajlm-2700	144	12	university	university	NOUN
ajlm-2700	144	13	of	of	ADP
ajlm-2700	144	14	the	the	DET
ajlm-2700	144	15	witwatersrand	witwatersrand	NOUN
ajlm-2700	144	16	research	research	NOUN
ajlm-2700	144	17	grants	grant	NOUN
ajlm-2700	144	18	provided	provide	VERB
ajlm-2700	144	19	the	the	DET
ajlm-2700	144	20	funds	fund	NOUN
ajlm-2700	144	21	for	for	ADP
ajlm-2700	144	22	study	study	NOUN
ajlm-2700	144	23	consumables	consumable	NOUN
ajlm-2700	144	24	.	.	PUNCT
ajlm-2700	145	1	data	datum	NOUN
ajlm-2700	145	2	availability	availability	NOUN
ajlm-2700	145	3	the	the	DET
ajlm-2700	145	4	data	datum	NOUN
ajlm-2700	145	5	that	that	PRON
ajlm-2700	145	6	support	support	VERB
ajlm-2700	145	7	the	the	DET
ajlm-2700	145	8	findings	finding	NOUN
ajlm-2700	145	9	of	of	ADP
ajlm-2700	145	10	this	this	DET
ajlm-2700	145	11	study	study	NOUN
ajlm-2700	145	12	are	be	AUX
ajlm-2700	145	13	available	available	ADJ
ajlm-2700	145	14	on	on	ADP
ajlm-2700	145	15	request	request	NOUN
ajlm-2700	145	16	from	from	ADP
ajlm-2700	145	17	the	the	DET
ajlm-2700	145	18	corresponding	corresponding	ADJ
ajlm-2700	145	19	author	author	NOUN
ajlm-2700	145	20	,	,	PUNCT
ajlm-2700	145	21	m.r.m	m.r.m	PROPN
ajlm-2700	145	22	.	.	PUNCT
ajlm-2700	145	23	disclaimer	disclaimer	PROPN
ajlm-2700	145	24	the	the	DET
ajlm-2700	145	25	views	view	NOUN
ajlm-2700	145	26	and	and	CCONJ
ajlm-2700	145	27	opinions	opinion	NOUN
ajlm-2700	145	28	expressed	express	VERB
ajlm-2700	145	29	in	in	ADP
ajlm-2700	145	30	this	this	DET
ajlm-2700	145	31	article	article	NOUN
ajlm-2700	145	32	are	be	AUX
ajlm-2700	145	33	those	those	PRON
ajlm-2700	145	34	of	of	ADP
ajlm-2700	145	35	the	the	DET
ajlm-2700	145	36	authors	author	NOUN
ajlm-2700	145	37	and	and	CCONJ
ajlm-2700	145	38	are	be	AUX
ajlm-2700	145	39	the	the	DET
ajlm-2700	145	40	product	product	NOUN
ajlm-2700	145	41	of	of	ADP
ajlm-2700	145	42	professional	professional	ADJ
ajlm-2700	145	43	research	research	NOUN
ajlm-2700	145	44	.	.	PUNCT
ajlm-2700	146	1	the	the	DET
ajlm-2700	146	2	article	article	NOUN
ajlm-2700	146	3	does	do	AUX
ajlm-2700	146	4	not	not	PART
ajlm-2700	146	5	necessarily	necessarily	ADV
ajlm-2700	146	6	reflect	reflect	VERB
ajlm-2700	146	7	the	the	DET
ajlm-2700	146	8	official	official	ADJ
ajlm-2700	146	9	policy	policy	NOUN
ajlm-2700	146	10	or	or	CCONJ
ajlm-2700	146	11	position	position	NOUN
ajlm-2700	146	12	of	of	ADP
ajlm-2700	146	13	any	any	DET
ajlm-2700	146	14	affiliated	affiliated	ADJ
ajlm-2700	146	15	institution	institution	NOUN
ajlm-2700	146	16	,	,	PUNCT
ajlm-2700	146	17	funder	funder	NOUN
ajlm-2700	146	18	,	,	PUNCT
ajlm-2700	146	19	agency	agency	NOUN
ajlm-2700	146	20	,	,	PUNCT
ajlm-2700	146	21	or	or	CCONJ
ajlm-2700	146	22	that	that	PRON
ajlm-2700	146	23	of	of	ADP
ajlm-2700	146	24	the	the	DET
ajlm-2700	146	25	publisher	publisher	NOUN
ajlm-2700	146	26	.	.	PUNCT
ajlm-2700	147	1	the	the	DET
ajlm-2700	147	2	authors	author	NOUN
ajlm-2700	147	3	are	be	AUX
ajlm-2700	147	4	responsible	responsible	ADJ
ajlm-2700	147	5	for	for	ADP
ajlm-2700	147	6	this	this	DET
ajlm-2700	147	7	article	article	NOUN
ajlm-2700	147	8	’s	’s	PART
ajlm-2700	147	9	results	result	NOUN
ajlm-2700	147	10	,	,	PUNCT
ajlm-2700	147	11	findings	finding	NOUN
ajlm-2700	147	12	,	,	PUNCT
ajlm-2700	147	13	and	and	CCONJ
ajlm-2700	147	14	content	content	NOUN
ajlm-2700	147	15	.	.	PUNCT
ajlm-2700	148	1	references	reference	NOUN
ajlm-2700	148	2	waziri	waziri	PROPN
ajlm-2700	148	3	b	b	PROPN
ajlm-2700	148	4	,	,	PUNCT
ajlm-2700	148	5	duarte	duarte	PROPN
ajlm-2700	148	6	r	r	PROPN
ajlm-2700	148	7	,	,	PUNCT
ajlm-2700	148	8	naicker	naicker	ADJ
ajlm-2700	148	9	s.	s.	PROPN
ajlm-2700	148	10	chronic	chronic	PROPN
ajlm-2700	148	11	kidney	kidney	NOUN
ajlm-2700	148	12	disease	disease	NOUN
ajlm-2700	148	13	-	-	PUNCT
ajlm-2700	148	14	mineral	mineral	NOUN
ajlm-2700	148	15	and	and	CCONJ
ajlm-2700	148	16	bone	bone	NOUN
ajlm-2700	148	17	disorder	disorder	NOUN
ajlm-2700	148	18	(	(	PUNCT
ajlm-2700	148	19	ckd	ckd	PROPN
ajlm-2700	148	20	-	-	PUNCT
ajlm-2700	148	21	mbd	mbd	PROPN
ajlm-2700	148	22	):	):	PUNCT
ajlm-2700	148	23	current	current	ADJ
ajlm-2700	148	24	perspectives	perspective	NOUN
ajlm-2700	148	25	.	.	PUNCT
ajlm-2700	149	1	int	int	NOUN
ajlm-2700	149	2	j	j	PROPN
ajlm-2700	149	3	nephrol	nephrol	PROPN
ajlm-2700	149	4	renovasc	renovasc	PROPN
ajlm-2700	149	5	dis	dis	PROPN
ajlm-2700	149	6	.	.	PUNCT
ajlm-2700	150	1	2019;12:263–276	2019;12:263–276	PROPN
ajlm-2700	150	2	.	.	PUNCT
ajlm-2700	151	1	https://doi.org/10.2147/ijnrd.s191156	https://doi.org/10.2147/ijnrd.s191156	PROPN
ajlm-2700	151	2	kaze	kaze	NOUN
ajlm-2700	151	3	ad	ad	NOUN
ajlm-2700	151	4	,	,	PUNCT
ajlm-2700	151	5	ilori	ilori	PROPN
ajlm-2700	151	6	t	t	PROPN
ajlm-2700	151	7	,	,	PUNCT
ajlm-2700	151	8	jaar	jaar	PROPN
ajlm-2700	151	9	bg	bg	PROPN
ajlm-2700	151	10	,	,	PUNCT
ajlm-2700	151	11	echouffo	echouffo	NOUN
ajlm-2700	151	12	-	-	PUNCT
ajlm-2700	151	13	tcheugui	tcheugui	PROPN
ajlm-2700	151	14	jb	jb	PROPN
ajlm-2700	151	15	.	.	PUNCT
ajlm-2700	152	1	burden	burden	NOUN
ajlm-2700	152	2	of	of	ADP
ajlm-2700	152	3	chronic	chronic	ADJ
ajlm-2700	152	4	kidney	kidney	NOUN
ajlm-2700	152	5	disease	disease	NOUN
ajlm-2700	152	6	on	on	ADP
ajlm-2700	152	7	the	the	DET
ajlm-2700	152	8	african	african	ADJ
ajlm-2700	152	9	continent	continent	NOUN
ajlm-2700	152	10	:	:	PUNCT
ajlm-2700	152	11	a	a	DET
ajlm-2700	152	12	systematic	systematic	ADJ
ajlm-2700	152	13	review	review	NOUN
ajlm-2700	152	14	and	and	CCONJ
ajlm-2700	152	15	meta	meta	ADJ
ajlm-2700	152	16	-	-	PUNCT
ajlm-2700	152	17	analysis	analysis	NOUN
ajlm-2700	152	18	.	.	PUNCT
ajlm-2700	153	1	bmc	bmc	ADJ
ajlm-2700	153	2	nephrol	nephrol	NOUN
ajlm-2700	153	3	.	.	PUNCT
ajlm-2700	154	1	2018;19:125	2018;19:125	NUM
ajlm-2700	154	2	.	.	PUNCT
ajlm-2700	154	3	https://doi.org/10.1186/s12882-018-0930-5	https://doi.org/10.1186/s12882-018-0930-5	PROPN
ajlm-2700	155	1	souberbielle	souberbielle	PROPN
ajlm-2700	155	2	j	j	PROPN
ajlm-2700	155	3	-	-	PUNCT
ajlm-2700	155	4	c	c	PROPN
ajlm-2700	155	5	,	,	PUNCT
ajlm-2700	155	6	boutten	boutten	VERB
ajlm-2700	155	7	a	a	DET
ajlm-2700	155	8	,	,	PUNCT
ajlm-2700	155	9	carlier	carlier	NOUN
ajlm-2700	155	10	m	m	NOUN
ajlm-2700	155	11	-	-	PUNCT
ajlm-2700	155	12	c	c	PROPN
ajlm-2700	155	13	,	,	PUNCT
ajlm-2700	155	14	et	et	PROPN
ajlm-2700	155	15	al	al	PROPN
ajlm-2700	155	16	.	.	PUNCT
ajlm-2700	156	1	inter	inter	ADJ
ajlm-2700	156	2	-	-	ADJ
ajlm-2700	156	3	method	method	ADJ
ajlm-2700	156	4	variability	variability	NOUN
ajlm-2700	156	5	in	in	ADP
ajlm-2700	156	6	pth	pth	NOUN
ajlm-2700	156	7	measurement	measurement	NOUN
ajlm-2700	156	8	:	:	PUNCT
ajlm-2700	156	9	implication	implication	NOUN
ajlm-2700	156	10	for	for	ADP
ajlm-2700	156	11	the	the	DET
ajlm-2700	156	12	care	care	NOUN
ajlm-2700	156	13	of	of	ADP
ajlm-2700	156	14	ckd	ckd	PROPN
ajlm-2700	156	15	patients	patient	NOUN
ajlm-2700	156	16	.	.	PUNCT
ajlm-2700	157	1	kidney	kidney	NOUN
ajlm-2700	157	2	int	int	NOUN
ajlm-2700	157	3	.	.	PUNCT
ajlm-2700	158	1	2006;70:345–350	2006;70:345–350	PROPN
ajlm-2700	158	2	.	.	PUNCT
ajlm-2700	159	1	https://doi.org/10.1038/sj.ki.5001606	https://doi.org/10.1038/sj.ki.5001606	PROPN
ajlm-2700	159	2	smit	smit	PROPN
ajlm-2700	159	3	ma	ma	PROPN
ajlm-2700	159	4	,	,	PUNCT
ajlm-2700	159	5	van	van	PROPN
ajlm-2700	159	6	kinschot	kinschot	PROPN
ajlm-2700	159	7	cmj	cmj	NOUN
ajlm-2700	159	8	,	,	PUNCT
ajlm-2700	159	9	van	van	PROPN
ajlm-2700	159	10	der	der	PROPN
ajlm-2700	159	11	linden	linden	PROPN
ajlm-2700	159	12	j	j	PROPN
ajlm-2700	159	13	,	,	PUNCT
ajlm-2700	159	14	van	van	PROPN
ajlm-2700	159	15	noord	noord	PROPN
ajlm-2700	159	16	c	c	PROPN
ajlm-2700	159	17	,	,	PUNCT
ajlm-2700	159	18	kos	kos	PROPN
ajlm-2700	159	19	s.	s.	PROPN
ajlm-2700	159	20	clinical	clinical	ADJ
ajlm-2700	159	21	guidelines	guideline	NOUN
ajlm-2700	159	22	and	and	CCONJ
ajlm-2700	159	23	pth	pth	NOUN
ajlm-2700	159	24	measurement	measurement	NOUN
ajlm-2700	159	25	:	:	PUNCT
ajlm-2700	159	26	does	do	AUX
ajlm-2700	159	27	assay	assay	VERB
ajlm-2700	159	28	generation	generation	NOUN
ajlm-2700	159	29	matter	matter	NOUN
ajlm-2700	159	30	?	?	PUNCT
ajlm-2700	160	1	endocr	endocr	PROPN
ajlm-2700	160	2	rev	rev	PROPN
ajlm-2700	160	3	.	.	PROPN
ajlm-2700	160	4	2019;40:1468–1480	2019;40:1468–1480	PROPN
ajlm-2700	160	5	.	.	PUNCT
ajlm-2700	161	1	https://doi.org/10.1210/er.2018-00220	https://doi.org/10.1210/er.2018-00220	PROPN
ajlm-2700	161	2	chen	chen	PROPN
ajlm-2700	161	3	h	h	PROPN
ajlm-2700	161	4	,	,	PUNCT
ajlm-2700	161	5	han	han	PROPN
ajlm-2700	161	6	x	x	PROPN
ajlm-2700	161	7	,	,	PUNCT
ajlm-2700	161	8	cui	cui	PROPN
ajlm-2700	161	9	y	y	PROPN
ajlm-2700	161	10	,	,	PUNCT
ajlm-2700	161	11	ye	ye	PROPN
ajlm-2700	161	12	y	y	PROPN
ajlm-2700	161	13	,	,	PUNCT
ajlm-2700	161	14	purrunsing	purrunse	VERB
ajlm-2700	161	15	y	y	PROPN
ajlm-2700	161	16	,	,	PUNCT
ajlm-2700	161	17	wang	wang	PROPN
ajlm-2700	161	18	n.	n.	PROPN
ajlm-2700	161	19	parathyroid	parathyroid	PROPN
ajlm-2700	161	20	hormone	hormone	NOUN
ajlm-2700	161	21	fragments	fragment	NOUN
ajlm-2700	161	22	:	:	PUNCT
ajlm-2700	161	23	new	new	ADJ
ajlm-2700	161	24	targets	target	NOUN
ajlm-2700	161	25	for	for	ADP
ajlm-2700	161	26	the	the	DET
ajlm-2700	161	27	diagnosis	diagnosis	NOUN
ajlm-2700	161	28	and	and	CCONJ
ajlm-2700	161	29	treatment	treatment	NOUN
ajlm-2700	161	30	of	of	ADP
ajlm-2700	161	31	chronic	chronic	ADJ
ajlm-2700	161	32	kidney	kidney	NOUN
ajlm-2700	161	33	disease	disease	NOUN
ajlm-2700	161	34	-	-	PUNCT
ajlm-2700	161	35	mineral	mineral	NOUN
ajlm-2700	161	36	and	and	CCONJ
ajlm-2700	161	37	bone	bone	NOUN
ajlm-2700	161	38	disorder	disorder	NOUN
ajlm-2700	161	39	.	.	PUNCT
ajlm-2700	161	40	biomed	biome	VERB
ajlm-2700	161	41	res	re	NOUN
ajlm-2700	161	42	int	int	NOUN
ajlm-2700	161	43	.	.	PUNCT
ajlm-2700	162	1	2018;2018:9619253	2018;2018:9619253	NUM
ajlm-2700	162	2	.	.	PUNCT
ajlm-2700	162	3	https://doi.org/10.1155/2018/9619253	https://doi.org/10.1155/2018/9619253	VERB
ajlm-2700	162	4	d’amour	d’amour	PRON
ajlm-2700	162	5	p.	p.	NOUN
ajlm-2700	162	6	circulating	circulate	VERB
ajlm-2700	162	7	pth	pth	NOUN
ajlm-2700	162	8	molecular	molecular	ADJ
ajlm-2700	162	9	forms	form	NOUN
ajlm-2700	162	10	:	:	PUNCT
ajlm-2700	162	11	what	what	PRON
ajlm-2700	162	12	we	we	PRON
ajlm-2700	162	13	know	know	VERB
ajlm-2700	162	14	and	and	CCONJ
ajlm-2700	162	15	what	what	PRON
ajlm-2700	162	16	we	we	PRON
ajlm-2700	162	17	do	do	AUX
ajlm-2700	162	18	n’t	not	PART
ajlm-2700	162	19	.	.	PUNCT
ajlm-2700	163	1	kidney	kidney	PROPN
ajlm-2700	163	2	int	int	PROPN
ajlm-2700	163	3	suppl	suppl	PROPN
ajlm-2700	163	4	.	.	PUNCT
ajlm-2700	164	1	2006;102	2006;102	NUM
ajlm-2700	164	2	:	:	PUNCT
ajlm-2700	164	3	s29	s29	PROPN
ajlm-2700	164	4	–	–	PUNCT
ajlm-2700	164	5	s33	s33	PROPN
ajlm-2700	164	6	.	.	PUNCT
ajlm-2700	165	1	https://doi.org/10.1038/sj.ki.5001599	https://doi.org/10.1038/sj.ki.5001599	PROPN
ajlm-2700	165	2	arya	arya	PROPN
ajlm-2700	165	3	ak	ak	PROPN
ajlm-2700	165	4	,	,	PUNCT
ajlm-2700	165	5	sachdeva	sachdeva	PROPN
ajlm-2700	165	6	n.	n.	PROPN
ajlm-2700	165	7	parathyroid	parathyroid	PROPN
ajlm-2700	165	8	hormone	hormone	NOUN
ajlm-2700	165	9	(	(	PUNCT
ajlm-2700	165	10	pth	pth	NOUN
ajlm-2700	165	11	)	)	PUNCT
ajlm-2700	165	12	assays	assay	NOUN
ajlm-2700	165	13	and	and	CCONJ
ajlm-2700	165	14	applications	application	NOUN
ajlm-2700	165	15	to	to	ADP
ajlm-2700	165	16	bone	bone	NOUN
ajlm-2700	165	17	disease	disease	NOUN
ajlm-2700	165	18	:	:	PUNCT
ajlm-2700	165	19	overview	overview	NOUN
ajlm-2700	165	20	on	on	ADP
ajlm-2700	165	21	methodology	methodology	NOUN
ajlm-2700	165	22	.	.	PUNCT
ajlm-2700	166	1	in	in	ADP
ajlm-2700	166	2	:	:	PUNCT
ajlm-2700	166	3	preedy	preedy	PROPN
ajlm-2700	166	4	vr	vr	PROPN
ajlm-2700	166	5	,	,	PUNCT
ajlm-2700	166	6	editor	editor	NOUN
ajlm-2700	166	7	.	.	PUNCT
ajlm-2700	167	1	biomarkers	biomarker	NOUN
ajlm-2700	167	2	in	in	ADP
ajlm-2700	167	3	bone	bone	NOUN
ajlm-2700	167	4	disease	disease	NOUN
ajlm-2700	167	5	.	.	PUNCT
ajlm-2700	168	1	dordrecht	dordrecht	PROPN
ajlm-2700	168	2	:	:	PUNCT
ajlm-2700	168	3	springer	springer	NOUN
ajlm-2700	168	4	;	;	PUNCT
ajlm-2700	168	5	2016	2016	NUM
ajlm-2700	168	6	,	,	PUNCT
ajlm-2700	168	7	p.	p.	NOUN
ajlm-2700	168	8	1–29	1–29	PROPN
ajlm-2700	168	9	.	.	PUNCT
ajlm-2700	169	1	cavalier	cavalier	ADJ
ajlm-2700	169	2	e	e	NOUN
ajlm-2700	169	3	,	,	PUNCT
ajlm-2700	169	4	delanaye	delanaye	VERB
ajlm-2700	169	5	p	p	NOUN
ajlm-2700	169	6	,	,	PUNCT
ajlm-2700	169	7	nyssen	nyssen	PROPN
ajlm-2700	169	8	l	l	PROPN
ajlm-2700	169	9	,	,	PUNCT
ajlm-2700	170	1	souberbielle	souberbielle	PROPN
ajlm-2700	170	2	jc	jc	PROPN
ajlm-2700	170	3	.	.	PROPN
ajlm-2700	170	4	problems	problem	NOUN
ajlm-2700	170	5	with	with	ADP
ajlm-2700	170	6	the	the	DET
ajlm-2700	170	7	pth	pth	NOUN
ajlm-2700	170	8	assays	assay	NOUN
ajlm-2700	170	9	.	.	PUNCT
ajlm-2700	171	1	ann	ann	PROPN
ajlm-2700	171	2	endocrinol	endocrinol	NOUN
ajlm-2700	171	3	.	.	PUNCT
ajlm-2700	172	1	2015;76:128–133	2015;76:128–133	NOUN
ajlm-2700	172	2	.	.	PUNCT
ajlm-2700	173	1	https://doi.org/10.1016/j.ando.2015.03.018	https://doi.org/10.1016/j.ando.2015.03.018	NOUN
ajlm-2700	173	2	cavalier	cavalier	ADJ
ajlm-2700	173	3	e.	e.	PROPN
ajlm-2700	173	4	parathyroid	parathyroid	PROPN
ajlm-2700	173	5	hormone	hormone	NOUN
ajlm-2700	173	6	results	result	VERB
ajlm-2700	173	7	interpretation	interpretation	NOUN
ajlm-2700	173	8	in	in	ADP
ajlm-2700	173	9	the	the	DET
ajlm-2700	173	10	background	background	NOUN
ajlm-2700	173	11	of	of	ADP
ajlm-2700	173	12	variable	variable	ADJ
ajlm-2700	173	13	analytical	analytical	ADJ
ajlm-2700	173	14	performance	performance	NOUN
ajlm-2700	173	15	.	.	PUNCT
ajlm-2700	174	1	j	j	PROPN
ajlm-2700	174	2	lab	lab	PROPN
ajlm-2700	174	3	precis	precis	PROPN
ajlm-2700	174	4	med	me	VERB
ajlm-2700	174	5	.	.	PUNCT
ajlm-2700	175	1	2019;4:1–11	2019;4:1–11	NUM
ajlm-2700	175	2	.	.	PUNCT
ajlm-2700	176	1	https://doi.org/10.21037/jlpm.2018.12.03	https://doi.org/10.21037/jlpm.2018.12.03	X
ajlm-2700	176	2	sturgeon	sturgeon	NOUN
ajlm-2700	176	3	cm	cm	NOUN
ajlm-2700	176	4	,	,	PUNCT
ajlm-2700	176	5	sprague	sprague	NOUN
ajlm-2700	176	6	s	s	PROPN
ajlm-2700	176	7	,	,	PUNCT
ajlm-2700	176	8	almond	almond	PROPN
ajlm-2700	176	9	a	a	X
ajlm-2700	176	10	,	,	PUNCT
ajlm-2700	176	11	et	et	PROPN
ajlm-2700	176	12	al	al	PROPN
ajlm-2700	176	13	.	.	PROPN
ajlm-2700	176	14	perspective	perspective	PROPN
ajlm-2700	176	15	and	and	CCONJ
ajlm-2700	176	16	priorities	priority	NOUN
ajlm-2700	176	17	for	for	ADP
ajlm-2700	176	18	improvement	improvement	NOUN
ajlm-2700	176	19	of	of	ADP
ajlm-2700	176	20	parathyroid	parathyroid	ADJ
ajlm-2700	176	21	hormone	hormone	NOUN
ajlm-2700	176	22	(	(	PUNCT
ajlm-2700	176	23	pth	pth	NOUN
ajlm-2700	176	24	)	)	PUNCT
ajlm-2700	176	25	measurement	measurement	NOUN
ajlm-2700	176	26	–	–	PUNCT
ajlm-2700	176	27	a	a	DET
ajlm-2700	176	28	view	view	NOUN
ajlm-2700	176	29	from	from	ADP
ajlm-2700	176	30	the	the	DET
ajlm-2700	176	31	ifcc	ifcc	NOUN
ajlm-2700	176	32	working	working	NOUN
ajlm-2700	176	33	group	group	NOUN
ajlm-2700	176	34	for	for	ADP
ajlm-2700	176	35	pth	pth	NOUN
ajlm-2700	176	36	.	.	PUNCT
ajlm-2700	177	1	clin	clin	PROPN
ajlm-2700	177	2	chim	chim	PROPN
ajlm-2700	177	3	acta	acta	PROPN
ajlm-2700	177	4	.	.	PUNCT
ajlm-2700	178	1	2017;467:42–47	2017;467:42–47	X
ajlm-2700	178	2	.	.	PROPN
ajlm-2700	178	3	https://doi.org/10.1016/j.cca.2016.10.016	https://doi.org/10.1016/j.cca.2016.10.016	PROPN
ajlm-2700	178	4	couchman	couchman	PROPN
ajlm-2700	178	5	l	l	PROPN
ajlm-2700	178	6	,	,	PUNCT
ajlm-2700	178	7	taylor	taylor	PROPN
ajlm-2700	178	8	dr	dr	PROPN
ajlm-2700	178	9	,	,	PUNCT
ajlm-2700	178	10	krastins	krastins	PROPN
ajlm-2700	178	11	b	b	NUM
ajlm-2700	178	12	,	,	PUNCT
ajlm-2700	178	13	lopez	lopez	PROPN
ajlm-2700	178	14	mf	mf	PROPN
ajlm-2700	178	15	,	,	PUNCT
ajlm-2700	178	16	moniz	moniz	PROPN
ajlm-2700	178	17	cf	cf	PROPN
ajlm-2700	178	18	.	.	PUNCT
ajlm-2700	179	1	lc	lc	PROPN
ajlm-2700	179	2	-	-	PUNCT
ajlm-2700	179	3	ms	ms	NOUN
ajlm-2700	179	4	candidate	candidate	NOUN
ajlm-2700	179	5	reference	reference	NOUN
ajlm-2700	179	6	methods	method	NOUN
ajlm-2700	179	7	for	for	ADP
ajlm-2700	179	8	the	the	DET
ajlm-2700	179	9	harmonisation	harmonisation	NOUN
ajlm-2700	179	10	of	of	ADP
ajlm-2700	179	11	parathyroid	parathyroid	ADJ
ajlm-2700	179	12	hormone	hormone	NOUN
ajlm-2700	179	13	(	(	PUNCT
ajlm-2700	179	14	pth	pth	NOUN
ajlm-2700	179	15	)	)	PUNCT
ajlm-2700	179	16	measurement	measurement	NOUN
ajlm-2700	179	17	:	:	PUNCT
ajlm-2700	179	18	a	a	DET
ajlm-2700	179	19	review	review	NOUN
ajlm-2700	179	20	of	of	ADP
ajlm-2700	179	21	recent	recent	ADJ
ajlm-2700	179	22	developments	development	NOUN
ajlm-2700	179	23	and	and	CCONJ
ajlm-2700	179	24	future	future	ADJ
ajlm-2700	179	25	considerations	consideration	NOUN
ajlm-2700	179	26	.	.	PUNCT
ajlm-2700	180	1	clin	clin	PROPN
ajlm-2700	180	2	chem	chem	NOUN
ajlm-2700	180	3	lab	lab	NOUN
ajlm-2700	180	4	med	med	PROPN
ajlm-2700	180	5	.	.	PUNCT
ajlm-2700	181	1	2014;52:1251–1263	2014;52:1251–1263	X
ajlm-2700	181	2	.	.	PUNCT
ajlm-2700	182	1	https://doi.org/10.1515/cclm-2014-0150	https://doi.org/10.1515/cclm-2014-0150	PROPN
ajlm-2700	182	2	soliman	soliman	PROPN
ajlm-2700	182	3	m	m	PROPN
ajlm-2700	182	4	,	,	PUNCT
ajlm-2700	182	5	hassan	hassan	PROPN
ajlm-2700	182	6	w	w	PROPN
ajlm-2700	182	7	,	,	PUNCT
ajlm-2700	182	8	yaseen	yaseen	PROPN
ajlm-2700	182	9	m	m	PROPN
ajlm-2700	182	10	,	,	PUNCT
ajlm-2700	182	11	rao	rao	PROPN
ajlm-2700	182	12	m	m	PROPN
ajlm-2700	182	13	,	,	PUNCT
ajlm-2700	182	14	sawaya	sawaya	PROPN
ajlm-2700	182	15	bp	bp	PROPN
ajlm-2700	182	16	,	,	PUNCT
ajlm-2700	182	17	el	el	PROPN
ajlm-2700	182	18	-	-	PUNCT
ajlm-2700	182	19	husseini	husseini	PROPN
ajlm-2700	182	20	a.	a.	NOUN
ajlm-2700	182	21	pth	pth	NOUN
ajlm-2700	182	22	assays	assay	NOUN
ajlm-2700	182	23	in	in	ADP
ajlm-2700	182	24	dialysis	dialysis	NOUN
ajlm-2700	182	25	patients	patient	NOUN
ajlm-2700	182	26	:	:	PUNCT
ajlm-2700	182	27	practical	practical	ADJ
ajlm-2700	182	28	considerations	consideration	NOUN
ajlm-2700	182	29	.	.	PUNCT
ajlm-2700	183	1	semin	semin	PROPN
ajlm-2700	183	2	dial	dial	PROPN
ajlm-2700	183	3	.	.	PUNCT
ajlm-2700	184	1	2019;32:9–14	2019;32:9–14	X
ajlm-2700	184	2	.	.	PUNCT
ajlm-2700	185	1	https://doi.org/10.1111/sdi.12743	https://doi.org/10.1111/sdi.12743	PROPN
ajlm-2700	185	2	lepage	lepage	PROPN
ajlm-2700	185	3	r	r	PROPN
ajlm-2700	185	4	,	,	PUNCT
ajlm-2700	185	5	roy	roy	PROPN
ajlm-2700	185	6	l	l	PROPN
ajlm-2700	185	7	,	,	PUNCT
ajlm-2700	185	8	brossard	brossard	PROPN
ajlm-2700	185	9	jh	jh	PROPN
ajlm-2700	185	10	,	,	PUNCT
ajlm-2700	185	11	et	et	PROPN
ajlm-2700	185	12	al	al	PROPN
ajlm-2700	185	13	.	.	PUNCT
ajlm-2700	186	1	a	a	DET
ajlm-2700	186	2	non-(1	non-(1	PROPN
ajlm-2700	186	3	-	-	PUNCT
ajlm-2700	186	4	84	84	NUM
ajlm-2700	186	5	)	)	PUNCT
ajlm-2700	186	6	circulating	circulate	VERB
ajlm-2700	186	7	parathyroid	parathyroid	ADJ
ajlm-2700	186	8	hormone	hormone	NOUN
ajlm-2700	186	9	(	(	PUNCT
ajlm-2700	186	10	pth	pth	NOUN
ajlm-2700	186	11	)	)	PUNCT
ajlm-2700	186	12	fragment	fragment	NOUN
ajlm-2700	186	13	interferes	interfere	VERB
ajlm-2700	186	14	significantly	significantly	ADV
ajlm-2700	186	15	with	with	ADP
ajlm-2700	186	16	intact	intact	ADJ
ajlm-2700	186	17	pth	pth	NOUN
ajlm-2700	186	18	commercial	commercial	ADJ
ajlm-2700	186	19	assay	assay	NOUN
ajlm-2700	186	20	measurements	measurement	NOUN
ajlm-2700	186	21	in	in	ADP
ajlm-2700	186	22	uremic	uremic	ADJ
ajlm-2700	186	23	samples	sample	NOUN
ajlm-2700	186	24	.	.	PUNCT
ajlm-2700	187	1	clin	clin	PROPN
ajlm-2700	187	2	chem	chem	NOUN
ajlm-2700	187	3	.	.	PUNCT
ajlm-2700	188	1	1998;44:805–809	1998;44:805–809	NOUN
ajlm-2700	188	2	.	.	PUNCT
ajlm-2700	189	1	https://doi.org/10.1093/clinchem/44.4.805	https://doi.org/10.1093/clinchem/44.4.805	X
ajlm-2700	189	2	slatopolsky	slatopolsky	ADJ
ajlm-2700	189	3	e	e	NOUN
ajlm-2700	189	4	,	,	PUNCT
ajlm-2700	189	5	finch	finch	PROPN
ajlm-2700	189	6	j	j	PROPN
ajlm-2700	189	7	,	,	PUNCT
ajlm-2700	189	8	clay	clay	NOUN
ajlm-2700	189	9	p	p	NOUN
ajlm-2700	189	10	,	,	PUNCT
ajlm-2700	189	11	et	et	PROPN
ajlm-2700	189	12	al	al	PROPN
ajlm-2700	189	13	.	.	PUNCT
ajlm-2700	190	1	a	a	DET
ajlm-2700	190	2	novel	novel	ADJ
ajlm-2700	190	3	mechanism	mechanism	NOUN
ajlm-2700	190	4	for	for	ADP
ajlm-2700	190	5	skeletal	skeletal	ADJ
ajlm-2700	190	6	resistance	resistance	NOUN
ajlm-2700	190	7	in	in	ADP
ajlm-2700	190	8	uremia	uremia	NOUN
ajlm-2700	190	9	.	.	PUNCT
ajlm-2700	191	1	kidney	kidney	NOUN
ajlm-2700	191	2	int	int	PROPN
ajlm-2700	191	3	.	.	PUNCT
ajlm-2700	192	1	2000;58:753–761	2000;58:753–761	X
ajlm-2700	192	2	.	.	PUNCT
ajlm-2700	193	1	https://doi.org/10.1016/s0085-2538(15)47156-x	https://doi.org/10.1016/s0085-2538(15)47156-x	PROPN
ajlm-2700	193	2	kidney	kidney	NOUN
ajlm-2700	193	3	disease	disease	NOUN
ajlm-2700	193	4	:	:	PUNCT
ajlm-2700	193	5	improving	improve	VERB
ajlm-2700	193	6	global	global	ADJ
ajlm-2700	193	7	outcomes	outcome	NOUN
ajlm-2700	193	8	(	(	PUNCT
ajlm-2700	193	9	kdigo	kdigo	PROPN
ajlm-2700	193	10	)	)	PUNCT
ajlm-2700	193	11	ckd	ckd	PROPN
ajlm-2700	193	12	-	-	PUNCT
ajlm-2700	193	13	mbd	mbd	PROPN
ajlm-2700	193	14	update	update	NOUN
ajlm-2700	193	15	work	work	NOUN
ajlm-2700	193	16	group	group	NOUN
ajlm-2700	193	17	.	.	PUNCT
ajlm-2700	194	1	kdigo	kdigo	PROPN
ajlm-2700	194	2	2017	2017	NUM
ajlm-2700	194	3	clinical	clinical	ADJ
ajlm-2700	194	4	practice	practice	NOUN
ajlm-2700	194	5	guideline	guideline	NOUN
ajlm-2700	194	6	update	update	NOUN
ajlm-2700	194	7	for	for	ADP
ajlm-2700	194	8	the	the	DET
ajlm-2700	194	9	diagnosis	diagnosis	NOUN
ajlm-2700	194	10	,	,	PUNCT
ajlm-2700	194	11	evaluation	evaluation	NOUN
ajlm-2700	194	12	,	,	PUNCT
ajlm-2700	194	13	prevention	prevention	NOUN
ajlm-2700	194	14	,	,	PUNCT
ajlm-2700	194	15	and	and	CCONJ
ajlm-2700	194	16	treatment	treatment	NOUN
ajlm-2700	194	17	of	of	ADP
ajlm-2700	194	18	chronic	chronic	ADJ
ajlm-2700	194	19	kidney	kidney	NOUN
ajlm-2700	194	20	disease	disease	NOUN
ajlm-2700	194	21	–	–	PUNCT
ajlm-2700	194	22	mineral	mineral	NOUN
ajlm-2700	194	23	and	and	CCONJ
ajlm-2700	194	24	bone	bone	NOUN
ajlm-2700	194	25	disorder	disorder	NOUN
ajlm-2700	194	26	(	(	PUNCT
ajlm-2700	194	27	ckd	ckd	PROPN
ajlm-2700	194	28	-	-	PUNCT
ajlm-2700	194	29	mbd	mbd	PROPN
ajlm-2700	194	30	)	)	PUNCT
ajlm-2700	194	31	.	.	PUNCT
ajlm-2700	195	1	kidney	kidney	PROPN
ajlm-2700	195	2	int	int	PROPN
ajlm-2700	195	3	suppl	suppl	PROPN
ajlm-2700	195	4	.	.	PUNCT
ajlm-2700	196	1	2017;7:1–5	2017;7:1–5	NUM
ajlm-2700	196	2	.	.	PUNCT
ajlm-2700	197	1	https://doi.org/10.1016/j.kisu.2017.04.001	https://doi.org/10.1016/j.kisu.2017.04.001	ADJ
ajlm-2700	197	2	clsi	clsi	NOUN
ajlm-2700	197	3	.	.	PUNCT
ajlm-2700	198	1	measurement	measurement	NOUN
ajlm-2700	198	2	procedure	procedure	NOUN
ajlm-2700	198	3	comparison	comparison	NOUN
ajlm-2700	198	4	and	and	CCONJ
ajlm-2700	198	5	bias	bias	NOUN
ajlm-2700	198	6	estimation	estimation	NOUN
ajlm-2700	198	7	using	use	VERB
ajlm-2700	198	8	patient	patient	ADJ
ajlm-2700	198	9	samples	sample	NOUN
ajlm-2700	198	10	;	;	PUNCT
ajlm-2700	198	11	approved	approve	VERB
ajlm-2700	198	12	guideline	guideline	NOUN
ajlm-2700	198	13	,	,	PUNCT
ajlm-2700	198	14	3rd	3rd	ADJ
ajlm-2700	198	15	ed	ed	NOUN
ajlm-2700	198	16	.	.	PUNCT
ajlm-2700	198	17	clsi	clsi	PROPN
ajlm-2700	198	18	document	document	NOUN
ajlm-2700	198	19	ep09	ep09	PROPN
ajlm-2700	198	20	-	-	PUNCT
ajlm-2700	198	21	a3	a3	NOUN
ajlm-2700	198	22	.	.	PUNCT
ajlm-2700	199	1	wayne	wayne	PROPN
ajlm-2700	199	2	,	,	PUNCT
ajlm-2700	199	3	pa	pa	PROPN
ajlm-2700	199	4	:	:	PUNCT
ajlm-2700	199	5	clinical	clinical	ADJ
ajlm-2700	199	6	and	and	CCONJ
ajlm-2700	199	7	laboratory	laboratory	NOUN
ajlm-2700	199	8	standards	standard	NOUN
ajlm-2700	199	9	institute	institute	PROPN
ajlm-2700	199	10	;	;	PUNCT
ajlm-2700	199	11	2014	2014	NUM
ajlm-2700	199	12	.	.	PUNCT
ajlm-2700	200	1	pourhoseingholi	pourhoseingholi	PROPN
ajlm-2700	200	2	ma	ma	PROPN
ajlm-2700	200	3	,	,	PUNCT
ajlm-2700	200	4	vahedi	vahedi	PROPN
ajlm-2700	200	5	m	m	PROPN
ajlm-2700	200	6	,	,	PUNCT
ajlm-2700	200	7	rahimzadeh	rahimzadeh	ADJ
ajlm-2700	200	8	m.	m.	NOUN
ajlm-2700	200	9	sample	sample	NOUN
ajlm-2700	200	10	size	size	NOUN
ajlm-2700	200	11	calculation	calculation	NOUN
ajlm-2700	200	12	in	in	ADP
ajlm-2700	200	13	medical	medical	ADJ
ajlm-2700	200	14	studies	study	NOUN
ajlm-2700	200	15	.	.	PUNCT
ajlm-2700	201	1	gastroenterol	gastroenterol	VERB
ajlm-2700	201	2	hepatol	hepatol	ADJ
ajlm-2700	201	3	bed	bed	NOUN
ajlm-2700	201	4	bench	bench	NOUN
ajlm-2700	201	5	.	.	PUNCT
ajlm-2700	202	1	2013;6:14–17	2013;6:14–17	NUM
ajlm-2700	202	2	.	.	PUNCT
ajlm-2700	203	1	adeniyi	adeniyi	PROPN
ajlm-2700	203	2	ab	ab	PROPN
ajlm-2700	203	3	,	,	PUNCT
ajlm-2700	203	4	laurence	laurence	PROPN
ajlm-2700	203	5	ce	ce	PROPN
ajlm-2700	203	6	,	,	PUNCT
ajlm-2700	203	7	volmink	volmink	PROPN
ajlm-2700	203	8	ja	ja	PROPN
ajlm-2700	203	9	,	,	PUNCT
ajlm-2700	203	10	davids	davids	PROPN
ajlm-2700	203	11	mr	mr	PROPN
ajlm-2700	203	12	.	.	PROPN
ajlm-2700	203	13	prevalence	prevalence	NOUN
ajlm-2700	203	14	of	of	ADP
ajlm-2700	203	15	chronic	chronic	ADJ
ajlm-2700	203	16	kidney	kidney	NOUN
ajlm-2700	203	17	disease	disease	NOUN
ajlm-2700	203	18	and	and	CCONJ
ajlm-2700	203	19	association	association	NOUN
ajlm-2700	203	20	with	with	ADP
ajlm-2700	203	21	cardiovascular	cardiovascular	ADJ
ajlm-2700	203	22	risk	risk	NOUN
ajlm-2700	203	23	factors	factor	NOUN
ajlm-2700	203	24	among	among	ADP
ajlm-2700	203	25	teachers	teacher	NOUN
ajlm-2700	203	26	in	in	ADP
ajlm-2700	203	27	cape	cape	NOUN
ajlm-2700	203	28	town	town	NOUN
ajlm-2700	203	29	,	,	PUNCT
ajlm-2700	203	30	south	south	PROPN
ajlm-2700	203	31	africa	africa	PROPN
ajlm-2700	203	32	.	.	PUNCT
ajlm-2700	204	1	clin	clin	PROPN
ajlm-2700	204	2	kidney	kidney	PROPN
ajlm-2700	204	3	j.	j.	PROPN
ajlm-2700	204	4	2017;10:363–369	2017;10:363–369	PROPN
ajlm-2700	204	5	.	.	PUNCT
ajlm-2700	205	1	https://doi.org/10.1093/ckj/sfw138	https://doi.org/10.1093/ckj/sfw138	PROPN
ajlm-2700	205	2	clsi	clsi	NOUN
ajlm-2700	205	3	.	.	PUNCT
ajlm-2700	206	1	user	user	NOUN
ajlm-2700	206	2	verification	verification	NOUN
ajlm-2700	206	3	of	of	ADP
ajlm-2700	206	4	precision	precision	NOUN
ajlm-2700	206	5	and	and	CCONJ
ajlm-2700	206	6	estimation	estimation	NOUN
ajlm-2700	206	7	of	of	ADP
ajlm-2700	206	8	bias	bias	NOUN
ajlm-2700	206	9	;	;	PUNCT
ajlm-2700	206	10	approved	approve	VERB
ajlm-2700	206	11	guideline	guideline	NOUN
ajlm-2700	206	12	.	.	PUNCT
ajlm-2700	207	1	3rd	3rd	ADJ
ajlm-2700	207	2	ed	ed	NOUN
ajlm-2700	207	3	.	.	PUNCT
ajlm-2700	207	4	clsi	clsi	PROPN
ajlm-2700	207	5	document	document	NOUN
ajlm-2700	207	6	ep15	ep15	PROPN
ajlm-2700	207	7	-	-	PUNCT
ajlm-2700	207	8	a3	a3	NOUN
ajlm-2700	207	9	.	.	PUNCT
ajlm-2700	208	1	wayne	wayne	PROPN
ajlm-2700	208	2	,	,	PUNCT
ajlm-2700	208	3	pa	pa	PROPN
ajlm-2700	208	4	:	:	PUNCT
ajlm-2700	208	5	clinical	clinical	ADJ
ajlm-2700	208	6	and	and	CCONJ
ajlm-2700	208	7	laboratory	laboratory	NOUN
ajlm-2700	208	8	standards	standard	NOUN
ajlm-2700	208	9	institute	institute	PROPN
ajlm-2700	208	10	;	;	PUNCT
ajlm-2700	208	11	2014	2014	NUM
ajlm-2700	208	12	.	.	PUNCT
ajlm-2700	209	1	roche	roche	PROPN
ajlm-2700	209	2	cobas	cobas	PROPN
ajlm-2700	209	3	®	®	PROPN
ajlm-2700	209	4	c601/602	c601/602	NOUN
ajlm-2700	209	5	.	.	PUNCT
ajlm-2700	210	1	elecsys	elecsys	PROPN
ajlm-2700	210	2	pth	pth	PROPN
ajlm-2700	210	3	.	.	PUNCT
ajlm-2700	211	1	order	order	NOUN
ajlm-2700	211	2	info	info	NOUN
ajlm-2700	211	3	(	(	PUNCT
ajlm-2700	211	4	2019	2019	NUM
ajlm-2700	211	5	-	-	SYM
ajlm-2700	211	6	01	01	NUM
ajlm-2700	211	7	v27.0	v27.0	NUM
ajlm-2700	211	8	):	):	PUNCT
ajlm-2700	211	9	ref	ref	NOUN
ajlm-2700	211	10	1172103122	1172103122	NUM
ajlm-2700	211	11	[	[	X
ajlm-2700	211	12	homepage	homepage	NOUN
ajlm-2700	211	13	on	on	ADP
ajlm-2700	211	14	the	the	DET
ajlm-2700	211	15	internet	internet	NOUN
ajlm-2700	211	16	]	]	PUNCT
ajlm-2700	211	17	.	.	PUNCT
ajlm-2700	212	1	[	[	X
ajlm-2700	212	2	cited	cite	VERB
ajlm-2700	212	3	2021	2021	NUM
ajlm-2700	212	4	oct	oct	NOUN
ajlm-2700	212	5	10	10	NUM
ajlm-2700	212	6	]	]	PUNCT
ajlm-2700	212	7	.	.	PUNCT
ajlm-2700	213	1	available	available	ADJ
ajlm-2700	213	2	from	from	ADP
ajlm-2700	213	3	:	:	PUNCT
ajlm-2700	213	4	https://diagnostics.roche.com/global/en/products/lab/elecsys-pth-cps-000506.html	https://diagnostics.roche.com/global/en/products/lab/elecsys-pth-cps-000506.html	PROPN
ajlm-2700	213	5	.	.	PUNCT
ajlm-2700	214	1	roche	roche	PROPN
ajlm-2700	214	2	cobas	cobas	PROPN
ajlm-2700	214	3	®	®	PROPN
ajlm-2700	214	4	c601/602	c601/602	NOUN
ajlm-2700	214	5	.	.	PUNCT
ajlm-2700	215	1	elecsys	elecsys	PROPN
ajlm-2700	215	2	pth	pth	PROPN
ajlm-2700	215	3	(	(	PUNCT
ajlm-2700	215	4	1	1	NUM
ajlm-2700	215	5	-	-	NUM
ajlm-2700	215	6	84	84	NUM
ajlm-2700	215	7	)	)	PUNCT
ajlm-2700	215	8	.	.	PUNCT
ajlm-2700	216	1	order	order	NOUN
ajlm-2700	216	2	info	info	NOUN
ajlm-2700	216	3	(	(	PUNCT
ajlm-2700	216	4	2019	2019	NUM
ajlm-2700	216	5	-	-	SYM
ajlm-2700	216	6	10	10	NUM
ajlm-2700	216	7	,	,	PUNCT
ajlm-2700	216	8	v	v	NOUN
ajlm-2700	216	9	7.0	7.0	NUM
ajlm-2700	216	10	):	):	PUNCT
ajlm-2700	216	11	ref	ref	NOUN
ajlm-2700	216	12	05608546190	05608546190	NUM
ajlm-2700	217	1	[	[	X
ajlm-2700	217	2	homepage	homepage	NOUN
ajlm-2700	217	3	on	on	ADP
ajlm-2700	217	4	the	the	DET
ajlm-2700	217	5	internet	internet	NOUN
ajlm-2700	217	6	]	]	PUNCT
ajlm-2700	217	7	.	.	PUNCT
ajlm-2700	218	1	[	[	X
ajlm-2700	218	2	cited	cite	VERB
ajlm-2700	218	3	2021	2021	NUM
ajlm-2700	218	4	oct	oct	NOUN
ajlm-2700	218	5	10	10	NUM
ajlm-2700	218	6	]	]	PUNCT
ajlm-2700	218	7	.	.	PUNCT
ajlm-2700	219	1	available	available	ADJ
ajlm-2700	219	2	from	from	ADP
ajlm-2700	219	3	:	:	PUNCT
ajlm-2700	219	4	https://diagnostics.roche.com/global/en/products/lab/elecsys-pth-1-84-cps-000505.html	https://diagnostics.roche.com/global/en/products/lab/elecsys-pth-1-84-cps-000505.html	PROPN
ajlm-2700	219	5	.	.	PUNCT
ajlm-2700	220	1	levey	levey	PROPN
ajlm-2700	220	2	as	as	ADP
ajlm-2700	220	3	,	,	PUNCT
ajlm-2700	220	4	stevens	stevens	PROPN
ajlm-2700	220	5	la	la	PROPN
ajlm-2700	220	6	,	,	PUNCT
ajlm-2700	220	7	schmid	schmid	PROPN
ajlm-2700	220	8	ch	ch	PROPN
ajlm-2700	220	9	,	,	PUNCT
ajlm-2700	220	10	et	et	PROPN
ajlm-2700	220	11	al	al	PROPN
ajlm-2700	220	12	.	.	PUNCT
ajlm-2700	221	1	a	a	DET
ajlm-2700	221	2	new	new	ADJ
ajlm-2700	221	3	equation	equation	NOUN
ajlm-2700	221	4	to	to	PART
ajlm-2700	221	5	estimate	estimate	VERB
ajlm-2700	221	6	glomerular	glomerular	ADJ
ajlm-2700	221	7	filtration	filtration	NOUN
ajlm-2700	221	8	rate	rate	NOUN
ajlm-2700	221	9	.	.	PUNCT
ajlm-2700	222	1	ann	ann	PROPN
ajlm-2700	222	2	intern	intern	PROPN
ajlm-2700	222	3	med	med	PROPN
ajlm-2700	222	4	.	.	PUNCT
ajlm-2700	223	1	2009;15:604–612	2009;15:604–612	X
ajlm-2700	223	2	.	.	PUNCT
ajlm-2700	224	1	https://doi.org/10.7326/0003-4819-150-9-200905050-00006	https://doi.org/10.7326/0003-4819-150-9-200905050-00006	PROPN
ajlm-2700	224	2	aarsand	aarsand	PROPN
ajlm-2700	224	3	ak	ak	PROPN
ajlm-2700	224	4	,	,	PUNCT
ajlm-2700	224	5	fernandez	fernandez	PROPN
ajlm-2700	224	6	-	-	PUNCT
ajlm-2700	224	7	calle	calle	PROPN
ajlm-2700	224	8	p	p	PROPN
ajlm-2700	224	9	,	,	PUNCT
ajlm-2700	224	10	webster	webster	PROPN
ajlm-2700	224	11	c	c	PROPN
ajlm-2700	224	12	,	,	PUNCT
ajlm-2700	224	13	et	et	PROPN
ajlm-2700	224	14	al	al	PROPN
ajlm-2700	224	15	.	.	PUNCT
ajlm-2700	225	1	eflm	eflm	PROPN
ajlm-2700	225	2	biological	biological	ADJ
ajlm-2700	225	3	variation	variation	NOUN
ajlm-2700	225	4	database	database	NOUN
ajlm-2700	226	1	[	[	X
ajlm-2700	226	2	homepage	homepage	NOUN
ajlm-2700	226	3	on	on	ADP
ajlm-2700	226	4	the	the	DET
ajlm-2700	226	5	internet	internet	NOUN
ajlm-2700	226	6	]	]	PUNCT
ajlm-2700	226	7	.	.	PUNCT
ajlm-2700	227	1	[	[	X
ajlm-2700	227	2	cited	cite	VERB
ajlm-2700	227	3	2021	2021	NUM
ajlm-2700	227	4	oct	oct	NOUN
ajlm-2700	227	5	10	10	NUM
ajlm-2700	227	6	]	]	PUNCT
ajlm-2700	227	7	.	.	PUNCT
ajlm-2700	228	1	available	available	ADJ
ajlm-2700	228	2	from	from	ADP
ajlm-2700	228	3	:	:	PUNCT
ajlm-2700	228	4	https://biologicalvariation.eu	https://biologicalvariation.eu	PROPN
ajlm-2700	228	5	mchugh	mchugh	PROPN
ajlm-2700	228	6	ml	ml	PROPN
ajlm-2700	228	7	.	.	PUNCT
ajlm-2700	229	1	interrater	interrater	PROPN
ajlm-2700	229	2	reliability	reliability	NOUN
ajlm-2700	229	3	:	:	PUNCT
ajlm-2700	229	4	the	the	DET
ajlm-2700	229	5	kappa	kappa	PROPN
ajlm-2700	229	6	statistic	statistic	PROPN
ajlm-2700	229	7	.	.	PUNCT
ajlm-2700	230	1	biochem	biochem	PROPN
ajlm-2700	230	2	med	med	PROPN
ajlm-2700	230	3	(	(	PUNCT
ajlm-2700	230	4	zagreb	zagreb	PROPN
ajlm-2700	230	5	)	)	PUNCT
ajlm-2700	230	6	.	.	PUNCT
ajlm-2700	231	1	2012;22:276–282	2012;22:276–282	NUM
ajlm-2700	231	2	.	.	PUNCT
ajlm-2700	232	1	https://doi.org/10.11613/bm.2012.031	https://doi.org/10.11613/bm.2012.031	PROPN
ajlm-2700	232	2	einbinder	einbinder	PROPN
ajlm-2700	232	3	y.	y.	PROPN
ajlm-2700	232	4	,	,	PUNCT
ajlm-2700	232	5	benchetrit	benchetrit	PROPN
ajlm-2700	232	6	s.	s.	PROPN
ajlm-2700	232	7	,	,	PUNCT
ajlm-2700	232	8	golan	golan	PROPN
ajlm-2700	232	9	e.	e.	PROPN
ajlm-2700	232	10	,	,	PUNCT
ajlm-2700	232	11	zitman	zitman	NOUN
ajlm-2700	232	12	-	-	PUNCT
ajlm-2700	232	13	gal	gal	ADJ
ajlm-2700	232	14	t.	t.	ADJ
ajlm-2700	232	15	comparison	comparison	NOUN
ajlm-2700	232	16	of	of	ADP
ajlm-2700	232	17	intact	intact	ADJ
ajlm-2700	232	18	pth	pth	NOUN
ajlm-2700	232	19	and	and	CCONJ
ajlm-2700	232	20	bio	bio	ADJ
ajlm-2700	232	21	-	-	ADJ
ajlm-2700	232	22	intact	intact	ADJ
ajlm-2700	232	23	pth	pth	NOUN
ajlm-2700	232	24	assays	assay	NOUN
ajlm-2700	232	25	among	among	ADP
ajlm-2700	232	26	non	non	ADJ
ajlm-2700	232	27	-	-	ADJ
ajlm-2700	232	28	dialysis	dialysis	ADJ
ajlm-2700	232	29	dependent	dependent	ADJ
ajlm-2700	232	30	chronic	chronic	ADJ
ajlm-2700	232	31	kidney	kidney	NOUN
ajlm-2700	232	32	disease	disease	NOUN
ajlm-2700	232	33	patients	patient	NOUN
ajlm-2700	232	34	.	.	PUNCT
ajlm-2700	233	1	ann	ann	PROPN
ajlm-2700	233	2	lab	lab	PROPN
ajlm-2700	233	3	med	med	PROPN
ajlm-2700	233	4	.	.	PUNCT
ajlm-2700	233	5	2017;37:381–387	2017;37:381–387	PROPN
ajlm-2700	233	6	.	.	PUNCT
ajlm-2700	234	1	https://doi.org/10.3343/alm.2017.37.5.381	https://doi.org/10.3343/alm.2017.37.5.381	PROPN
ajlm-2700	234	2	dupuy	dupuy	PROPN
ajlm-2700	234	3	am	be	AUX
ajlm-2700	234	4	,	,	PUNCT
ajlm-2700	234	5	bargnoux	bargnoux	VERB
ajlm-2700	234	6	as	as	ADP
ajlm-2700	234	7	,	,	PUNCT
ajlm-2700	234	8	morena	morena	PROPN
ajlm-2700	234	9	m	m	PROPN
ajlm-2700	234	10	,	,	PUNCT
ajlm-2700	234	11	et	et	PROPN
ajlm-2700	234	12	al	al	PROPN
ajlm-2700	234	13	.	.	PUNCT
ajlm-2700	235	1	moving	move	VERB
ajlm-2700	235	2	from	from	ADP
ajlm-2700	235	3	the	the	DET
ajlm-2700	235	4	second	second	NOUN
ajlm-2700	235	5	to	to	ADP
ajlm-2700	235	6	the	the	DET
ajlm-2700	235	7	third	third	ADJ
ajlm-2700	235	8	generation	generation	NOUN
ajlm-2700	235	9	roche	roche	NOUN
ajlm-2700	235	10	pth	pth	NOUN
ajlm-2700	235	11	assays	assay	NOUN
ajlm-2700	235	12	:	:	PUNCT
ajlm-2700	235	13	what	what	PRON
ajlm-2700	235	14	are	be	AUX
ajlm-2700	235	15	the	the	DET
ajlm-2700	235	16	consequences	consequence	NOUN
ajlm-2700	235	17	for	for	ADP
ajlm-2700	235	18	clinical	clinical	ADJ
ajlm-2700	235	19	practice	practice	NOUN
ajlm-2700	235	20	?	?	PUNCT
ajlm-2700	236	1	clin	clin	PROPN
ajlm-2700	236	2	chem	chem	NOUN
ajlm-2700	236	3	lab	lab	NOUN
ajlm-2700	236	4	med	me	VERB
ajlm-2700	236	5	.	.	PUNCT
ajlm-2700	237	1	2018;57:244–249	2018;57:244–249	PROPN
ajlm-2700	237	2	.	.	PUNCT
ajlm-2700	238	1	https://doi.org/10.1515/cclm-2018-0300	https://doi.org/10.1515/cclm-2018-0300	INTJ
ajlm-2700	239	1	hecking	hecking	PROPN
ajlm-2700	239	2	m	m	PROPN
ajlm-2700	239	3	,	,	PUNCT
ajlm-2700	239	4	kainz	kainz	PROPN
ajlm-2700	239	5	a	a	PRON
ajlm-2700	239	6	,	,	PUNCT
ajlm-2700	239	7	bielesz	bielesz	PROPN
ajlm-2700	239	8	b	b	NOUN
ajlm-2700	239	9	,	,	PUNCT
ajlm-2700	239	10	et	et	PROPN
ajlm-2700	239	11	al	al	PROPN
ajlm-2700	239	12	.	.	PROPN
ajlm-2700	240	1	clinical	clinical	ADJ
ajlm-2700	240	2	evaluation	evaluation	NOUN
ajlm-2700	240	3	of	of	ADP
ajlm-2700	240	4	two	two	NUM
ajlm-2700	240	5	novel	novel	ADJ
ajlm-2700	240	6	biointact	biointact	NOUN
ajlm-2700	240	7	pth	pth	NOUN
ajlm-2700	240	8	(	(	PUNCT
ajlm-2700	240	9	1	1	NUM
ajlm-2700	240	10	-	-	NUM
ajlm-2700	240	11	84	84	NUM
ajlm-2700	240	12	)	)	PUNCT
ajlm-2700	240	13	assays	assay	NOUN
ajlm-2700	240	14	in	in	ADP
ajlm-2700	240	15	hemodialysis	hemodialysis	NOUN
ajlm-2700	240	16	patients	patient	NOUN
ajlm-2700	240	17	.	.	PUNCT
ajlm-2700	241	1	clin	clin	PROPN
ajlm-2700	241	2	biochem	biochem	PROPN
ajlm-2700	241	3	.	.	PUNCT
ajlm-2700	242	1	2012;45:1645–1651	2012;45:1645–1651	X
ajlm-2700	242	2	.	.	PUNCT
ajlm-2700	243	1	https://doi.org/10.1016/j.clinbiochem.2012.08.006	https://doi.org/10.1016/j.clinbiochem.2012.08.006	PROPN
ajlm-2700	243	2	hashim	hashim	PROPN
ajlm-2700	243	3	sm	sm	PROPN
ajlm-2700	243	4	,	,	PUNCT
ajlm-2700	243	5	tuan	tuan	PROPN
ajlm-2700	243	6	ismail	ismail	PROPN
ajlm-2700	243	7	ts	ts	PROPN
ajlm-2700	243	8	,	,	PUNCT
ajlm-2700	243	9	che	che	PROPN
ajlm-2700	243	10	soh	soh	PROPN
ajlm-2700	243	11	na	na	PROPN
ajlm-2700	243	12	.	.	PROPN
ajlm-2700	243	13	agreement	agreement	NOUN
ajlm-2700	243	14	of	of	ADP
ajlm-2700	243	15	parathyroid	parathyroid	ADJ
ajlm-2700	243	16	hormone	hormone	NOUN
ajlm-2700	243	17	status	status	NOUN
ajlm-2700	243	18	measured	measure	VERB
ajlm-2700	243	19	by	by	ADP
ajlm-2700	243	20	intact	intact	ADJ
ajlm-2700	243	21	and	and	CCONJ
ajlm-2700	243	22	biointact	biointact	VERB
ajlm-2700	243	23	parathyroid	parathyroid	ADJ
ajlm-2700	243	24	hormone	hormone	NOUN
ajlm-2700	243	25	assays	assay	NOUN
ajlm-2700	243	26	among	among	ADP
ajlm-2700	243	27	chronic	chronic	ADJ
ajlm-2700	243	28	kidney	kidney	NOUN
ajlm-2700	243	29	disease	disease	NOUN
ajlm-2700	243	30	patients	patient	NOUN
ajlm-2700	243	31	and	and	CCONJ
ajlm-2700	243	32	its	its	PRON
ajlm-2700	243	33	correlation	correlation	NOUN
ajlm-2700	243	34	with	with	ADP
ajlm-2700	243	35	bone	bone	NOUN
ajlm-2700	243	36	turnover	turnover	NOUN
ajlm-2700	243	37	parameters	parameter	NOUN
ajlm-2700	243	38	.	.	PUNCT
ajlm-2700	244	1	malays	malays	PROPN
ajlm-2700	244	2	j	j	PROPN
ajlm-2700	244	3	med	med	PROPN
ajlm-2700	244	4	sci	sci	PROPN
ajlm-2700	244	5	.	.	PROPN
ajlm-2700	245	1	2023;30:69–82	2023;30:69–82	NUM
ajlm-2700	245	2	.	.	PUNCT
ajlm-2700	246	1	https://doi.org/10.21315/mjms2023.30.2.6	https://doi.org/10.21315/mjms2023.30.2.6	X
ajlm-2700	246	2	o’flaherty	o’flaherty	NUM
ajlm-2700	246	3	d	d	PROPN
ajlm-2700	246	4	,	,	PUNCT
ajlm-2700	246	5	sankaralingam	sankaralingam	PROPN
ajlm-2700	246	6	a	a	PRON
ajlm-2700	246	7	,	,	PUNCT
ajlm-2700	246	8	scully	scully	ADV
ajlm-2700	246	9	p	p	X
ajlm-2700	246	10	,	,	PUNCT
ajlm-2700	246	11	manghat	manghat	DET
ajlm-2700	246	12	p	p	X
ajlm-2700	246	13	,	,	PUNCT
ajlm-2700	246	14	goldsmith	goldsmith	PROPN
ajlm-2700	246	15	d	d	PROPN
ajlm-2700	246	16	,	,	PUNCT
ajlm-2700	246	17	hampson	hampson	PROPN
ajlm-2700	246	18	g.	g.	PROPN
ajlm-2700	247	1	the	the	DET
ajlm-2700	247	2	relationship	relationship	NOUN
ajlm-2700	247	3	between	between	ADP
ajlm-2700	247	4	intact	intact	ADJ
ajlm-2700	247	5	pth	pth	NOUN
ajlm-2700	247	6	and	and	CCONJ
ajlm-2700	247	7	biointact	biointact	NOUN
ajlm-2700	247	8	pth	pth	NOUN
ajlm-2700	247	9	(	(	PUNCT
ajlm-2700	247	10	1	1	NUM
ajlm-2700	247	11	-	-	NUM
ajlm-2700	247	12	84	84	NUM
ajlm-2700	247	13	)	)	PUNCT
ajlm-2700	247	14	with	with	ADP
ajlm-2700	247	15	bone	bone	NOUN
ajlm-2700	247	16	and	and	CCONJ
ajlm-2700	247	17	mineral	mineral	NOUN
ajlm-2700	247	18	metabolism	metabolism	NOUN
ajlm-2700	247	19	in	in	ADP
ajlm-2700	247	20	pre	pre	ADJ
ajlm-2700	247	21	-	-	ADJ
ajlm-2700	247	22	dialysis	dialysis	ADJ
ajlm-2700	247	23	chronic	chronic	ADJ
ajlm-2700	247	24	kidney	kidney	NOUN
ajlm-2700	247	25	disease	disease	NOUN
ajlm-2700	247	26	(	(	PUNCT
ajlm-2700	247	27	ckd	ckd	PROPN
ajlm-2700	247	28	)	)	PUNCT
ajlm-2700	247	29	.	.	PUNCT
ajlm-2700	248	1	clin	clin	PROPN
ajlm-2700	248	2	biochem	biochem	PROPN
ajlm-2700	248	3	.	.	PUNCT
ajlm-2700	249	1	2013;46:1405–1409	2013;46:1405–1409	NUM
ajlm-2700	249	2	.	.	PUNCT
ajlm-2700	250	1	https://doi.org/10.1016/j.clinbiochem.2013.06.023	https://doi.org/10.1016/j.clinbiochem.2013.06.023	PROPN
ajlm-2700	250	2	bekő	bekő	VERB
ajlm-2700	250	3	g	g	PROPN
ajlm-2700	250	4	,	,	PUNCT
ajlm-2700	250	5	butz	butz	ADJ
ajlm-2700	250	6	h	h	NOUN
ajlm-2700	250	7	,	,	PUNCT
ajlm-2700	250	8	berta	berta	PROPN
ajlm-2700	250	9	k	k	PROPN
ajlm-2700	250	10	,	,	PUNCT
ajlm-2700	250	11	et	et	PROPN
ajlm-2700	250	12	al	al	PROPN
ajlm-2700	250	13	.	.	PUNCT
ajlm-2700	251	1	switching	switch	VERB
ajlm-2700	251	2	between	between	ADP
ajlm-2700	251	3	parathyroid	parathyroid	ADJ
ajlm-2700	251	4	hormone	hormone	NOUN
ajlm-2700	251	5	(	(	PUNCT
ajlm-2700	251	6	pth	pth	NOUN
ajlm-2700	251	7	)	)	PUNCT
ajlm-2700	251	8	assays	assay	NOUN
ajlm-2700	251	9	:	:	PUNCT
ajlm-2700	251	10	the	the	DET
ajlm-2700	251	11	impact	impact	NOUN
ajlm-2700	251	12	on	on	ADP
ajlm-2700	251	13	the	the	DET
ajlm-2700	251	14	diagnosis	diagnosis	NOUN
ajlm-2700	251	15	of	of	ADP
ajlm-2700	251	16	renal	renal	ADJ
ajlm-2700	251	17	osteodystrophy	osteodystrophy	PROPN
ajlm-2700	251	18	.	.	PUNCT
ajlm-2700	252	1	clin	clin	PROPN
ajlm-2700	252	2	chem	chem	NOUN
ajlm-2700	252	3	lab	lab	NOUN
ajlm-2700	252	4	med	med	PROPN
ajlm-2700	252	5	.	.	PUNCT
ajlm-2700	253	1	2013;51:1251–1256	2013;51:1251–1256	NUM
ajlm-2700	253	2	.	.	PUNCT
ajlm-2700	254	1	https://doi.org/10.1515/cclm-2012-0485	https://doi.org/10.1515/cclm-2012-0485	PROPN
ajlm-2700	254	2	wójtowicz	wójtowicz	PROPN
ajlm-2700	254	3	m	m	PROPN
ajlm-2700	254	4	,	,	PUNCT
ajlm-2700	254	5	piechota	piechota	PROPN
ajlm-2700	254	6	m	m	PROPN
ajlm-2700	254	7	,	,	PUNCT
ajlm-2700	254	8	wańkowicz	wańkowicz	VERB
ajlm-2700	254	9	z.	z.	PROPN
ajlm-2700	254	10	comparison	comparison	NOUN
ajlm-2700	254	11	of	of	ADP
ajlm-2700	254	12	second	second	ADJ
ajlm-2700	254	13	and	and	CCONJ
ajlm-2700	254	14	third	third	ADJ
ajlm-2700	254	15	generation	generation	NOUN
ajlm-2700	254	16	parathyroid	parathyroid	PROPN
ajlm-2700	254	17	hormone	hormone	NOUN
ajlm-2700	254	18	test	test	NOUN
ajlm-2700	254	19	results	result	NOUN
ajlm-2700	254	20	in	in	ADP
ajlm-2700	254	21	patients	patient	NOUN
ajlm-2700	254	22	with	with	ADP
ajlm-2700	254	23	chronic	chronic	ADJ
ajlm-2700	254	24	kidney	kidney	NOUN
ajlm-2700	254	25	disease	disease	NOUN
ajlm-2700	254	26	.	.	PUNCT
ajlm-2700	255	1	med	med	PROPN
ajlm-2700	255	2	sci	sci	PROPN
ajlm-2700	255	3	monit	monit	PROPN
ajlm-2700	255	4	.	.	PUNCT
ajlm-2700	256	1	2020;26	2020;26	NUM
ajlm-2700	256	2	:	:	PUNCT
ajlm-2700	256	3	e928301	e928301	NOUN
ajlm-2700	256	4	.	.	PUNCT
ajlm-2700	257	1	https://doi.org/10.12659/msm.928301	https://doi.org/10.12659/msm.928301	NOUN
ajlm-2700	257	2	boudou	boudou	NOUN
ajlm-2700	257	3	p	p	NOUN
ajlm-2700	257	4	,	,	PUNCT
ajlm-2700	257	5	ibrahim	ibrahim	PROPN
ajlm-2700	257	6	f	f	PROPN
ajlm-2700	257	7	,	,	PUNCT
ajlm-2700	257	8	cormier	cormier	PROPN
ajlm-2700	257	9	c.	c.	PROPN
ajlm-2700	257	10	thirdor	thirdor	PROPN
ajlm-2700	257	11	second	second	ADJ
ajlm-2700	257	12	-	-	PUNCT
ajlm-2700	257	13	generation	generation	NOUN
ajlm-2700	257	14	parathyroid	parathyroid	ADJ
ajlm-2700	257	15	hormone	hormone	NOUN
ajlm-2700	257	16	assays	assay	NOUN
ajlm-2700	257	17	:	:	PUNCT
ajlm-2700	257	18	a	a	DET
ajlm-2700	257	19	remaining	remain	VERB
ajlm-2700	257	20	debate	debate	NOUN
ajlm-2700	257	21	in	in	ADP
ajlm-2700	257	22	the	the	DET
ajlm-2700	257	23	diagnosis	diagnosis	NOUN
ajlm-2700	257	24	of	of	ADP
ajlm-2700	257	25	primary	primary	ADJ
ajlm-2700	257	26	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	257	27	.	.	PUNCT
ajlm-2700	258	1	j	j	PROPN
ajlm-2700	258	2	clin	clin	PROPN
ajlm-2700	258	3	endocrinol	endocrinol	PROPN
ajlm-2700	258	4	metab	metab	PROPN
ajlm-2700	258	5	.	.	PUNCT
ajlm-2700	259	1	2005;90:6370–6372	2005;90:6370–6372	NUM
ajlm-2700	259	2	.	.	PUNCT
ajlm-2700	259	3	https://doi.org/10.1210/jc.2005-0715	https://doi.org/10.1210/jc.2005-0715	PROPN
ajlm-2700	259	4	bonansea	bonansea	PROPN
ajlm-2700	259	5	tc	tc	PROPN
ajlm-2700	259	6	,	,	PUNCT
ajlm-2700	259	7	ohe	ohe	PROPN
ajlm-2700	259	8	mn	mn	PROPN
ajlm-2700	259	9	,	,	PUNCT
ajlm-2700	259	10	brandao	brandao	PROPN
ajlm-2700	259	11	c	c	PROPN
ajlm-2700	259	12	,	,	PUNCT
ajlm-2700	259	13	et	et	PROPN
ajlm-2700	259	14	al	al	PROPN
ajlm-2700	259	15	.	.	PROPN
ajlm-2700	259	16	experience	experience	NOUN
ajlm-2700	259	17	with	with	ADP
ajlm-2700	259	18	a	a	DET
ajlm-2700	259	19	third	third	ADJ
ajlm-2700	259	20	-	-	PUNCT
ajlm-2700	259	21	generation	generation	NOUN
ajlm-2700	259	22	parathyroid	parathyroid	ADJ
ajlm-2700	259	23	hormone	hormone	NOUN
ajlm-2700	259	24	assay	assay	NOUN
ajlm-2700	259	25	(	(	PUNCT
ajlm-2700	259	26	bio	bio	NOUN
ajlm-2700	259	27	-	-	NOUN
ajlm-2700	259	28	pth	pth	NOUN
ajlm-2700	259	29	)	)	PUNCT
ajlm-2700	259	30	in	in	ADP
ajlm-2700	259	31	the	the	DET
ajlm-2700	259	32	diagnosis	diagnosis	NOUN
ajlm-2700	259	33	of	of	ADP
ajlm-2700	259	34	primary	primary	ADJ
ajlm-2700	259	35	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	259	36	in	in	ADP
ajlm-2700	259	37	a	a	DET
ajlm-2700	259	38	brazilian	brazilian	ADJ
ajlm-2700	259	39	population	population	NOUN
ajlm-2700	259	40	.	.	PUNCT
ajlm-2700	260	1	arch	arch	ADJ
ajlm-2700	260	2	endocrinol	endocrinol	NOUN
ajlm-2700	260	3	metab	metab	NOUN
ajlm-2700	260	4	.	.	PUNCT
ajlm-2700	261	1	2016;60:420–425	2016;60:420–425	NOUN
ajlm-2700	261	2	.	.	PUNCT
ajlm-2700	262	1	https://doi.org/10.1590/2359-3997000000183	https://doi.org/10.1590/2359-3997000000183	PROPN
ajlm-2700	262	2	bilezikian	bilezikian	PROPN
ajlm-2700	262	3	jp	jp	PROPN
ajlm-2700	262	4	,	,	PUNCT
ajlm-2700	262	5	khan	khan	PROPN
ajlm-2700	262	6	aa	aa	PROPN
ajlm-2700	262	7	,	,	PUNCT
ajlm-2700	262	8	silverberg	silverberg	PROPN
ajlm-2700	262	9	sj	sj	PROPN
ajlm-2700	262	10	,	,	PUNCT
ajlm-2700	262	11	et	et	PROPN
ajlm-2700	262	12	al	al	PROPN
ajlm-2700	262	13	.	.	PUNCT
ajlm-2700	262	14	evaluation	evaluation	NOUN
ajlm-2700	262	15	and	and	CCONJ
ajlm-2700	262	16	management	management	NOUN
ajlm-2700	262	17	of	of	ADP
ajlm-2700	262	18	primary	primary	ADJ
ajlm-2700	262	19	hyperparathyroidism	hyperparathyroidism	NOUN
ajlm-2700	262	20	:	:	PUNCT
ajlm-2700	262	21	summary	summary	NOUN
ajlm-2700	262	22	statement	statement	NOUN
ajlm-2700	262	23	and	and	CCONJ
ajlm-2700	262	24	guidelines	guideline	NOUN
ajlm-2700	262	25	from	from	ADP
ajlm-2700	262	26	the	the	DET
ajlm-2700	262	27	fifth	fifth	ADJ
ajlm-2700	262	28	international	international	ADJ
ajlm-2700	262	29	workshop	workshop	NOUN
ajlm-2700	262	30	.	.	PUNCT
ajlm-2700	263	1	j.	j.	PROPN
ajlm-2700	263	2	bone	bone	PROPN
ajlm-2700	263	3	miner	miner	NOUN
ajlm-2700	263	4	.	.	PUNCT
ajlm-2700	264	1	res	re	NOUN
ajlm-2700	264	2	.	.	PUNCT
ajlm-2700	265	1	2022;37:2293–2314	2022;37:2293–2314	NOUN
ajlm-2700	265	2	.	.	PUNCT
ajlm-2700	266	1	https://doi.org/10.1002/jbmr.4677	https://doi.org/10.1002/jbmr.4677	VERB
ajlm-2700	266	2	cavalier	cavalier	ADJ
ajlm-2700	266	3	e	e	NOUN
ajlm-2700	266	4	,	,	PUNCT
ajlm-2700	266	5	vasikaran	vasikaran	NOUN
ajlm-2700	266	6	s	s	PART
ajlm-2700	266	7	,	,	PUNCT
ajlm-2700	266	8	bhattoa	bhattoa	PROPN
ajlm-2700	266	9	hp	hp	PROPN
ajlm-2700	266	10	,	,	PUNCT
ajlm-2700	266	11	heijboer	heijboer	NOUN
ajlm-2700	266	12	ac	ac	PROPN
ajlm-2700	266	13	,	,	PUNCT
ajlm-2700	266	14	makris	makris	VERB
ajlm-2700	266	15	k	k	PROPN
ajlm-2700	266	16	,	,	PUNCT
ajlm-2700	266	17	ulmer	ulmer	PROPN
ajlm-2700	266	18	cz	cz	PROPN
ajlm-2700	266	19	.	.	PUNCT
ajlm-2700	267	1	the	the	DET
ajlm-2700	267	2	path	path	NOUN
ajlm-2700	267	3	to	to	ADP
ajlm-2700	267	4	the	the	DET
ajlm-2700	267	5	standardization	standardization	NOUN
ajlm-2700	267	6	of	of	ADP
ajlm-2700	267	7	pth	pth	NOUN
ajlm-2700	267	8	:	:	PUNCT
ajlm-2700	267	9	is	be	AUX
ajlm-2700	267	10	this	this	PRON
ajlm-2700	267	11	a	a	DET
ajlm-2700	267	12	realistic	realistic	ADJ
ajlm-2700	267	13	possibility	possibility	NOUN
ajlm-2700	267	14	?	?	PUNCT
ajlm-2700	268	1	a	a	DET
ajlm-2700	268	2	position	position	NOUN
ajlm-2700	268	3	paper	paper	NOUN
ajlm-2700	268	4	of	of	ADP
ajlm-2700	268	5	the	the	DET
ajlm-2700	268	6	ifcc	ifcc	NOUN
ajlm-2700	268	7	c	c	PROPN
ajlm-2700	268	8	-	-	PUNCT
ajlm-2700	268	9	bm	bm	PROPN
ajlm-2700	268	10	.	.	PROPN
ajlm-2700	269	1	clin	clin	PROPN
ajlm-2700	269	2	chim	chim	PROPN
ajlm-2700	269	3	acta	acta	PROPN
ajlm-2700	269	4	.	.	PUNCT
ajlm-2700	270	1	2021;15:44–51	2021;15:44–51	NUM
ajlm-2700	270	2	.	.	PUNCT
ajlm-2700	271	1	https://doi.org/10.1016/j.cca.2020.12.022	https://doi.org/10.1016/j.cca.2020.12.022	NOUN